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Abstract
The Aspergillus genus is highly diverse and contains more than 300 species. Several
of these have high impact on society, beneficial as well as harmful, including the
opportunistic pathogen A. fumigatus, the food spoiler A. flavus, the citric acid
and enzyme producer A. niger, and the food fermentor A. oryzae. Aspergillus
species are known to produce a high number of secondary metabolites and have
been shown to have an even higher genomic potential based on the number of
predicted secondary metabolite gene clusters in the genomes. Some secondary
metabolites have bioactivities which are useful medically such as antibiotics, im-
munosupressants, and cholesterol-lowering agents. The Aspergillus whole genus
sequencing project (of which this project is a part of) aims to produce a genome
sequence for a representative strain of each species within the genus. In this thesis,
we investigate both the opportunities and challenges in exploring this genus using
the vast data created from the genome sequencing project. We focus on secondary
metabolism addressing the challenge of how we can identify beneficial bioactive
clusters using the diversity and self-resistance mechanisms. Moreover, we investi-
gate the diversity and similarities of species spanning several sections and across
the Flavi section.
As part of the Aspergillus sequencing project, this thesis work will publish 25
genomes. We have investigated the genome characteristics and used the diversity
of the genomes to create novel insights and hence knowledge-based hypothesis.
To characterize and utilize a bioactive compound industrially, it is important to
know which genes are responsible for the biosynthesis. There are many ways of
linking gene clusters to compounds and here we present an overview of these by
divide them into strategies. Moreover, we have demonstrated the use of some of
the strategies based on comparative genomics and retrobiosynthesis to identify pu-
tative clusters for, among others, the bioactive compounds novofumigatonin and
chlorflavonin, of which the novofumigatonin cluster has been experimentally veri-
fied subsequently [1]. Investigating the Flavi section, we have identified common
traits such as large genomes and a high number of predicted biosynthetic gene
clusters, but also differences such as variations in gene cluster families. Examina-
tion of the phylogeny have led to questions regarding the evolution in the A. flavus
clade and domestication of A. oryzae and A. sojae. The carbohydrate-active en-
zyme (CAZy) potential is large within the Flavi section with a maximum of 663
CAZymes found in A. parasiticus.
With the large number of predicted secondary metabolite gene clusters it is a
challenge to select the most promising clusters and prioritize the experimental ef-
vforts in the quest of novel bioactive compounds. In order to overcome this challenge
we have developed a pipeline, FRIGG (Fungal ResIstance Gene-directed Genome
mining), using genome sequences to identify putative bioactive gene clusters based
on duplicated self-resistance genes. This pipeline thereby provides a means of se-
lecting which clusters to investigate and dramatically shortens the experimental
process. Applying the pipeline to 51 Aspergillus and Penicillium species, we have
identified a total of 72 protein families with putative resistance genes found in
clusters including the verified resistance gene for fellutamide B. We selected a
cluster for experimental investigation and preliminary results indicate it could be
producing N-acetyl-glutamine which have shown bioactivity as a psycostimulant
and in a complex with aluminium as an antiulcer agent and [2, 3, 4].
In summary, this work has not only contributed to to the Aspergillus commu-
nity with new genome sequences and insights from comparative genomics analysis,
but also with strategies to link gene clusters and compounds and a pipeline identi-
fying putative resistance genes and bioactive clusters. In the future, this pipeline
can be used as a guide in the quest for novel bioactive compounds, which are des-
perately needed. The exploration of the newly sequenced genomes has only just
started with our generated insights and hypothesis and it will continue to move
the field forward gaining many more insights in the time ahead.
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Aspergillus slægten er meget divers og indeholder mere end 300 arter, hvoraf flere
har stor indvirkning p˚a samfundet; gavnlige s˚avel som skadelige. Dette inkluderer
den opportunistiske patogen A. fumigatus, den afgrøde ødelæggende A. flavus,
citronsyre og enzym producenten A. niger samt A. oryzae, som bruges til i det
asiatiske køkken til fermentering. Aspergillus arter er kendte for at producere et
højt antal sekundære metabolitter, desuden har de udvist et højt genomisk po-
tentiale baseret p˚a antallet af forventede sekundære metabolit genclustre fundet
i genomerne. Nogle sekundære metabolitter har bioaktiviteter, som er brugbare
medicinsk s˚asom antibiotika, immunosuppressiver, og kolesterol sænkende stoffer.
Aspergillus hel-slægts sekventeringsprojektet (hvilket dette projekt er en del af)
sigter efter at generere en genomsekvens for repræsentative stammer af hver art i
slægten. I denne afhandling, undersøger vi b˚ade de muligheder og udfordringer,
der er forbundet med at udforske slægten ved brug af den enorme mængde data
genereret af sekventeringsprojektet. Vi fokuserer p˚a sekundær metabolisme og
adresserer udfordringen af, hvordan vi identificerer bioaktive genclustre ved at
bruge diversiteten og selv-resistensmekanismer. Derudover undersøger vi diver-
siteten og lighederne mellem arter fra forskellige dele af slægten samt p˚a tværs af
Flavi sektionen.
Som en del af Aspergillus sekventeringsprojektet kommer denne afhandling
til at publicere 25 genomer. Vi har undersøgt genom-egenskaberne samt brugt
genomerne til at f˚a nye indblik og dermed lave videns baserede hypoteser. For
at karakterisere og kunne bruge bioaktive stoffer industrielt er det vigtigt at vide
hvilke gener, som er ansvarlige for biosyntesen. Der findes mange m˚ader at koble
genclustre og stoffer p˚a, vi har skabt et overblik over disse ved at dele dem ind
i strategier. Derudover har vi vist brugen af nogle af disse strategier baseret p˚a
sammenlignende genom-analyser og retro-biosyntese til at identificere formodede
genclustre for blandt andet de bioaktive stoffer novofumigatonin og chlorflavonin,
hvor novofumigatonin clusteret efterfølgende er blevet verificeret eksperimentelt
[1]. Ved at undersøge sektion Flavi har vi identificeret fælles træk s˚a som store
genomer og et højt antal forventede biosyntetiske genclustre, men ogs˚a forskelle
som variationer i cluster familier. Undersøgelse af fylogenien har ført til spørgsm˚al
vedrørende udviklingen i A. flavus claden samt domesticering af A. oryzae og A.
sojae. Det kulhydrataktive enzym potentiale er ogs˚a stort indenfor sektion Flavi
med 663 enzymer fundet i A. parasiticus som det højeste.
Med det enorme antal formodede sekundære metabolit genclustre er det en
udfordring at udvælge de mest lovende clustre og prioritere den eksperimentelle
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indsats i jagten efter nye bioaktive stoffer. For at overkomme denne udfordring har
vi udviklet en pipline, FRIGG (Fungal ResIstance Gene-directed Genome mining),
som bruger genomsekvenser og den genetiske diversitet til at identificere mulige
bioaktive genclustre baseret p˚a et duplikeret selv-resistensgen. Dette giver dermed
en m˚ade at udvælge hvilke genclustre, man skal fokusere p˚a og undersøge, hvilket
drastisk forkorter processen. Ved at anvende pipelinen p˚a 51 Aspergillus og Peni-
cillium arter har vi identificeret 72 protein familier med formodede resistensgener,
som er fundet i genclustre inklusiv det verificerede resistensgen for fellutamid B.
Vi udvalgte et gencluster til eksperimentel undersøgelse og de foreløbige resultater
indikerer, at det kan være N-acetyl-glutamin, som clusteret producerer hvilket har
udvist bioaktivitet mod maves˚ar (i et kompleks med aluminium) og som psykos-
timulerende stof [2, 3, 4].
Samlet set har dette arbejde ikke alene bidraget til Aspergillus forskningsfeltet
med nye genomer og indblik fra sammenlignende genom-analyser men ogs˚a med
strategier til at koble genclustre og stoffer samt en pipeline, som identificerer
mulige resistensgener og bioaktive clustre. I fremtiden kan den udviklede pipeline
blive brugt som guide i jagten efter nye bioaktive stoffer, hvilket der er et stort
behov for. Udforskningen af de ny-sekventerede genomer er kun lige begyndt med
vores undersøgelser og frembragte hypoteser. Denne ressource vil fortsætte med at
flytte forskningsfeltet og være et vigtigt aktiv for fremtidige forskningsresultater
og indsigter.
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1 Chapter 1. Introduction
1 Introduction
1.1 Project motivation
The fungal kingdom is a highly diverse group of organisms growing in most habi-
tats on earth estimated to include up to 5.1 million species which are extremely
important in ecosystems as decomposers and essential associates of other organ-
isms [5, 6]. Moreover, fungal species can cause damaging infections in plants as
well as animals and humans and thereby pose a serious threat to society. Fun-
gal infections in plants have long been a recognized problem, one that has even
changed human history with the late blight that led to the Irish potato famine.
Plant fungal infections are still a serious problem recognized as a threat to food se-
curity [7, 8]. More recently, fungal infections are also being recognized as a threat
to animal health and ecosystems [8] and fungal infections also contribute substan-
tially to human morbidity and mortality, but is often overlooked. The mortality
rate of invasive fungal infections is extremely high (often more than 50%) and it
is estimated that more than 1.5 million die from fungal infections every year [9].
Invasive fungal infections often affect immunocompromised patients (due to organ
transplant or other underlying diseases) and it is an increasing problem [10, 11,
12, 9].
There are few available drugs treating fungal infections; these can be divided
into three classes by the mode of action; triazoles and allylamines targeting ste-
role synthesis, polyenes and echindocandins targeting the cell wall, and pyrimidine
analogs (flucytosine) targeting DNA synthesis [13, 9]. The global market for an-
tifungal drugs was valued to $13.1 billion in 2016 and is estimated to increase
and reach $16.1 billion by 2021 [14]. Recently emerging resistance to azoles has
been seen in Aspergillus species [15, 16, 17] and it has been suggested that the
increasing resistance in environmental samples is caused by the massive use of
azole fungicides for plant protection in agriculture [18, 19].
The current status is thus the following; fungal infection pose a serious threat
to food security, there is an increasing number of invasive fungal infections with
high mortality rates, few antifungal agents, and a rise of resistance. This situation
desperately calls for action.
Ironically many antifungal compounds (such as griseofulvins and echinocan-
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dins) are naturally produced by fungi, thus making them an excellent source of
novel antifungals. Especially the Aspergillus genus is known to produce an extraor-
dinary number of bioactive compounds (eliciting pharmacological or toxicological
effects) known as secondary metabolites [20]. Several of these have been used
extensively in the medical industry including the antibiotic penicillin [21] and
cholesterol-lowering lovastatin [22]. Under standard laboratory conditions only
relatively few compounds are produced, but whole genome sequences of A. nidu-
lans, A. oryzae and A. fumigatus have revealed a much larger potential [23, 24,
25, 26]. As of 2015 a collaboration between JBEI, DTU, and JGI started genome
sequencing all the species in the Aspergillus genus, the so-called Aspergillus whole
genus sequencing project. This project has dramatically increased the available
amount of data and the potential of finding novel antifungals. In order to ex-
ploit this rich natural resource and fully reap the benefits, the bioactive secondary
metabolites have to be identified and knowledge of the biosynthetic gene cluster
and the target gene have to be obtained.
The objective of this PhD is not only to rationally identify bioactive secondary
metabolites such as new antifungals but also to establish the links to the biosyn-
thetic genes and the target. Furthermore we will advance the comparative genomic
research of the Aspergillus genus to get a deeper understanding of these important
species and their potential uses.
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1.2 Project aim and outline
This project falls within the three interrelated subjects; secondary metabolites,
biosynthetic gene clusters, and targets affected by secondary metabolites, all con-
nected by genome mining. The unique resource of data from the Aspergillus genus
project as well as publicly available genome sequences was used in this project.
The overall aim of this PhD project was to investigate and establish links between
these three subjects – secondary metabolites, genes, and targets. To fulfill this
goal, four objectives are laid out:
1. Develop methods for linking compounds and clusters using whole genome
sequences and comparative genomics.
2. Publish 25 Aspergillus genome sequences to support genome-driven research
in the Aspergillus genus.
3. Describe and investigate the biological and chemical diversity found within
Aspergillus species using comparative genomics.
4. Identify and verify clusters containing putative resistance genes using genome
sequences.
These aims are addressed throughout the thesis which is is divided into chapters.
The chapters are outlined here briefly:
Chapter 2 provides background for the project, introducing the genus As-
pergillus, secondary metabolism, self-resistance mechanisms, and methods of link-
ing compounds to clusters and vice versa which are presented in manuscript I.
This chapter gives the background needed for the following chapters in addition
to explaining state-of-the-art strategies for linking compounds and clusters hence
addressing aim 1.
Chapter 3 is concerned with comparative genomics and the uses of compar-
ative genomics in linking compound to cluster thereby related to both aims 1, 2
and 3. The chapter includes one published paper and manuscript II. The paper
compares the genomes of 13 species and uses this to identify putative biosynthetic
gene clusters for specific compounds. Furthermore it compares the opportunistic
pathogen A. fumigatus to the closely related species A. novofumigatus to identify
allergens and pathogenicity factors. The manuscript compares 23 section Flavi
species investigating the diversity, the secondary metabolism, and carbohydrate
active enzyme potential across the section.
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Chapter 4 presents a pipeline developed for resistance gene directed genome
mining. It includes manuscript III demonstrating the pipeline and results from a
test dataset of 51 Aspergillus and Penicillium species. It is followed by a section
concerning the investigation of a selected cluster with a putative resistance gene.
The third and fourth aim is thereby addressed in this chapter.
Chapter 5 summarizes the work and includes a few future perspective.
The Appendix includes additional figures, tables, and information from the
paper, chapters, and manuscripts and is ordered based on the sections.
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2 Background
2.1 Aspergillus – a genus with a large impact
The Aspergillus genus is a highly diverse group of filamentous fungi containing
more than 300 species [27]. The species are widely distributed worldwide and
have an enormous impact on society, beneficial as well as harmful [27, 28]. The
genus is currently divided into four subgenera (Aspergillus, Circumdati, Fumigati
and Nidulantes) and further into 20 sections [29, 30].
The main harmful effects include human infections by pathogenic species and
food spoilage by mycotoxin producers. A. fumigatus is an important opportunis-
tic pathogen and the major cause of Aspergillosis which causes severe and often
fatal infections in humans [31, 32, 33]. This is a growing problem due to the
increasing number of immunocompromised patients [31, 34, 33]. In addition,
several members of the Aspergillus genus are known as food and feed spoilers in-
fecting crops and producing mycotoxinc [35]. Aflatoxin an important and highly
toxic compound is produced by A. flavus and A. parasiticus which infects corn
and peanuts. The toxicological effect depends on the exposure but ranges from
acute effects, including rapid death, and chronic outcomes such as liver cancer [36,
35, 37]. Other important toxins produced by members of the Aspergillus genus
include ochratoxins, fumonisins, patulin, gliotoxin and cyclopiazonic acid [35].
On the beneficial side, Aspergillus species are used in industrial production of
enzymes and medical compounds as a model organism for microbiology studies
and for food fermentation. The Aspergillus genus include some major industrial
workhorses such as A. niger widely used for citric acid production [38, 39, 40]
and enzyme production [38, 41, 42]. A. oryzae is also extensively used for enzyme
production since it naturally secretes a high amount of enzymes [41, 42, 43]. Both
A. niger and A. oryzae have obtained the status of ’Generally regarded as safe’
(GRAS) for several processes [38, 44]. Another use of A. oryzae along with A. so-
jae is in food fermentation which has a very long history of use in Asian countries
for the production of miso (bean curd seasoning), soy sauce, and sake [44, 45, 46].
In addition, A. nidulans is used as a classical model organism for developmental
studies and gene regulation aiding the understanding of filamentous fungi [47]. Be-
sides the aforementioned toxic compounds, members of Aspergillus also produce
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many medically useful compounds [20] including the cholesterol-lowering lovas-
tatin produced by A. terreus [48] and the antibiotic penicillin produced by A.
nidulans [49]. Members of the Aspergillus genus are known to produce a high
number of these beneficial and toxic compounds (also known as natural products)
with an average of 5.77 compounds per species which is significantly higher than
the sister genus Penicillium producing 3.77 compounds per species [50, 35].
The genomics era of Aspergillus was accelerated in 2005 when A. fumigatus,
A. nidulans and A. oryzae were whole genome sequenced [25, 23, 24]. Quickly
more species followed [51, 52, 53, 54] and investigation of the genomes not only
revealed an immense diversity but also a hidden potential of natural products [26,
55]. Predictions based on the genome sequences indicated that the number of
potential compounds could be 10 times higher than the compounds detected by UV
and MS [26, 50]. Following the whole genome sequencing, comparative genomics
studies have provided insights into evolution of the genus, the species concept,
genome dynamics and pathogenicity [56, 57, 58, 59]. In addition it became the
start of genome mining for novel natural products [60, 55].
To take the genomics era of Aspergillus to the next level, the Aspergillus
whole genus sequencing project was initiated with the aim of sequencing a rep-
resentative of each species from the entire Aspergillus genus comprising more
than 300 species [27]. This ambitious project was started in 2013 by a col-
laboration of researchers from the Technical University of Denmark, Westerdijk
Fungal Biodiversity Institute, DoE Joint BioEnergy Institute and Joint Genome
Institute. Another fungal sequencing project, the 1000 fungal genomes (http:
//1000.fungalgenomes.org/home/), has the purpose of capturing as much diver-
sity as possible across the fungal kingdom sequencing representatives from each
of the recognized fungal families covering large evolutionary distances. Hence it
will provide reference genomes for future studies and help advance diverse research
fields of plant-microbe interactions, microbial emission and capture of greenhouse
gasses, and environmental metagenomic sequencing. The Aspergillus sequencing
project has another more focused purpose mapping the similarities and differences
of an entire genus. Having many members from the same genus gives the oppor-
tunity to identify traits and mapping genotype to phenotype, this is also ideal
for genome mining searching for specific features. The Aspergillus project will
provide an unseen dataset for the fungal research community which will be used
to, gain a deeper understanding of the evolution of the genus, obtain insights for
optimization of fungal cell factories, and discover novel natural products.
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2.2 Secondary metabolism
As mentioned earlier, members of the Aspergillus genus are known to produce
a wide range of natural products, also known as secondary metabolites (SMs).
Secondary metabolites are, unlike primary metabolites, not essential for normal
growth or the survival of the producing organism but they play adaptive roles
for example by functioning as signaling molecules in ecological interactions or as
defence compounds thereby giving the organism survival benefits [61, 26, 62, 49].
The properties that provides the beneficial survival attributes have also found
applications in pharmacology which has ensured significant research within the
field of secondary metabolism and drug discovery [63].
The genes responsible for producing secondary metabolites are, most com-
monly, organized in gene clusters on the genome and they are typically co-regulated
[64, 65, 62, 55]. These biosynthetic gene clusters most often consist of 1) one or
more backbone gene(s) responsible for production of the core structure of the
compound, 2) potentially tailoring enzymes decorating or modifying the core
structure and 3) possibly other genes not directly involved in the biosynthesis
of the compound such as regulators, transporters and self-resistance genes [26,
62, 65]. Although secondary metabolites are highly diverse and chemically com-
plex, they are all derived from a limited number of precursors from primary
metabolism [26]. The biosynthetic backbone genes can therefore be categorized
based on the precursors they use; polyketide synthases (PKSs), non-ribosomal pep-
tide synthetases (NRPSs), terpene cyclases (TCs) and prenyltransferases/dimethy-
lallyl transferases (DMATs) [65, 66].
The most common backbone genes are PKSs followed by NRPSs. Both are so-
called mega-enzymes consisting of several active domains. PKSs assemble simple
acyl units using Claisen C–C bond formation which can be followed by various de-
grees of reduction or methylation. PKSs in fungi can use each domain several times
and are therefore called iterative. Depending on the domains and the polyketide
produced, the PKSs can be divided into highly reducing (HR) or partially reduc-
ing making macrolides and non-reducing (NR) creating aromatic compounds [67,
68, 69]. NRPSs assembles amino acids into small peptides. Unlike the PKSs, the
NRPSs in fungi only use each domain once and hence the enzyme is ordered in
modules where each module is responsible for the addition of one unit [69, 70].
Examples of polyketide-derived compounds includes the cholesterol lowering com-
pound, lovastatin [22, 71] and cladosporin with bioactivities counting antifungal,
antibiotic, plant-growth inhibitory properties, anti-inflammatory responses and
antimalarial [72]. Cladosporin is produced by a combination of a HR- and a NR-
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PKS. Well-known non-ribosomal peptides include the anti-fungal echinochandin
which is produced by a six-module NRPS in among others Aspergillus rugulo-
sus [73]. The immunosuppressant drug cyclosporin also shows both antifungal
and antiviral activity, it is produced by an 11 module NRPS by Tolypocladium
inflatum [74]
2.3 Self resistance mechanisms
Fungi can encounter a wide range of environments and have developed ways of
avoiding attacks from biotic agents and coping with abiotic agents such as chemi-
cals, fungicides, salt etc. These coping mechanisms are also known as resistance.
Here we focus on a specific kind of resistance, resistance to the factors the fungi
produce themselves, self-resistance.
Detoxification DuplicationTransportation 
Inside
Outside Compartment
Insensitive Target
More Target
Figure 2.1 Self-resistance mechanisms to secondary metabolites. Detoxification
– the bioactive toxic form of the secondary metabolite is modified to a nontoxic
version within the cell. Transportation – the secondary metabolite is exported
from the cell or kept in certain enclosed compartments. Duplication – the tar-
get gene affected by the secondary metabolite is duplicated and either the sheer
number of extra target proteins give the resistance, or the duplicated version is
insensitive and can tolerate the secondary metabolite.
Many secondary metabolites (SMs) provide certain advantages to the fungi
since they have some bioactivity. The bioactivity of the SM is often a result of
the SM attacking essential cellular proteins where many of them are also found
in the fungi producing that specific SM. In order to avoid the harmful effects
and suicide, the producing fungi needs to develop protective mechanisms, self-
resistance [63]. These self-resistance mechanisms have been seen to be embedded
in the biosynthetic gene cluster encoding the bioactive SM and can be divided
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into three main strategies 1) detoxification of the SM 2) transportation of the
SM and 3) duplication of the target gene. These mechanisms were reviewed for
antibiotic producing bacteria already in the seventies and eighties [75, 76] but
have until recently only attracted little attention in fungi and hence only few
fungal examples are characterized.
The detoxification strategy is essentially a mechanism where the fungus pos-
sesses an additional enzyme modifying the chemical structure of the SM thereby
preventing the molecule from binding to its target (or making the binding less
effective). An example of this strategy is found in the gliotoxin cluster in A. fumi-
gatus, where GliT (an oxidoreductase) modifies the gliotoxin structure creating a
less toxic compound within the producing fungi whereas other fungi do not have
this mechanism and are therefore attacked by the toxin [77, 78].
The transportation strategy covers both exportation and compartmentaliza-
tion of the compound. This is one of the best known strategies fungi use to get rid
of toxic materials in general and this mechanism is also found in biosynthetic gene
clusters. Transporter genes such as the ABC superfamily and major facilitator
superfamily (MFS) are often found in biosynthetic gene cluster. These can have
many functions such as transportation of precursors into the cells, transporta-
tion of intermediates to subcellular compartments, ensuring that the compounds
reach the extra-cellular environment or as self-protection mechanism transport-
ing the toxic compound out of the cell or into a specific compartment [63]. In the
gliotoxin cluster, the transporter gliA encodes a highly effective eﬄux pump which
is involved in resistance to gliotoxin [78]. Tri12 encodes a MSF-type transporter
located within the trichothecenes cluster and it has been shown to be involved
in self-resistance [79, 80]. There are also several examples of transporters not
located within a biosynthetic gene cluster conferring resistance [81]. The localiza-
tion within the cell is a less studied aspect of secondary metabolite biosynthesis,
but recently it has been shown to be an important factor in successful SM biosyn-
thesis and in self-resistance [63, 82]. One example is aflatoxin production in A.
parasiticus, which is carried out in several different vesicles including the special-
ized aflatoxisomes thought to confer self-resistance [83, 84, 63]. The production of
penicillin, deoxynivalenol and trichothecene have also been shown to be compart-
mentalized [82, 63].
The third self-resistance mechanism is ’duplication of the target gene’. The
resistance can originate from two different mechanisms; sheer numbers – having
overexpressed and hence more of the target protein or insensitivity – or having
a modified insensitive version of the target gene. There are several examples of
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clusters containing a second version of the target genes including the lovastatin,
compactin, and fumagillin clusters [85, 71, 86]. These are hypothesized to confer
resistance, but whether the mechanism is due to more copies or if the duplicated
version is insensitive is not known. The mycophenolic acid cluster was identified
based on the resistance gene, a duplication of the target gene, IMP dehydrogenase
(IMPDH) [87]. It has later been shown that the second copy is an insensitive ver-
sion conferring resistance [88, 89]. More recent examples of this mode of resistance
include the fellutamide B cluster [90] and the aspterric acid [91] indicating that
this mode of resistance might be more widely distributed than previously known.
Despite utilizing one of these strategies the producing fungi can also be slightly
affected since the resistance mechanism might ensure survival but not completely
unaffected cells. However as long as the producing fungi is surviving better than
the others it is a viable tactic.
2.4 Manuscript I – Review: linking compounds and gene
clusters
Only a small fraction of the enormous natural resource of biological and chemical
diversity have been explored thus leaving a large untapped potential. In order
to exploit this resource for novel pharmaceutical and industrial uses and creating
economically viable cell factories it is important to establish the link between the
compound and the gene clusters. Here we present a review, Manuscript I, where we
have outlined various strategies for linking biosynthetic gene cluster to compounds
and vice versa.
Manuscript I will be submitted to Fungal Genetics and Biology.
Strategies to establish the link between biosynthetic gene clusters
and compounds
Inge Kjæbøllinga, Uffe H. Mortensena, Tammi Vestha, Mikael R. Andersena
aTechnical University of Denmark
Abstract
Filamentous fungi produce a vast number of bioactive secondary metabolites (SMs) where
some have found applications in the pharmaceutical industry including antibiotics and im-
munosuppressants. As more and more species are whole genome sequenced the number of
predicted clusters is ever increasing - holding a promise of novel useful bioactive SMs. To be
able to fully utilize the potential of novel SMs it is necessary to link the SM and the genes
responsible for producing it. This can be very challenging but there are many strategies and
tools developed for this purpose. In this review we provide an overview of the methods used
to establish the link between SM and biosynthetic gene cluster and vice versa, along with
the challenges and advantages of each of the methods.
Keywords: Secondary Metabolites, Biosynthetic Gene Clusters, Filamentous fungi
1. Introduction1
Fungal secondary metabolites (SMs) are a unique and extraordinary source of bioactive2
SMs including both medically utilized and novel promising SMs. The best known exploited3
fungal bioactive SMs includes antibiotics such as penicillin and cephalosporin, hypercholes-4
terolaemic agents such as lovastatin, immunosuppressants such as cyclosporinand mycophe-5
nolic acid, as well as antifungals such as echinocandin and derivatives [54, 47, 86]. Besides6
the SMs with beneficial properties, fungal SMs also includes harmful toxins. The most car-7
cinogenic toxins aflatoxins are produced by members of the genus Aspergillus [10]. Other8
toxins are detrimental to human, animal and plant health including fumonisins, ochratoxin9
and gliotoxin [10, 59].10
The genes responsible for producing the SMs are arranged in clusters on the genome usu-11
ally containing an enzyme creating the core structure of the compound (backbone enzymes),12
tailoring enzymes, and potentially regulatory enzymes and resistance genes, such as trans-13
porters [79, 20]. The most common backbone enzymes are polyketide synthases (PKSs) or14
a non-ribosomal peptide synthetases (NRPSs), which both have highly conserved domains.15
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Due to the highly conserved domains of the backbone genes and the arrangement of the16
genes in clusters it is possible to predict secondary metabolite gene clusters in genomes with17
sequence domain and knowledge-based algorithms such as SMURF and antiSMASH [55, 15].18
There are however also secondary metabolite gene clusters (SMGCs) that do not follow the19
conventions and therefore they are difficult to predict using these algorithms, this includes20
tryptoquivaline in A. clavatus [43] and the echinocandin in Emericella rugulosa [23] which21
are split in two parts. Some cluster types are not easily detected by the prediction algo-22
rithms such as terpenoid based clusters since the terpene synthase are not as conserved as23
PKS and NRPS. Extra genome mining have to be done to identify them as demonstrated24
by Bromann et al. [21].25
With an ever increasing number of whole genome sequenced fungal strains and species,26
it is clear that the number of SMGCs far exceeds our expectations from known SMs and the27
number of expressed clusters. This indicates a big potential of novel useful bio-active SMs.28
To fully understand and exploit the rich resource of fungal SMs, it is important to29
establish the link between the SM and the SMGC, both to be able to discover novel SMs30
but also to optimize production of the SMs, to make it feasible for an industrial setting.31
Knowing which genes are responsible for the production of a SM makes it possible to use32
metabolic engineering strategies to make an economically viable process which is essential33
in unlocking the potential of fungal SMs. Here we present an overview of various strategies34
that can be used to discover the connection between a SM and gene cluster. The aim of35
this review is to give an overview of strategies that have been used to study secondary36
metabolism in fungi, illustrated by selected examples.37
This review consists of two main parts: 1) Forward strategies going from cluster to SM38
and 2) Reverse strategies going from SM to cluster. The forward strategies are divided into39
two parts: native and heterologous strategies. These are further divided into strategies for40
active and silent clusters for native hosts, while the heterologous strategies are divided into41
hosts and constructs. The reverse strategies are divided into three parts depending on the42
approach: 1) Homology search 2) Retro-biosynthesis and 3) Comparative genomics.43
2. Forwards strategies from cluster to secondary metabolite44
In our definition, the starting point of the forward strategies is an identified biosynthetic45
gene cluster of interest and a wish to elucidate the produced secondary metabolite (SM).46
At this initial point the first thing to consider is the species the cluster is identified in. This47
is crucial for which strategy to use – native or heterologous – expression. Each of these48
strategies will be outlined and discussed in detail below.49
2.1. Strategies in native hosts50
If the secondary metabolite gene cluster (SMGC) of interest is found in a suitable host,51
with established molecular tools and is cultivatable in the laboratory, there are several52
strategies that can be employed. Which to choose depends mainly on the native activity of53
the cluster, if the cluster is expressed it is called active and if it is not expressed it is denoted54
silent. This information is often not known initially, but can be investigated directly by55
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reverse transcription polymerase chain reaction (RT-PCR) or globally with transcriptomics56
or proteomics. The examination of a SMGC is usually not a single process and often it57
requires a combination of various strategies to clarify the link between secondary metabolite58
and secondary metabolite gene cluster and to elucidate the biosynthesis.59
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Figure 1: Strategies for investigating a cluster in the native host. On top are the strategies useful for
active (expressed) secondary metabolite gene clusters, A1 – gene deletion and A2 – the generation of a gene
deletion library. At the bottom the strategies used for silent (not expressed) gene clusters are illustrated,
S1 – overexpression of a global or cluster specific transcription factor, S2 – promoter exchange of all the
biosynthetic genes, S3 – using various environmental stimuli (change pH, tempearure, media components
or co-culture with other microorganisms) to change the expression profile, S4 – epigenetics or chromatin
remodelling wither by adding compounds monipulating the epigenome or by gene deletions of epigenetic
regulators.
2.1.1. Gene deletion or disruption strategies in active clusters60
Cluster specific gene deletions or disruptions. If a secondary metabolite gene cluster (SMGC)61
is active under some known condition, it is possible to make gene deletions, disruptions or62
silencing in the cluster to elucidate the pathway or simply to couple the cluster to a secondary63
metabolite (SM), see Figure 1 A1. By comparing the chemical spectrum of a wild type with64
the modified strain, it is possible to identify the SM missing in the modified strain and65
potentially identify intermediates in the biosynthetic pathway.66
3
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The strategy of gene deletions (Figure 1 A1) has been used in countless studies. Disrup-67
tion of the FUM5 gene combined with complementation studies revealed the involvement68
in fumonisin production in Gibberella fujikuroi [84]. Later FUM6-FUM9 were identified in69
Fusarium verticillioides, analysed and disrupted showing that these genes are also involved70
in Fumonisins production [93]. To investigate the red pigment aurofusarin produced by71
Fusarium pseudograminearum and F. graminearum Malz et al. created aurofusarin defi-72
cient mutants using first random mutagenesis revealing a locus of interest including a PKS,73
PKS12. To confirm the PKS12 gene involvement in aurofusarin production a targeted74
gene disruption was performed [66]. The cyclopiazonic acid (CPA) biosynthetic genes were75
identified in Aspergillus flavus where three genes were disrupted and two of these mutants76
completely abolished CPA production [25]. In A. niger, the albA gene was shown to be77
responsible for the production of pigments as well as naphtho-γ-pyrones through a deletion78
study. This helped identify the link between SM and genes. In addition, it created a useful79
strain for further analysis since some of the main SMs produced by A. niger are disposed of,80
resulting in a more clean background strain [26]. In some cases gene deletion or disruption81
has turned out not to be possible and RNA silencing has been used as an alternative. This82
was seen in a study identifying the cytochalasin gene cluster in Penicillium expansum [92].83
The advantage of the gene deletion strategy is that it is a straight-forward approach often84
resulting in establishing links between secondary metabolites and the responsible genes, while85
the drawbacks are that it requires an expressed cluster, a cultivable organism and molecular86
tools. Many clusters are not active under standard laboratory conditions and several studies87
have thus combined deletion strategies with other methods such as transcription factor88
overexpression. One example of this is a study by Neubauer et al. where a transcription89
factor was overexpressed to activate a cluster, followed by gene deletions thereby identifying90
the ergochrome gene cluster in Claviceps purpurea [74]. More examples will be given under91
the respective combination strategy in the following sections. Another limitation of the92
deletion strategy is that it is highly sensitive to the methods used both during extraction93
and isolation. The SM of interest needs to be detectable with the extraction method used94
and isolated in amounts above the detection limit of the instrument. It is therefore essential95
to select which methods to use depending on the SM of interest.96
Gene deletion libraries. A further sophistication of the deletion strategy focusing on one97
secondary metabolite gene cluster (SMGC) of interest is the generation of deletion libraries,98
Figure 1 A2. Nielsen et al. generated a polyketide synthases (PKS) deletion library, deleting99
each of the 32 predicted PKSs in A. nidulans where a few were already known. By growing100
the mutants on various media and comparing with the reference, they were able to identify101
PKSs involved in arugosins, violaceol, austinol and dehydroaustinol biosynthesis [75]. In a102
similar study in Gibberella zeae, 15 PKSs were disrupted and known SMs such as zearalenone,103
aurofusarin, fusarin C and the black perithecial pigment were linked to specific genes [41].104
Another deletion library focused on the regulatory genes in A. nidulans, where 128 kinases105
were deleted. In this study it was observed that the secondary metabolism was affected106
in several of the mutants [33]. Yaegashi et al. screened this knockout library for changes107
in secondary metabolism. They found the SM aspernidine A and identified the secondary108
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metabolite genes in A. nidulans [109].109
Using a panel of deletion mutants in the manner presented above has a great potential110
for future studies, given the developments in genome editing technologies for fungi sparked111
by the CRISPR-Cas9 technologies [78].112
2.1.2. Strategies for triggering activation of silent secondary metabolite gene clusters113
With the sequencing of the first fungal genomes, one of the major discoveries was that114
the number of secondary metabolite gene clusters (SMGCs) greatly outnumbered the known115
SMs thereby revealing an even bigger resource but also showing that most SMGCs are not116
active or active enough to produce a detectable amount of SM during standard laboratory117
cultivation [54, 77, 80, 91]. The gene clusters that are not expressed during standard con-118
ditions are often referred to as silent, while gene clusters where the product is unknown is119
referred to as orphan or cryptic clusters. With a large number of predicted but unexplored120
clusters, efforts have gone into the development of strategies for activating these silent gene121
clusters. The strategies include global changes such as global regulators, modified growth122
conditions and epigenetics plus cluster specific strategies such as promoter replacement and123
transcription factor overexpression.124
Global regulators of Secondary Metabolism. Firstly we will focus on global regulation, Figure125
1 S1. Bok et al. identified the protein LaeA regulating secondary metabolite production in126
several Aspergillus species [18]. In laeA deletion strains, the production of sterigmatocystin127
and penicillin and gliotoxin was decreased in A. nidulans and A. fumigatus respectively,128
whereas in A. terreus overexpression of laeA increased the production of lovastatin. LaeA129
was thus established as a global regulator of secondary metabolism in Aspergillus species [18].130
In a following study, laeA deletion and overexpression strains were used to identify active131
clusters through expression analysis in A. nidulans. A gene deletion in one of the clusters132
revealed that the cluster is responsible for producing terrequinone A [17]. The study of LaeA133
has been expanded to many other filamentous Ascomycetes where the link between LaeA134
and secondary metabolite production has been studied for instance in the study of T-toxin135
in Cochliobolus heterostrophus [14] and bikaverin, fumonisins, fusaric acid and fusarins in136
Fusarium verticillioides [22] just to mention a few. For an excellent review of this topic137
please refer to Jain and Keller [51].138
It has been shown that the LaeA is part of the velvet complex with VeA and VelB which139
connects light-response, developmental regulation and regulation of secondary metabolism [8].140
In a study comparing the transcriptional profile of an A. fumigtus wild type, laeA deletion141
and a complementation control strain showed that 13 out of 22 SMGCs were positively142
regulated by LaeA. Of the LaeA-regulated clusters 54% are located within 300 kb of telom-143
eres [81]. This could suggest a relationship between LaeA activity and chromatin modifi-144
cation which has been hypothezised by Keller et al. [54] however the hypothesis that LaeA145
methylates histones has not yet been verified nor refuted [51].146
Several other proteins have been shown to have general regulatory functions affecting147
secondary metabolism these includes the nitrogen regulator AreA [52, 70, 103], the pH148
regulator PacC [37] and the carbon regulator CreA [35, 36]149
5
15 Chapter 2. Background
The immediate advantage of using global regulators is that more SMGCs are expressed150
and more metabolites are produced, the main disadvantage is that the effect is not specific,151
thus many clusters are affected which can make the chemical analysis difficult. If a specific152
cluster of interest is investigated it is not certain that it will be affected by the global153
regulator.154
Cluster specific transcription factors. A more targeted strategy connected to regulation is155
the overexpression of a cluster-specific transcription factor (TF), Figure 1 S1. The method156
was first applied by Bergmann et al. in A. nidulans where the cluster specific TF was157
integrated ectopicaly under the control of an inducible promoter. This led to the elucidation158
of the novel SMs aspyridones A and B and identification of the PKS-NRPS hybrid SMGC159
responsible for production [12]. Subsequently, several SMs and clusters have been linked and160
characterized using a similar strategy e.g Asperfuranone in A. nidulans [28], a diterpene in161
A. nidulans [21] and Azaphilone in A. niger [112]. In Fusarium fujikuroi, a pathway specific162
TF and the PKS backbone enzyme was overexpressed resulting in the production of 4 new163
SMs, fujikurins A-D [52, 98]. Scopularide A and the responsible cluster was identified and164
verified by overexpression of the cluster specific transcription factor in a marine-derived165
Scopulariopsis brevicaulis strain [63].166
It is clear that the overexpression of a cluster-specific regulator can be a powerful strategy.167
However, it is not always straightforward. In a cluster containing two NRPS genes and168
a regulatory gene named scpR (for secondary metabolism cross-pathway regulator), the169
overexpression of scpR led not to the activation of the NRPSs as expected, but to the170
activation of the asperfuranone cluster located on another chromosome in A. nidulans [11].171
This showed that cluster-specific TFs are not necessarily located within the cluster it is172
affecting and thus adds another layer of complexity to SMGC regulation.173
The main advantage of the method is that it – when successful – allows coordinated174
expression of all SM pathway genes. Other advantages of expressing a cluster-specific TF175
include that only one gene has to be manipulated and the integration can be ectopic which176
evades the limitations of homologous recombination. The main limitation of this method is177
that it requires the cluster of interest to have a pathway specific TF.178
Promoter exchange. When no cluster specific transcription factor is available, another option179
is to replace the promoters of all the genes in the SMGC to force the expression of the cluster180
genes, Figure 1 S2. This was done by Yeah et al. in 2016 for the fellutamide B cluster in A.181
nidulans, where the promoter of six genes were replaced with the regulatable alcA promoter182
by recycling a selectable marker [110]. A similar strategy was used in A. nidulans for the183
cluster responsible for a conidiophore pigment where the promoters of three genes (ivoA-C )184
were replaced with the alcA promoter [97].185
The main advantage of this method is that it is specific and can be used for all clusters,186
no transcription factor is required. Disadvantages are that it requires molecular tools in the187
organism and it is quite labour intensive especially if the cluster consists of many genes.188
Epigenetics / chromatin remodelling. As mentioned in connection with LaeA, chromatin re-189
modelling has been shown to be involved in regulation of secondary metabolites (SMs). The190
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relationship between SM and chromatin structure can be exploited to activate otherwise191
silent gene clusters. The epigenetic landscape can both be modified by molecular meth-192
ods (e.g. gene deletion) or chemically by adding small molecules manipulating the fungal193
epigenome.194
In 2007, Shwab et al. deleted hdaA encoding a histone deacetylase (HDAC) in A. nidu-195
lans showing that the levels of the two sub-telomeric cluster products, penicillin and sterig-196
matocystin, increased while terraquinone A levels were unaffected and this cluster is not197
subtelomeric. To investigate the mechanism in other fungi, A. alternate and P. expansum198
were treated with a HDAC inhibitor (Trichostatin A) which resulted in significant increased199
levels of several SMs in both species. This study showed that HdaA plays an important role200
in suppression of SM located in the sub-telomeric regions and that it might be a conserved201
mechanism across the fungal species [94]. In a study by Williams et al. it was shown that202
small-molecule epigenetic modifiers were effective in eleven out of 12 species tested where203
one or more modifiers caused the production of new SMs or enhanced production of known204
SMs compared to untreated controls. Two species were investigated further, Cladosporium205
cladosporioides and Diatrype disciformis and several new SMs were identified and charac-206
terised in each species showing the applicability of the method [104]. In a study of A. niger207
it was shown that many of the clusters were affected by deacetylase inhibitors [39] illustrat-208
ing the potential of chromatin remodelling in the activation of silent gene clusters. Again it209
was also shown that the affect was mainly on clusters located near the telomeric regions.210
CclA is a part of the complex COMPASS, an eukaryotic transcriptional effector methy-211
lating lysine 4 of histone H3 (H3K4)1 thus affecting chromatin-mediated processes. The212
deletion of CclA, in A. nidulans showed activated expression of otherwise silent SMGC in-213
cluding the new cluster generating monodictyphenone, emodin and emodin derivatives, plus214
a cluster encoding two anti-osteoporosis polyketides, F9775A and F9775B [16].215
Many of the advantages and disadvantages of this strategy are similar to the global216
regulator strategy, however comparing those two strategies, the advantage here is that it217
can be made in species without molecular tools if using small molecule inhibitors.218
Environmental stimuli. Secondary metabolite gene clusters (SMGCs) are induced at specific219
conditions, under which conditions they are active can be identified by changing the envi-220
ronment or adding various stimuli. Gressler et al. had tried expression of a transcriptional221
activator in the cluster of interest in A. terreus, but without success, instead they turned to222
environmental stimuli. A combination of metabolic profiling, monitoring gene expression,223
and a lacZ reporter strain was used to identify on which media the cluster was active and224
this strategy finally led to the identification of isoflavipucine and dihydroisoflavipucine [45].225
It has further been shown that ionic liquids can stimulate the secondary metabolism in226
A. nidulans where 32% of described backbone genes were upregulated whereof several were227
normally silent [4].228
Co-cultivation of fungal species with bacteria is another environmental stimulus that has229
been used successfully to activate silent gene clusters. Wakefield et al. grew A. fumiga-230
tus MR2012 with isolates of Streptomyces leeuwenhoekii which led to the production and231
identification of luteoride D (a luteoride derivative) and pseurotin G (a pseurotin deriva-232
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tive) plus production of SMs not previously identified in this species (terezine D and 11-O-233
methylpseurotin A) [99].234
The advantages of using environmental stimuli is similar to global regulator and chro-235
matin remodelling in that more clusters are activated however again it is not specific and236
it is not known if the cluster of interest will be affected. Another advantage is that it is237
possible to use this strategy for unexplored species, since no molecular tools are needed.238
Future possibilities in native strategies. With the advancement of molecular tools such as239
CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) in fungi [78],240
many of the native strategies will be applicable in more non model species. Another future241
possibility based on the CRISPR-Cas system is the development of synthetic transcription242
factors where a deficient Cas9 can be fused to an effector domain thus inducing transcription243
of specific genes which has already been applied in yeast [38].244
2.2. Heterologous Strategies245
Heterologous expression strategies can be applied if the cluster of interest is found in a246
species not easily genetically manipulated, or if the native strategies have been tested and247
failed. The first thing to consider with heterologous expression is which host to select. This248
choice depends on many factors. We will here focus on three categories of hosts; bacterial,249
yeast and filamentous fungi. The second thing to consider is the construct and how com-250
prehensive it should be, including only backbone synthase, promoter, swap of transcription251
factor or engineering of the whole cluster with new promoters etc. for all genes in the cluster.252
Which construct to use depends on the cluster and the aim. In the follwing section the three253
categories of hosts are examined follwed by a section covering the construct254
Bacterial host. The first group of hosts we will consider is bacterial hosts such as Escherichia255
coli and Streptomyces coelicolor. S. coelicolor has been used as a hosts to express the 6-256
methylsalicylic acid synthase gene from Penicillium patulum [9]. Later the 6-methylsalicylic257
acid synthase gene from P. patulum was successfully expressed in E. coli and S. cerevisiae258
producing 6-methylsalicylic acid [53].259
In a more recent study the gene encoding the BbBEAS nonribosomal peptide synthetase260
isolated from B. bassiana was heterologously expressed in E. coli which was then able to261
produce beauvericin when the precursor D-Hiv was added [48, 108]262
Several of the tropolone biosynthetic genes from Talaromyces stipitatus were expressed263
in E. coli and purified for in vitro analysis thus verifying the expected biosynthetic path-264
way [32]. The PKS4 protein from Gibberella fujikuroi was expressed in E. coli, purified265
and in vitro analysis was performed showing a functional enzyme producing the secondary266
metabolite SMA76a [65]. Similarly the LovD protein from lovastatin biosynthetic cluster267
was expressed in E. coli, purified and analysed in vitro [105]. In an investigation of the268
basidiomycete Coprinus cinereus, six sesquiterpene synthases were expressed in E. coli and269
5 of the products were identified directly from E. coli cultures using GC-MS [2]. Using the270
same approach 11 sesquiterpene synthetase from Omphalotus olearus were characterised by271
heterologous expression in E.coli [102].In the investigation of the Azaphilone gene cluster the272
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gene AzaH (a FAD-dependent monooxygenase) was expressed in E. coli in order to make in273
vitro assays of the protein and investigate its function in the azaphilone biosynthesis [112].274
E. coli has several advantages as a host for heterologous expression; 1) easy to culture and275
fast growing 2) a well developed molecular toolbox 3) a well-understood primary metabolism276
and 4) the absence of endogenous secondary metabolite pathways thus limiting the risk of277
cross-talk and interference with native proteins [44, 82]. There are however also several chal-278
lenges when heterologously expressing fungal secondary metabolite genes in bacterial hosts.279
The challenges include; 1) bacteria’s inability to process eukaryotic introns which thus have280
to be eliminated 2) codon bias can cause problems in expression 3) correctly folding of the281
synthesized proteins 4) required post-translational phosphopantetheinylation/modifications282
and 5) availability of the precursors [3, 44, 48]. Bacterial hosts are therefore most often used283
for in vitro enzyme analysis of a specific biosynthetic gene.284
Yeast as a heterologous host. The second host we will consider is yeast, in particular Sac-285
charomyces cerevisiae, which taxonomically is closer to filamentous fungi than bacteria,286
belonging to the same kingdom.287
As mentioned earlier the gene encoding 6-methylsalicylic acid synthase from P. patu-288
lum was expressed in a S. cerevisiae strain including a heterologous phosphopantetheinyl289
transferase which creates the active holo PKS from the apo-PKS [60, 53]. From this strain290
6-methylsalicylic acid was produced and the amount was twice as high as in the native291
species and much higher than in E. coli [53].292
The lovastatin nonaketide synthase, LovB from A. terreus was expressed in an engineered293
strain of S. cerevisiae containing the a phosphopantetheinyl (ppant) transferase gene npgA294
from A. nidulans [71], in order to perform in-depth in vitro investigation of the catalytic295
function and mechanism [64].296
Ishiuchi et al. engineered a S. cerevisiae strain to include matB (malonyl-CoA syn-297
thetase) and npgA (phosphopantetheinyl transferase) and successfully used this for expres-298
sion of five PKS and one NRPS and characterization of the produced SMs [49]. Several299
other studies have used optimized versions of S. cerevisiae for heterologous expression of300
synthase genes, for identification of the products and characterization of the mechanisms,301
including identification of 10,11-Dehydro-curvularin and characterization of a mechanism302
for aryl-aldehyde[100, 107]303
Not only synthase genes have been expressed in S. cerevisiae, but also whole clusters.304
The biosynthetic genes from the hypothemycin gene cluster from Hypomyces subiculosus305
were for instance expressed in a PKS optimized yeast strain [53, 85] and based on these306
experiments it was possible to propose a biosynthetic pathway [85]. In another study by307
Rugbjerg et al. three biosynthetic genes from Fusarium graminearum were co-expressed308
with the phosphopantetheinyl transferase (npgA) gene from A. fumigatus resulting in the309
production of Rubrofusarin [89].310
In a recent study, Harvey et al. developed HEx (Heterologous EXpression) synthetic311
biology platform for fast and scalable expression of fungal biosynthetic genes and their312
encoded metabolites in S. cerevisiae [46]. In this study 41 biosynthetic gene clusters from313
diverse ascomycete and basidiomycete fungal species were expressed in S. cerevisiae and314
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54% resulted in SMs not natively found in yeast [46]. This platform brings the method315
of heterologous expression in yeast a big step forward and potentially opens the door to316
discovery of many natural products.317
Using S. cerevisiae as a heterologous host has many advantages, some of which are similar318
to those mentioned for E.coli, but there are additional advantages to using S. cerevisiae:319
1) S. cerevisiae is a unicellular organism, easy to culture and it grows faster than most320
filamentous fungi; 2) Powerful genetic tools have been developed for protein expression321
and pathway construction, including highly efficient homologous recombination; 3) Native322
secondary metabolism is very limited in S. cerevisiae thus minimizing the background and323
potential cross-talk [95]; 4) The building blocks for polyketide synthesis such as acetyl-CoA324
and malonyl-CoA plus cofactors such as NADPH and S-adenosylmethionine are naturally325
produced in yeast; 5) Lastly yeast also belongs to the fungal kingdom and it can typically326
produce tailoring enzymes and support correct folding [19, 3] .327
The challenges of using S. cerevisiae as a heterologous host includes: 1) A heterologous328
gene is required for activation of the synthase such as the surfactin P-pant transferase (Sfp)329
from Bacillus subtilis [53]; 2) S. cerevisiae has different and few introns which can cause330
problems in mRNA splicing [58]; 3) In yeast codon usage is biased towards AT which can331
cause problems if the gene of interest is GC rich [73]; A low or even lacking production332
of required precursors and building blocks [53, 73]; 4) Lack of compartmentalization which333
might be important for SM production [88]; 5) Lastly there is a risk of toxicity of the334
produced SM.335
Filamentous fungi as heterologous host. Many of the challenges seen for yeast and bacterial336
hosts can be overcome by using a filamentous fungal hosts. The model fungus Aspergillus337
nidulans is often used, because it has a well developed genetic toolbox, also A. oryzae which338
has a limited endogenous secondary metabolism is often employed.339
Initially many of the studies of heterologous expression were based on a single gene, often340
the backbone enzyme. One example is the study of albA from A. fumigatus which is involved341
in conidial pigment biosynthesis and it was heterologously expressed in A. oryzae to show342
that the PKS is a naphthopyrone synthase (expected based on the sequence similarity) and343
not a tetrahydroxynaphtalene synthase (expected from the color) [101]. The drawback of344
single gene studies is that most often they do not give the final secondary metabolite (SM)345
or the biosynthetic pathway.346
Other studies have expressed whole clusters in heterologous hosts, Smith et al. was one347
of the first to do this. They cloned the penicillin biosynthetic gene cluster from Penicil-348
lium chrysogenum on to a cosmid vector, transferred it to Neurospora crassa and A. niger349
and showed that penicillin was produced [96]. This approach however relies on the native350
promoters functioning in the new host and correct mRNA processing.351
One method of circumventing this dependency is to put the transcription factor under352
a strong promoter. This approach was seen in a study of a cryptic polyketide cluster from353
Trichophyton tonsurans where four biosynthetic genes of the cluster were expressed from354
their own promoters, and only the cluster specific transcription factor promoter was replaced355
with the strong A. nidulans gpdA promoter [111]. A neat detail in the design of this study356
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was that the cluster was inserted in the wA locus of A. nidulans encoding a pigment PKS,357
facilitating the screening of correct recombination.358
Many studies have been conducted investigating biosynthetic gene clusters by heterolo-359
gous expression including pyripyropene from A. fumigatus expressed in A. oryzae[50], the360
citrinin cluster from Monascus purpureus expressed in A. oryzae [90] and the Pfma cluster361
from Pestalotiopsis fici expressed in A. nidulans synthesizeing the melanin 8-dihydroxy-362
naphthalene (DHN) [113] just to mention a few.363
Heterologous expression in filamentous fungi can give rise to some challenges, the host364
can be affected by the inserted cluster causing a changed metabolite profile or cross-talk365
between the inserted cluster and native clusters can arise which makes it difficult to identify366
the correct new SM. This was illustrated by a study expressing a polyketide gene cluster orig-367
inating from a fungal endophyte in Fusarium verticillioides [106], where the main product368
identified was fusaric acid, which is a mycotoxin normally found in Fusarium species.369
There are several studies optimizing heterologous hosts to make the strategy more ef-370
fective. Chiang et al. developed an optimized heterologous expression system in A. nidu-371
lans [27]. Their first step was to delete native biosynthetic gene clusters (of sterigmato-372
cystin, emericellamide, orsellinic acid/F9775A,B, asperfuranone, monodictyphenone, and373
terrequinone) in order to reduce the SM background and facilitate detection of novel prod-374
ucts plus to increase the pool of pre-cursors for the desired products. Next they developed375
a method for heterologous expression of biosynthetic genes using a system of a recycable376
marker thus permitting the expression of entire clusters which was shown for the asperfura-377
none cluster from A. terreus.378
A more recent effort by Clevenger et al. using fungal artificial chromosomes (FACs) and379
metabolomic scoring (MS) have made the it possible to scale up the analysis which was380
demonstrated by investigating 56 SMGCs originating from A. terreus, A. aculeatus and A.381
wentii in A. nidulans [30]. In the study, they detected 17 SMs produced by 15 different382
FACs. In a subsequent study the FAC-MS method was used to elucidate the biosynthesis383
of acu-dioxomorpholine [87].384
The advantages of using a filamentous fungi as host includes; 1) The genetic systems385
are generally compatible correctly translation folding and post-translational modifying the386
foreign gene(s) hence obviating the need for codon optimization, intron removal etc. 2) The387
secondary metabolite machinery is present, making most common precursors available. The388
downside is that there is a lot of background which can make the chemical analysis difficult389
and cause cross-chemistry making it complicated to identify the SM produced by the inserted390
genes. An additional disadvantage is that it is very time consuming using filamentous fungi391
as hosts since they are challenging to engineer and slow growing.392
Design of constructs. Besides selecting the host for heterologous expression, another ting393
to consider is the construct as mentioned earlier. Expressing a gene heterologously either394
depends on the host having similar promoters and terminators and mRNA transcript pro-395
cessing or it requires extensive engineering of the cluster. The design of the constructs396
depends on the cluster of interest, the host and the aim. Here we have divided it into three397
main strategies: 1) Expression of the synthase/synthetase, 2) Inserting the natural cluster,398
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potentially with engineering of the transcription factor and 3) Engineering of the whole399
cluster including new promoter etc. for all genes.400
In some initial studies of cryptic biosynthetic gene clusters only the synthase has been401
expressed. This method is used to investigate the core structure of the secondary metabo-402
lite (SM) to give an initial indication of what structure is produced and can also be used403
in screening studies. Expressing only the synthase has the advantage that it is most often404
only one gene, making it easier and less labour intensive to exchange promoter and oc-405
casionally terminator. This strategy was used in the study of six sesquiterpene synthases406
from mushroom-forming fungi (Agaricomycetes) where the sesquiterpene synthases were ex-407
pressed in E. coli and/or S. cerevisiae thereby characterizing the enzymes and identifying408
the major sesquiterpene hydrocarbons produced [2]. Ishiuchi et al. expressed five PKSs and409
an NRPS in S. cerevisiae and identified the corresponding natural products [49]. Likewise410
two polyketide synthases responsible for cladosporin production was expressed in S. cere-411
visiae to confirm the involvement in cladosporin production and understand the mechanism412
and biosynthesis [31]. Munawar et al. expressed a nonribosomal peptide synthetase from413
Fusarium sacchari in A. oryzae and showed that it is responsible for producing the siderio-414
hore ferrirhodin [72]. The disadvantage is that it does not give the final SM but it gives the415
core structure of the SM and the initial step in the biosynthesis.416
most often several genes have to be expressed in order to analyze an entire biosynthetic417
cluster. Examples have been seen where an entire gene cluster is transferred without mod-418
ifying it, this requires that the heterologous host is closely related to the native species so419
that the transcriptional and translational machinery is compatible, however the amount of420
produced SM is often quite low. The citrinin gene cluster from Monascus purpureus was421
expressed in A. oryzae without modifying the cluster resulting in low production [90]. If the422
cluster contains a cluster specific transcription factor (TF) it is possible to only exchange423
the promoter of the TF and get increased expression of the rest of the cluster, similar to424
the strategy of activating silent gene clusters in section 2.1.2. This strategy was employed425
on the citrinin gene cluster which contains a TF, this way an almost 400-fold higher citrinin426
production was achieved [90]. Similarly, the geodin cluster from A. terreus was successfully427
expressed in A. nidulans by replacing the promoter of the TF with a strong constitutive428
promoter [76].429
The advantage of this strategy is that it produces the final SM of the cluster and it430
requires minimal engineering of the cluster. The disadvantage is that it requires compatible431
cellular machinery of the native and heterologous host or the presence of a cluster specific432
TC.433
If the cluster of interest does not contain a TF, the third approach can be utilized which434
is engineering of the entire cluster exchanging all the promoters. Four biosynthetic genes435
from Phoma betae was expressed in A. oryzae in a vector-based approach using the starch-436
inducible promoter/terminator from the amyB gene thereby producing aphidicolin [40]. Bai-437
ley et al. successfully expressed seven biosynthetic genes from the basideomycete Clitopilus438
passeckerianus in A. oryzae using constitutive A. oryzae promoters thereby producing pleu-439
romutilin [6].440
The advantage of engineering the entire cluster is that there is no requirements or re-441
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strictions as to which clusters can be investigated. The drawback is that it is a more labour442
intensive method. There are several excellent reviews on the subject of heterologous expres-443
sion, for further reading please refer to [3, 5, 61].444
Future perspectives. As the price of synthesis of long stretches of DNA keeps dropping due445
to technical advancement, novel strategies are emerging, making it possible to circumvent446
several time consuming cloning steps and thereby easier to investigate selected clusters or447
screen more clusters. Especially the strategy of promoter swapping of all genes in a cluster448
becomes much more feasible when using synthetic DNA.449
3. Reverse strategies going from secondary metabolite to cluster450
An alternative to the approach of starting from an interesting cluster and linking it to451
a secondary metabolite (SM), is to start from a SM of interest. If a SM has been identified452
in a certain species, there are several methods for identifying the responsible biosynthetic453
gene cluster. Here we have divided it into three main approaches 1) Homology search454
2) Retro biosynthesis and 3) Comparative genomics (Figure 2). Which strategy to use455
essentially depends on the initial knowledge. As seen in the forward strategies, a combination456
of several strategies is often needed to identify and verify the secondary metabolite gene457
cluster (SMGC). All the strategies mentioned here requires whole genome sequences of the458
producing organism. These methods has thus only been made possible in the post-genomic459
era. As whole genome sequences are becoming more and more attainable, the use of these460
strategies will surely only increase.461
3.1. Homology Search462
The first strategy presented here is based on homology search, Figure 2 strategy 1. The463
starting point is a known secondary metabolite (SM) where the same or a similar SM is464
produced in another species where the secondary metaboolite gene cluster is known. In465
this case, the known cluster genes can be used to search for similar genes in the selected466
organism. The most important is the synthase/synthetase responsible for producing the467
backbone of the SM. A derivative of this strategy (genetic dereplication) has a wider scope,468
not focusing on a single SM but instead identifying homologs of all characterized biosynthetic469
gene clusters. When a novel species have been whole genome sequenced this approach is470
very useful to identify the known and novel clusters.471
The ochratoxin gene cluster was identified in A. carbonarius using homology search of the472
ochratoxin cluster predicted in A. niger. The following deletion of a PKS in the predicted473
cluster eliminated all production of ochratoxin confirming the biosynthetic role[42]. The474
method of homology search can also be used to find the putative clusters for similar SMs that475
could use parts of the same biosynthetic pathway. This was shown for in the identification476
of the novofumigatonin cluster in A. novofumigatus which was identified based on homology477
to another meroterpenoid, the terretonin cluster from A. terreus [57, 67].478
Using homology search, it is also possible to investigate the secondary metabolite po-479
tential of a newly sequenced species. The secondary metabolism was investigated in the480
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Figure 2: Three strategies for linking secondary metabolite to clusters using whole genome sequences. 1)
Homology search – starting with a known compound produced by organisms A and the same or similar
compound produced by organism B where the cluster has been identified it is possible to use the known
cluster from organism B to search for a similar cluster in the genome of organism A and thereby identify the
cluster of interest. 2) Retro-biosynthesis – starting with a known compound but no similar clusters identified
it is possible the predict the enzyme activities needed to produce the compound (backbone and tailoring
enzymes) and from these predictions find putative clusters matching the requirements in the genome. 3)
Comparative genomic – starting with a set of organisms where some produces the compound of interest
and some do not it is possible to identify homologous gene clusters in the producing and filter based on no
homologs in the non producing and thereby identify candidate gene clusters.
wheat pathogen Zymoseptoria tritici using MultiGene Basic Local Alignment Search Tools481
(BLAST) [69] to identify known clusters. This strategy revealed a cluster similar to the482
ferrichrome-A biosynthetic locus from a maize pathogen, Ustilago maydis. Putative clus-483
ters for carotenoid/opsin, an epipolythiodioxopiperazine, fumonisin and AM-toxin were also484
identified [24]. After whole genome sequencing of Penicillium griseofulvum various cluster485
products were predicted based on homology to known clusters from the MIBiG database [68].486
This revealed that Penicillium griseofulvum has putative gene clusters for patulin, roquefor-487
tine C / meleagrin, griseofulvin, penicillin, cyclopiazonic acid, yanuthone D and chanoclavine488
I [7]. Similarly, the genome of Aspergillus ustus a rare human pathogen was searched for489
known clusters and several commonly known aspergillus SM clusters were identified; mono-490
dictyphenone, sterigmatocystin, emericellamide, ferricrocin and asperthecin. In addition491
a putative cluster for viridicatumtoxin not previously identified in Aspergillus species was492
identified in A. ustus [83]. A homology search approach (based on ClusterBLAST module493
embedded within FungiSMASH [15]) was also applied in the investigation of the lichen,494
Cladonia uncialis. This revealed genes homologs to the lichen metabolite grayanic acid from495
14
2.4. Manuscript I – Review: linking compounds and gene clusters 24
C. grayi in addition to clusters likely encoding fungal SMs not identified in lichens before496
such as patulin and betaenones AC [13].497
The immediate advantage of this method is that it can be used on all species as long as498
there is a genome sequence. The disadvantage is that it requires both a genome sequence499
and a similar cluster already characterized, and it only finds known clusters or derivatives500
but not truly new SMs. Lastly, the results are putative and requires some experimental501
verification. Homology search is an extremely powerful and highly employed approach for502
coupling clusters and SMs especially in the investigation of newly sequenced genomes. As503
the number of whole genome sequences increases and the algorithms aiding in the predictions504
are improved, this method is likely to expand.505
3.2. Retro Biosynthesis506
The second strategy seen on Figure 2 is based on retro-biosynthesis, here the secondary507
metabolite (SM) is known and the chemical structure of it but nothing else. Based on508
the chemical structure and knowledge of secondary metabolite biosynthesis it is possible to509
deduce what enzyme activities are needed to produce the SM which can be used to identify510
a putative gene cluster matching the requirements.511
The anticancer lipopeptide, scopularide A, is produced by a marine derived Scopulari-512
opsis brevicaulis and the chemical structure consists of a reduced carbon chain coupled to513
five amino acids. The SM is structurally related to emericellamide A and W493-B from514
Aspergillus nidulans and Fusarium pseudograminearum respectively. After the sequencing515
of S. brevicaulis, Lukassen et al. wanted to identify the cluster responsible for scopular-516
ide A production in order to optimize the production. This was done primarily based on517
retro-biosynthetic approached supported by homologous comparisons. By combining the518
knowledge of the structure with predicted secondary metabolite gene clusters it was possi-519
ble to identify genes encoding the SM, a NRPS with five modules and a reducing PKS. The520
identified genes also showed homology to the clusters for the structurally related SMs emeri-521
cellamide A and W493-B. The putative cluster included a predicted TF. To further support522
the prediction and to improve the production of scopularide A the TF was overexpressed523
which significantly increased the production of scopularide A thus indirectly verifying the524
prediction [63].525
A retro-biosynthesis based approach was also used in the identification of the putative526
usnic acid cluster in the lichen fungal partner of Cladonia uncialis [1]. After de novo se-527
quencing of C. uncialis, the genome was mined for PKS genes. From the structure of usnic528
acid and an earlier labelling experiment, it was suggested that usinic acid biosynthesis re-529
quires a non-reducing PKS including a methylation domain and a terminal Claisen cyclase530
(CLC) domain plus an oxidative tailoring enzyme, most likely a cytochrome P450. Based531
on this information, the predicted PKS clusters were screened, and only one matched the532
requirements. Transcriptional analysis of the genes was performed under conditions where533
only usnic acid was produced. This confirmed that the identified genes were transcriptionally534
active which further supports the predictions.535
Khater et al. have attempted to develop a computational protocol based on the concept536
of retro-biosynthesis to reconstruct biosynthetic pathways of polyketides and nonribosomal537
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peptides [56]. The aim is to predict the enzymes and the gene functions involved in the538
biosynthesis of a certain SM and thus be able to predict and identify the responsible biosyn-539
thetic gene cluster in an automated manner. The developed approach was tested based on540
78 experimentally characterized secondary metabolites (51 PKS/HYBRID, 27 NRPS), here541
it was able to predict 37% correctly, 13% with minor errors, 24% partially correct and 26%542
incorrectly. The predictive methods are still in the early stage and needs more knowledge543
of the mechanisms behind the secondary metabolite production and development but it has544
the potential to become a very powerful tool in the future.545
3.3. Comparative Genomics546
Comparative genomics is the third approach identified in our metaanalysis, Figure 2.547
This approach requires the whole genome sequences of several species where the differences548
or similarities can be used to identify a specific gene cluster. The species used could for549
instance be distantly related species producing the same secondary metabolite (SM) or550
closely related species sharing high degree of secondary metabolism but not the SM of551
interest.552
The identification of the viridicatumtoxin and griseofulvin gene clusters in Penicillium553
aethiopicum was accomplished using such comparative genomics strategies: P. aethiopicum554
was sequenced and compared to the Penicillium chrysogenum genome which is a closely555
related species but it does not produce the SMs of interest. This way 9 out of 30 predicted556
PKSs could be ruled out due to homology between them. To further narrow it down retro-557
biosynthetic methods was used to identify the most likely kind of PKS and to the check that558
the surrounding genes match the expected tailoring enzymes. This way candidate clusters559
for both SMs were identified and these were verified by gene deletion and RNA silencing [29].560
The biosynthetic clusters of the (+)/(-)-notoamide, paraherquamide and malbrancheamide561
pathways (all based on bicyclo[2.2.2]diazaoctane indole alkaloid core) were identified based562
on homology search and comparative genomics. The genomes of A. versicolor NRRL35600,563
P. fellutanum ATCC20841, and M. aurantiaca were sequenced and the (-)notoamide cluster564
known from Aspergillus sp. MF297-2 [34] was used to search for homologs in the newly565
sequenced species [62]. Comparison of the identified clusters led to the identification of566
genes responsible in the formation of the bicyclo[2.2.2]diazaoctane core along with specific567
enzymes responsible for specific differences in the chemical structures [62].568
The advantages of using comparative genomics is that no knowledge about the cluster or569
biosynthesis is required, only a set of genomes to show a specific pattern for the cluster of in-570
terest (e.g. the corresponding species produce a SM of interest). Disadvantages includes that571
whole genome sequences are required as well as knowledge of producer and non-producers572
of the SM of interest. Caution needs to be applied since non-producers could have silent573
clusters and therefore a chemical negative should not be taken as an absolute but rather574
a indication. As more and more species are sequenced, we expect that the comparative575
analysis will expand and more sophisticated methods will develop.576
Comparative genomics strategies are often used with a combination of retro-biosynthesis577
and/or homology search, again showing that a combination of strategies is most often needed578
to establish the links between SM and gene clusters.579
16
2.4. Manuscript I – Review: linking compounds and gene clusters 26
4. Conclusion580
Many strategies have been developed and employed in the quest to link secondary581
metabolites to their secondary metabolite gene clusters and vice versa. As the technolo-582
gies and tools continue to evolve and we get a deeper understanding of the mechanisms583
behind secondary metabolite production the speed and efficiency of linking SM and clusters584
will increase.585
We see three major areas of advancement in the near future. Firstly, molecular tools586
are developing making it feasible to work with many different species and thereby making587
it possible to conduct analysis in the native species. We will therefore see more studies588
from non-model organisms. Secondly, as the price of de novo synthesis of DNA is rapidly589
decreasing heterologous expression of silent clusters will become easier, opening for larger590
high throughput screening studies. Thirdly, with the increasing number of whole genome591
sequences and knowledge more compartive genomics approaches will be used and advanced592
bioinformtaic tools will emerge making more accurate and more advanced predictions.593
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3 Exploring genomic diversity and
linking compounds to clusters
This chapter includes a paper and a manuscript both investigating de novo se-
quenced species using comparative genomics. The whole genome sequences of di-
verse and closely related species are used to get new insights and create knowledge-
based predictions. An example of this is seen in Paper I, where whole genome
sequences are used in a combination with knowledge of secondary metabolite
biosynthesis to predict biosynthetic gene clusters of specific compounds. Another
example is in Manuscript I where comparative genomics of the important section
Flavi species are used to gain an understanding of the evolutionary relationship
among the species and their capabilities as secondary metabolite and carbohydrate
producers. Both Paper I and Manuscript II illustrate the power and versatility of
whole genome sequencing and comparative genomics.
3.1 Paper I – Linking compounds to gene clusters through
genome sequencing
Paper I is the publication of four high quality de novo PacBio sequenced Aspergillus
species from diverse sections of the Aspergillus genus. These genomes will function
as reference genomes in the ongoing and future Aspergillus comparative work. In
addition to these four, two more genomes were sequenced using Illumina technol-
ogy to support secondary metabolite predictions. Linking secondary metabolites
to biosynthetic gene clusters is not a trivial task, however with whole genome
sequences at hand, it is possible to use new methods to solve this challenge, as
mentioned in section 2.4. Here we show several ways of identifying the biosynthetic
gene cluster responsible for producing specific identified compounds one example
is the novofumigatonin cluster which was identified here and later the predicted
cluster was verified experimentally [1]. This study also compared the opportunistic
pathogen A. fumigatus with a closely related species A. novofumigatus showing
that A. novofumigatus has the majority of allergens and virulence factors known
from A. fumigatus suggesting that A. novofumigatus has the genetic potential to
be pathogenic as well. The analysis showed that A. novofumigatus contains many
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unique secondary metabolite gene clusters suggesting a big arsenal of potential
novel bioactive compounds.
The paper is an excellent example demonstrating various insights and hypoth-
esis that can be gained from comparative genomics studies ranging from biosyn-
thetic cluster predictions to assessing pathogenicity potential.
Paper I was published in Proceedings of the National Academy of Sciences (PNAS)
of the United States of America January 9, 2018. The supplementary material can
be found in Appendix A.
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The fungal genus of Aspergillus is highly interesting, containing
everything from industrial cell factories, model organisms, and hu-
man pathogens. In particular, this group has a prolific production of
bioactive secondary metabolites (SMs). In this work, four diverse
Aspergillus species (A. campestris, A. novofumigatus, A. ochraceor-
oseus, and A. steynii) have been whole-genome PacBio sequenced
to provide genetic references in three Aspergillus sections. A. tai-
chungensis and A. candidus also were sequenced for SM elucidation.
Thirteen Aspergillus genomes were analyzed with comparative ge-
nomics to determine phylogeny and genetic diversity, showing that
each presented genome contains 15–27% genes not found in other
sequenced Aspergilli. In particular, A. novofumigatuswas compared
with the pathogenic species A. fumigatus. This suggests that A.
novofumigatus can produce most of the same allergens, virulence,
and pathogenicity factors as A. fumigatus, suggesting that A. novo-
fumigatus could be as pathogenic as A. fumigatus. Furthermore,
SMs were linked to gene clusters based on biological and chemical
knowledge and analysis, genome sequences, and predictive algorithms.
We thus identify putative SM clusters for aflatoxin, chlorflavonin, and
ochrindol in A. ochraceoroseus, A. campestris, and A. steynii, respec-
tively, and novofumigatonin, ent-cycloechinulin, and epi-aszonalenins
in A. novofumigatus. Our study delivers six fungal genomes, showing
the large diversity found in the Aspergillus genus; highlights the
potential for discovery of beneficial or harmful SMs; and supports
reports of A. novofumigatus pathogenicity. It also shows how bio-
logical, biochemical, and genomic information can be combined to
identify genes involved in the biosynthesis of specific SMs.
Aspergillus | fumigatus | comparative genomics | secondary metabolism
The Aspergillus genus is a diverse group of fungal species foundworldwide in varying habitats. Several species are used in
biotechnological industries for the production of enzymes and
metabolites (commodity chemicals and pharmaceuticals), and as
fermentation agents in food (1). Certain species, such as A.
clavatus and A. fumigatus, are known food spoilers, mycotoxin
producers, and opportunistic pathogens (1, 2). To study this diversity,
it is important to have reference genomes of high assembly quality in
all major clades of the genus. For this purpose, we selected four
diverse Aspergillus species, A. campestris, A. novofumigatus, A.
ochraceoroseus, and A. steynii, representing four phylogenetically
very different sections in Aspergillus, for high-quality PacBio se-
quencing. The four selected genomes represent diverse and geno-
mically unexplored sections of the Aspergillus genus: A. campestris
is the first member of section Candidi to be sequenced, and likewise
A. steynii is the first member of section Circumdati to be sequenced.
A. ochraceoroseus, the first member of section Ochraceorosei, has
recently been draft genome sequenced (3) and is available only in a
large number of scaffolds. Here we also present a greatly improved
assembly that may serve as a reference genome for this section.
Furthermore, we have added a highly interesting member of
section Fumigati, A. novofumigatus, which has a diverse secondary
metabolite (SM) profile (4), as well as potentially being an op-
portunistic pathogen with close relation to the medically very
important A. fumigatus (5). In addition, two strains from the Candidi
section were Illumina sequenced to elucidate the chlorflavonin
biosynthesis.
Significance
The genus of Aspergillus holds fungi relevant to plant and
human pathology, food biotechnology, enzyme production,
model organisms, and a selection of extremophiles. Here we
present six whole-genome sequences that represent un-
explored branches of the Aspergillus genus. The comparison of
these genomes with previous genomes, coupled with exten-
sive chemical analysis, has allowed us to identify genes for
toxins, antibiotics, and anticancer compounds, as well as show
that Aspergillus novofumigatus is potentially as pathogenic as
Aspergillus fumigatus, and has an even more diverse set of
secreted bioactive compounds. The findings are of interest to
industrial biotechnology and basic research, as well as medical
and clinical research.
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The four PacBio sequenced species explored in this study can
act as a reference strain in their respective phylogenetic sections.
The species may also be used to assess the natural variation
within the Aspergillus genus via analysis of species-specific genes
in comparison with other genome-sequenced species. Accordingly,
we have compared our sequenced genomes with nine published
Aspergillus reference genomes (from sections Nidulantes, Nigri,
Fumigati, Flavi, Clavati, and Terrei) to serve as a compilation of
reference strains for the genus.
In addition, the biosynthetic potential of these species is of
interest. Filamentous fungi produce a diverse range of SMs, in-
cluding bioactive compounds such as pharmaceuticals and toxins
(6). SMs are not required for growth, but provide important
benefits in the growth environment (7). Members of the Asper-
gillus genus are known to produce a wide variety of SMs with
industrial, agricultural, medical, and economic importance (7, 8).
The biosynthetic genes of SMs are located in clusters setting the
stage for common gene regulation (9, 10). Clusters often span
tens of kilobases (kbs) (11) and usually contain a gene or genes
coding for one or more synthases (backbone enzyme) that define
the product class of the cluster [i.e., polyketide synthases (PKS),
nonribosomal peptide synthetases, and prenyltransferases or terpene
cyclases (12)], in addition to tailoring enzymes such as transferases,
hydroxylases, and regulatory proteins and transporters (11, 12).
With the increasing number of whole-genome sequences, the
opportunity of performing analysis based on comparative geno-
mics arises, which can give important insights and knowledge.
With a focus on investigating bioactive and toxic compounds, we
have here identified biosynthetic gene clusters responsible for
interesting compounds from each of the PacBio sequences by
combining genome analysis with knowledge of biochemical path-
ways and compound structure. We have identified candidates for
the ochrindol cluster in A. steynii, and the chlorflavonin cluster in
A. campestris.
A. novofumigatus was investigated on a genetic level, focusing
on SMs. The secondary metabolic potential has been investi-
gated, and biosynthetic gene clusters for three compounds (novo-
fumigatonin, epi-aszonalenin, and ent-cycloechi) have been identified.
Furthermore, the genomic differences and similarities of the closely
related species A. novofumigatus and the pathogen A. fumigatus
have been investigated, focusing on SMs, allergens, and virulence
factors, and thereby addressing the potential pathogenicity of A.
novofumigatus and how closely related the two morphologically
similar species are.
In addition, the evolution of the aflatoxin (a highly carcino-
genic compound) gene cluster from A. ochraceoroseus was in-
vestigated. The biosynthetic gene cluster was identified and studied
earlier in several species, including A. flavus, A. parasiticus, and A.
ochraceoroseus (13, 14). It has been seen that the synteny of the
clusters are quite varying and that A. ochraceoroseus is missing
some essential genes (aflQ and aflP) in the biosynthesis of afla-
toxin known from A. flavus (14). With whole-genome sequences at
hand, we have addressed some of these questions concerning the
evolution of this biosynthetic gene cluster.
Results and Discussion
Genome Statistics. The genomes of A. campestris, A. novofumi-
gatus, A. ochraceoroseus, and A. steynii were sequenced using
PacBio RS, whereas A. taichungensis and A. candidus were sequenced
using Illumina (see SI Appendix for details). Annotation of the
genomes was completed using the JGI Annotation Pipeline (15).
Table 1 lists genome sequence statistics for each of the six species.
The four PacBio sequenced genomes have a relatively low number
of scaffolds and do not contain internal gaps. For that reason, they
are highly useful as references for comparative genomics, as well as
for studies of the individual genomes. Of the sequenced genomes,
A. steynii has the largest genome size and is comparable with that
of A. oryzae (16). The genome of A. steynii is ∼27% larger than A.
ochraceoroseus, which has the smallest genome in this set and has a
genome size comparable with A. clavatus (17). The difference in
genome size also reflects the numbers of predicted genes in the
two species, which range from 13,211 to 8,924, respectively.
Investigation of DNA Methylation. Because the four Aspergillus
genomes (A. steynii, A. campestris, A. novofumigatus, A. ochra-
ceoroseus) have been sequenced using PacBio, it is possible to
investigate the presence of N6-methyldeoxyadenine (6mA) (18).
Previous attempts at validation of such low abundance of 6mA
have proven challenging, making it difficult to conclude whether
6mA is present in these fungi and, if so, to discriminate between
real 6mA sites and false-positives (18). The presence of 6mA was
therefore explored across the four Aspergillus genomes (Table 2).
Consistent with previous reports (18) of low levels of 6mA in the
Dikarya, we detect very little 6mA in the Aspergilli, ranging from
0.012 (A. steynii) to 0.038 (A. campestris) percent adenines
methylated compared with early-diverging fungi, in which up to
2.8% of all adenines were methylated (Table 2) (18). Further-
more, only a handful of 6mA sites were at ApT dinucleotides,
and none was found symmetrically at ApTs, both of which are
characteristic features of 6mA modification in early-diverging
fungi (18). The results therefore suggest an absence or very
low occurrence of 6mA methylation in Aspergilli.
Whole-Genome Phylogeny Confirms Species Found in Separate
Clades. To provide an overview of the relationships among the
sequenced species in the Aspergillus genus, we constructed a
phylogenetic tree of the four PacBio sequenced species and the
11 reference strains, including Penicillium chrysogenum and
Neurospora crassa as outgroups (Fig. 1).
The constructed phylogenetic tree supports the results de-
scribed earlier by Peterson (21), where a tree was constructed
based on DNA sequences of four loci. A. campestris most closely
resembles A. terreus of the reference genomes, whereas A. steynii
relates closest to A. flavus and A. oryzae. Members of the Fumigati
Table 1. Overview of sequencing and annotation data for the four investigated PacBio-sequenced species, plus two additional
Illumina-sequenced species
A. campestris A. novofumigatus A. ochraceoroseus A. steynii A. candidus A. taichungensis
Genome size, Mbp 28.3 32.4 27.7 37.8 27.3 27.12
Number of proteins 9,764 11,549 8,924 13,211 9,641 9,692
Number of scaffolds 62 62 34 37 268 310
Number of scaffolds ≥2 kbp 56 62 32 36 168 283
Scaffold N50 6 4 4 4 23 47
Scaffold L50 1,703,432 3,768,347 2,489,623 3,921,250 391,998 207,690
Fraction of GC, % 51.2 49.1 44.2 49.1 51.8 51.44
Coverage of gaps, % 0 0 0 0 0.0298 0.0155
Coverage of InterPro, % 68 67 67 66 75 25
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section are in a single clade (marked in blue on Fig. 1), with
A. clavatus as a close relative. A. ochraceoroseus is placed next to
A. nidulans, and both belong to the subgenus Nidulantes. All the
species belonging to subgenus Circumdati (A. niger,A. oryzae,A. flavus,
A. steynii, A. terreus, and A. campestris) are also placed in one clade.
The tree further confirms that the three species A. ochraceoroseus,
A. steynii, and A. campestris indeed represent distinct branches in
the Aspergillus phylogram (22).
Unique Genes in the Genomes Often Encode Regulatory Proteins and
Enzymes Involved in Secondary Metabolism.We have identified and
investigated species-specific genes for the four newly sequenced
species to examine the diversity within the Aspergillus genus.
Genes that are unique to a species or a small group of species
may be associated with phenotypic traits and adaptation of these
species to specific environments. We define species-specific genes
as those without any orthologs in other sequenced genomes. This
definition makes the set of species-specific genes dependent on the
strains included in the analysis. As more genomes are included,
especially genomes from closely related species or strains, fewer
species-specific genes will be identified. The species-specific genes
for each genome were identified using a set consisting of the four
PacBio sequenced genomes and 11 reference genomes (SI Appendix,
Table S1). Two closely related strains will share most of their genes,
and they will as such not be unique to the individual species. The
unique genes are not expected to encode any key functions in the
cell, as they are found in only one organism; instead, these genes
might be involved in environmental adaptation and/or speciation.
The strains have 22%, 15%, 21%, and 27% unique genes for
A. campestris, A. novofumigatus, A. ochraceoroseus, and A. steynii,
respectively, indicating the vast diversity found within the
Aspergillus genus. Approximately one third of the species-specific
genes could be associated with an InterPro sequence domain (SI
Appendix, Table S1) (23), suggesting that these genes are not false
annotations.
Comparative Analysis of the Genomes of A. novofumigatus and
A. fumigatus. A. novofumigatus and A. fumigatus are considered
to be two closely related species, and A. novofumigatus has only
been regarded a separate species since 2005 (24). The homology
between A. novofumigatus and A. fumigatus has been investigated
based on the number of A. novofumigatus proteins with BLASTP
hits (≥50% identity ≥130% coverage of query plus hit) in A.
fumigatus. Based on this, 8,385 of A. novofumigatus proteins have
homologous proteins in A. fumigatus, corresponding to 73%. The
synteny between the two species was also examined using NUCmer
(Nucleotide Mummer) from the MUMmer 3.0 package to map
A. novofumigtus genome to the reference genome of A. fumigatus
(25–27). Based on these alignments, 23.1 Mbp of the A. novo-
fumigatus genome can be mapped to A. fumigatus, corresponding
to 71% of the A. novofumigatus genome. The maximum block
size is 75 kbp, and the mean block size is 4.6 kbp.
To explore this difference genetically and functionally, we
have explored the similarities and differences between these two
species with a focus on allergens, genes involved in virulence, and
production of SMs.
Secondary Metabolite Profile of A. novofumigatus Compared with
A. fumigatus. The extrolite production in A. fumigatus has been
extensively studied, and an abundance of SMs have been identified
(4). A. novofumigatus is also known to have a versatile secondary
metabolism; however, there is very little overlap of extrolite pro-
duction between the two closely related species, making it very in-
teresting to compare their genetic potential for producing SMs (4).
To investigate what type of SM gene clusters A. fumigatus and
A. novofumigatus have in common, the SM gene clusters were
predicted for each genome, using an implementation of SMURF
(28). An overview of the predicted clusters and homologs in A.
novofumigatus and A. fumigatus is presented in Fig. 2 A and B,
respectively. Of the 34 predicted clusters in A. fumigatus and
56 predicted clusters in A. novofumigatus, 24 appear to be shared
among the two species, based on bidirectional BLAST hits of the
synthase (Fig. 2C). Of the 11 elucidated clusters from A. fumi-
gatus [based on MIBiG (29)], homologs of seven (Gliotoxin,
hexadehydro-astechrome, pseurotin A, fumagillin, endocrocin,
helvolic acid, and trypacidin) can be found in A. novofumigatus
(based on homology of the synthase). Several of these SMs are
known to be involved in the virulence of A. fumigatus and are
examined in more detail in the Comparative Genomics of Genes
Encoding Allergens, Virulence, and Pathogenicity Factors.
The prediction of SM gene clusters also revealed considerable
differences between the two closely related species. First, as seen
in Fig. 2A, A. novofumigatus has 17 predicted clusters with no
orthologs in any of the reference species. This is in contrast to A.
fumigatus, which has only three clusters without orthologs in the
reference species (Fig. 2B). Second, A. novofumigatus has 56
predicted SM clusters, whereas A. fumigatus has only 34 (Fig.
2D). Third, A. novofumigatus also has more different types of
clusters. An overview of the cluster types and the number of
clusters found in the two species can be seen in Fig. 2D. The
diversity of SM gene clusters supports the identification of these
two organisms as separate species.
SMs can present a competitive advantage in the battle for
resources, but if the environment is stable, there is no need for a
large arsenal of different metabolites. Thus, the large difference
in SM potential between A. fumigatus and A. novofumigatus
might be a reflection of the difference in natural environment
and the competition in these environments, indicating that A.
novofumigatus normally exists in a highly competitive environ-
ment and has a need for a larger repertoire of SMs. These results
do not suggest in which conditions the metabolites are produced.
Perhaps the differences are influenced by that fact that A. fumigatus
Af293 is from a clinical isolate, whereas A. novofumigatus have been
isolated from chamise chaparral soil after a bush fire in Southern
California (2, 24). Indeed, earlier analyses have shown that clinical
isolates produce fewer exometabolites and sporulate less (4, 30, 31).
It is clear that the sequence of A. novofumigatus represents a
significant number of unknown gene clusters, and thereby possibly
interesting bioactive compounds. To start explore this treasure
chest and to illustrate our approach of linking metabolites to their
respective gene clusters, we have here identified four highly in-
teresting compounds (novofumigatonin, ent-cycloechinulin, and
epi-aszonalenin A and C) by liquid chromatography–mass spec-
trometry analysis (SI Appendix, Fig. S1), and we have identified
the biosynthetic gene clusters by using comparative genomics. Our
analysis targeted these four model compounds, as they represent
major metabolites produced by A. novofumigatus and because we
have them as pure standards in our in-house collection of fungal
metabolites (32).
Novofumigatonin is chemically a very complex compound con-
taining an orthoester and is at present only known to be produced by
A. novofumigatus (33). It has been suggested that novofumigatonin
Table 2. Overview of the methylation pattern of A. campestris,
A. novofumigatus, A. ochraceoroseus, and A. steynii
Lineage
Percentage
adenines
methylated
Total
number
of sites
Percentage
modifications
at ApT sites
A. steynii 0.012 6,753 0.054
A. campestris 0.038 9,156 0.041
A. novofumigatus 0.03 7,917 0.058
A. ochraceoroseus 0.021 7,355 0.027
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is a meroterpenoid produced from the aromatic polyketide, 3,5-
dimethylorsellinic acid, as an initial precursor. Terretonin is an-
other fungal meroterpenoid derived from 3,5-dimethylorsellinic
acid, and thus we hypothesized that the early-stage biosynthetic
route for novofumigatonin would follow the same pathway as that
for terretonin, found in A. terreus (34).
The terretonin biosynthetic genes in A. terreus were used to
find homologs in A. novofumigatus, using BLASTP. Exactly one
candidate cluster was identified (Fig. 3C), containing orthologs
to all of the genes from the early stages of the terretonin path-
way, with one exception: a terpene cyclase (trt1). However, we
found this just upstream of the identified predicted cluster, and it
was thus included in the putative cluster and in Fig. 3C.
Novofumigatonin is closely related to fumigatonin, which has
been reported to be produced by A. fumigatus (35). Interestingly,
no similar cluster could be found in A. fumigatus. The most similar
cluster in A. fumigatus (which is not a very strong hit: three proteins
with amino acid identity <50%) is an already known cluster re-
sponsible for production of another meroterpenoid, pyripyropene A
(36). This is very puzzling, and one could speculate that the report of
fumigatonin might have been obtained from a misidentified isolate
supposed to be A. fumigatus (35), but in reality an A. novofumigatus
strain, which was only recently described as a separate species (24).
A putative cluster (scaffold 3, 33,642–53,133 bp) for ent-
cycloechinulin (SI Appendix, Fig. S2) in A. novofumigatus was
identified using the fumitremorgins (ftm) cluster from A. fumigatus
as the starting point. Fumitremorgins are similar to ent-cycloechinulin
(SI Appendix, Fig. S2), but with some important differences. Ent-
cycloechinulin uses alanine instead of proline as a starter unit.
Furthermore, the following prenylation occurs in a reverse man-
ner. The genes responsible for these steps therefore have a low
identity (≤35%). The following hydroxylation and O-methylation,
however, are more similar, which is also reflected in the identity for
the genes (≥65%). Even though the identity for the identified
genes is low, they still represent the best hits in A. novofumigatus,
supporting that this is the best candidate cluster.
In a similar fashion, a putative cluster for epi-aszonalenin A and C
in A. novofumigatus was identified using a similar acetylaszonalenin
cluster (SI Appendix, Fig. S2 for chemical structure) from A. terreus.
Again, the acetylaszonalenin cluster proteins were used for a com-
parative genomics search in A. novofumigatus. This way, a very
similar cluster was identified (scaffold 3, 1,663,448–1,719,848 bp) as
a candidate for epi-aszonalenin A and C biosynthesis.
Comparative Genomics of Genes Encoding Allergens, Virulence, and
Pathogenicity Factors. A. fumigatus is known to be a common
opportunistic human pathogen (37), whereas A. novofumigatus
has only been reported as pathogenic in one instance (5). This
difference in known pathogenicity offers the opportunity to
identify and compare allergens and genes involved in the path-
ogenicity based on orthology, and to gather insights into the
potential harmfulness of A. novofumigatus.
A list of currently accepted allergenic proteins from the well-
studied A. fumigatus can be extracted from the Allergome database
(www.allergome.org). The sequences of the allergenic proteins from
this list were compared with the annotated A. novofumigatus protein
list using BLAST+, with parameters set to report full-length
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Fig. 1. Phylogenetic tree of 15 strains constructed from a composition vector approach of whole-proteome sequences using CVTree3 with a K’mer size of
eight (19, 20). The time scale has been scaled to the root, thereby making the branch lengths relative to the distance between the root and the species. This
time will therefore depend on what species are included in the set. The four PacBio-sequenced species are marked with orange, and the Fumigati section is
marked with blue.
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sequence matches. Results shown in SI Appendix, Table S2 in-
dicate that all A. fumigatus allergen proteins are represented in
the A. novofumigatus genome. Of a total of 41 proteins, 34 pro-
teins showed >90% identity, four showed 85–90% identity, and
three showed 50–80% identity. As proteins with >50% identity
are likely to cross-react to IgE (38), these results strongly indicate
that A. novofumigatus possesses a strong allergen repertoire that
will at least cross-react strongly with IgE to A. fumigatus and is
likely to be able to provoke an immune response in the same
manner as A. fumigatus. It is not possible to rule out the possi-
bility that A. novofumigatus could be a more virulent pathogen or
allergenic sensitizer than A. fumigatus.
A set of 35 potential virulence genes was assembled from recent
literature, as well as genes responsible for biosynthesis of the SMs
melanin, fumagillin, fumitremorgins, gliotoxin, and helvolin, which
are reported to play a direct role in virulence (4, 39, 40). The re-
sults are shown in SI Appendix, Table S3. The majority of the
potential virulence genes are shared between A. fumigatus and A.
novofumigatus with high similarity (>85% identity); only arp2 and
gel2 had identity just below 50%. The fumitremorgins cluster
consists of nine genes, six of which have identity <50%, including
the synthase indicating that A. novofumigatus is unable to produce
fumitremorgins. The two SM gene clusters for gliotoxin and
fumagillin in A. fumigatus both have highly similar matches in A.
novofumigatus. The cluster for helvolic acid has three genes of nine
with low BLASTP identity of 42–48%. However, A. novofumigatus
has been reported to produce helvolic acid, indicating that a high
amino acid similarity of these genes is not required (4).
It is likely that different combinations of virulence factors
among the species affect pathogenicity (31). It has been sug-
gested that species unable to produce some metabolites may be
able to produce proxy-exometabolites that can serve the same
function. This could indicate that species producing many dif-
ferent kinds of exometabolites are potentially pathogenic (4).
A. novofumigatus possesses the full range of allergen proteins
expressed by A. fumigatus, in addition to the majority of virulence
factors including several SMs. Furthermore, A. novofumigatus has
an extensive potential for SM production with 56 predicted gene
clusters compared with 34 for A. fumigatus. Together, these results
indicate that A. novofumigatus has a considerable potential to be
pathogenic. The observation of only a single instance of invasive
infection by A. novofumigatus (5) may result from the recent de-
velopment of methods to identify this species, which has pre-
viously not been distinguishable from A. fumigatus. It has been
found that ∼4–5% of A. fumigatus isolated from patients later
turned out to be closely related species (41). Thus, the true path-
ogenic potential of A. novofumigatus might be underestimated.
Similarly, allergen sensitization to A. novofumigatus is not currently
A
B C
D
2410 32
0 20 40 60 80 100
Mean % identity
0 20 40 60 80 100
Mean % identity
A. fumigatus
2
0
9
7
14
2
0
34
4
3
16
5
24
2
2
56
A. novofumigatus
A. fumigatus A. novofumigatus
DMAT
HYBRID
NRPS
NRPS-like
PKS
PKS-like
TC
Total
A. oryzae
A. campestris
A. niger ATCC 1015
A. nidulans
A. ochraceoroseus
P. chrysogenum
A. clavatus
A. terreus
A. steynii
A. fumigatus Af293
A. fumigatus A1163
A. novofumigatus
A. fumigatus Af293
A. fumigatus A1163
A. novofumigatus
A. oryzae
A. nidulans
A. ochraceoroseus
P. chrysogenum
A. campestris
A. steynii
A. terreus
A. niger ATCC 1015
A. clavatus
32
30
_3
35
96
_2
5
36
75
_8
55
66
_6
67
99
_1
5
21
98
_5
16
38
_5
82
_5
35
15
_4
35
19
_7
32
69
_1
1
91
89
_2
4
70
48
_3
82
66
_7
84
47
_1
5
75
16
_3
45
03
_7
35
29
_1
15
86
_1
7
79
29
_2
44
27
_8
58
79
_1
6
85
27
_7
90
3_
9
46
78
_1
2
34
08
_6
46
02
_1
1
17
59
_1
0
46
56
_5
93
13
_1
92
14
_1
91
70
_1
1
93
85
_1
80
33
_1
7
43
29
88
_8
20
61
50
_6
36
20
84
_6
43
90
78
_4
44
67
31
_3
48
07
20
_1
44
91
86
_4
50
75
88
_1
0
45
49
88
_1
2
51
54
76
_1
0
45
84
46
_2
42
56
23
_6
42
54
95
_1
0
45
55
69
_1
1
42
60
64
_1
8
45
89
66
_1
48
06
45
_6
51
59
35
_7
51
06
72
_1
8
50
94
93
_3
50
81
79
_7
50
75
50
_7
50
73
23
_1
50
67
79
_2
50
27
55
_1
47
17
30
_4
45
81
75
_1
1
44
94
53
_8
44
86
08
_1
3
43
56
20
_1
3
42
25
27
_1
1
42
06
66
_4
38
03
84
_2
2
41
87
70
_1
2
44
80
94
_9
37
44
31
_2
5
47
13
08
_1
4
50
40
80
_1
45
05
81
_6
51
12
55
_3
42
41
78
_2
2
45
08
99
_1
2
44
63
94
_8
51
11
60
_2
3
46
34
37
_1
2
48
77
76
_3
46
09
08
_1
0
51
61
20
_1
45
48
86
_1
5
43
58
34
_1
1
37
75
55
_1
0
37
71
65
_1
46
34
80
_1
41
57
98
_3
39
69
77
_9
37
98
03
_1
9
Fig. 2. (A) Overview of the SM gene clusters predicted in A. novofumigatus and their homologs in the reference species. (B) Overview of the SM gene clusters
predicted in A. fumigatus and their homologs in the reference species. (C) A Venn diagram of the A. fumigatus and A. novofumigatus SM gene clusters.
(D) The number and different types of SM gene clusters predicted in A. fumigatus and A. novofumigatus. DMATS, dimethylallyl tryptophan synthase; NRPS,
nonribosomal peptide synthetase; PKS, polyketide synthase; TC, terpene cyclase.
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tested, and this species may also have potential to contribute to the
burden of fungal allergy.
Investigation and Evolution of the Aflatoxin Gene Cluster in
A. ochraceoroseus. It is well known that A. ochraceoroseus can
produce aflatoxin, and the biosynthetic cluster has been iden-
tified (14). Also, it has been noted that the aflatoxin gene
cluster in A. ochraceoroseus is missing homologs to the aflP and
aflQ gene involved in the conversion of sterigmatocystin (ST)
to aflatoxin.
Here we have compared the aflatoxin gene cluster from the whole-
genome-sequenced A. flavusNRRL3357 with A. ochraceoroseus. The
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Fig. 3. Synteny plots of investigated clusters made using Easyfig tBLASTx. (A) The synteny of the predicted aflatoxin cluster in A. flavus NRRL3357 and the
identified candidate aflatoxin cluster in A. ochraceoroseus (scaffold 2, 4,201,774–4,251,209 bp). (B) Synteny plot of the candidate cluster for ochrindol in A.
steynii (scaffold 7, 2,783,445–2,824,507 bp) and terrequinone cluster in A. nidulans. The terrequinone cluster consists of a single-module nonribosomal
peptide synthetase (tdiA), a prenyltransferase (tdiB), an oxidoreductase (tdiC), an aminotransferase (tdiD), and a gene of unknown function similar to a
methyl transferase (tdiE). (C) Synteny plot of the known meroterpenoid cluster of terretonin in A. terreus and the candidate cluster of novofumigatonin in A.
novofumigatus (scaffold 14, 103,246–136,450 bp). (D) The chemical structure of chlorflavonin and the candidate cluster for chlorflavonin in A. campestris
(scaffold 1, 576,100–603,958 bp). The hydroxylation has been highlighted with blue, the O-methylation has been highlighted in purple, and the PKS backbone
has been highlighted in orange. (E) Synteny plot of putative chlorflavonin clusters in A. candidus and A. campestris.
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clusters were identified in both species by using the aflatoxin genes
identified in A. flavus AF70 (AY510453) (42).
Comparing the two clusters from A. flavus NRRL3357 with
A. ochraceoroseus, it is evident that the synteny is character-
ized by gene shuffling (Fig. 3A). The identified cluster in A.
ochraceoroseus is more similar to the ST gene cluster known
from A. nidulans in the organization of genes, which was also
the result of previous findings (14). This is evolutionary very
interesting, as the clusters producing the same compound are
quite different in their synteny, suggesting cluster dynamics or
distant evolutionary origin.
As found by Cary et al. (14) it was seen that the A. flavus aflP
and aflQ genes are missing in the A. ochraceoroseus aflatoxin
cluster. These genes are important for the biosynthesis of afla-
toxin. The whole-genome sequence was searched for orthologs
to the aflP and aflQ genes from A. flavus, using BLASTP. The
best hit for aflQ was JGI protein 547596, with identity 56.3% and
coverage of 95.3%. The best hits for aflP were JGI proteins
430163, 506769, and 427152, with identity ranging from 40.5% to
36.6% and coverage between 31.4% and 37.7%. All the potential
genes are located on a different scaffold than the aflatoxin
cluster. The genes identified here are possible candidates for the
A. ochraceoroseus version of the aflP and aflQ genes. With this
information, it is not possible to determine exactly which genes
are responsible for the conversion from ST to aflatoxin, but based
on homology, these are the best candidates. Another possibility
could be that the aflP and aflQ genes in A. ochraceoroseus have
arisen via convergent evolution, and would thus not be found via
homology analysis.
In summary, the identified aflatoxin gene cluster in this A.
ochraceoroseus genome shows that A. ochraceoroseus and A.
flavus most likely represent various stages of the aflatoxin cluster
evolution. However, to get the full picture and truly understand
the evolution of the clusters, more aflatoxin and sterigmatocystin
producers need to be sequenced to be able to make bigger
comparisons and get a better idea of where and when the dif-
ferent variations were created.
Identifying the Ochrindol Cluster in A. steynii. Ochrindoles are
prenylated bisindolyl benzoid/quinone metabolites (SI Appendix,
Fig. S2) that have shown anti-insectant properties (43), one
reason that A. steynii is an interesting species. Ochrindol is
produced by A. steynii, and the chemical structure is known, but
the biosynthetic pathway is unknown (44). However, the bio-
synthesis of a similar compound, terrequinone (SI Appendix, Fig.
S2), produced by A. nidulans, is known, and so are the five
biosynthetic genes tdiA–tdiE (45). It has been shown that
ochrindol D is produced as an intermediate during biosynthesis
of terrequinone. We therefore hypothesize that the genes for the
biosynthesis would be partly similar, and could thus be used to
identify the ochrindol cluster.
First, the five tdi genes were identified in the A. nidulans ge-
nome in a predicted cluster consisting of 17 genes. Significantly,
five genes similar to A. nidulans tdiA–tdiE were identified in a
predicted cluster of 17 genes, with the synteny of the tdiA–tdiE
orthologs conserved (Fig. 3B and SI Appendix, Table S4).
However, none of the genes next to the five tdi genes showed any
homology or synteny, suggesting that the size of the cluster is
overpredicted, at least in A. nidulans. In A. steynii, some of the
extra genes could be involved in ochrindol production.
Identifying the Chlorflavonin Cluster in A. campestris. Chlorflavonin
was the first fully characterized flavone with fungal origin, and it is
also the first naturally occurring flavone discovered to be chlori-
nated. It has been shown to have antifungal properties against
specific species (46). The chemical structure of chlorflavonin (SI
Appendix, Fig. S2) is known, and a biosynthetic pathway has been
proposed, but no genes associated with the biosynthesis have been
identified (47). With the whole-genome sequence for A. campestris
at hand, we started exploring the genetic potential to identify the
biosynthetic gene cluster responsible for producing this interesting
compound.
Initially, looking at the chemical structure of this fungal fla-
vonoid, an obvious idea for the biosynthesis would be that the
backbone structure is created by a type III PKS, as the com-
pound is so similar to plant flavonoids produced by type III PKS
(48, 49). However, no type III PKS were found in A. campestris,
suggesting a fungal-specific mode of biosynthesis. Next, investi-
gating the chemical structure and proposed general biosynthesis
for chlorflavonin (47), it could be deduced that the cluster must
contain at least a PKS/hybrid backbone, three monooxygenases,
three methyltransferases, and a chlorinating enzyme. Only one
cluster met the requirements of three monooxygenases and three
methyltransferases (Fig. 3D). The only concern with this candi-
date cluster is the lack of the essential chlorinating enzyme (SI
Appendix, Table S5, Part 3).
First, sequences of known chlorinating enzymes (SI Appendix,
Table S5, Part 1) were used to search for similar proteins in A.
campestris, using BLASTP, but no genes were found (51–54).
Second, relevant possible chlorinating InterPro domains were
identified and found in four genes (SI Appendix, Table S5, Part
2), although it was not possible to pinpoint the best candidate of
the chlorinating enzyme with these methods. However, the identi-
fied cluster is currently the best candidate cluster for chlorflavonin in
A. campestris. Verification of this by knock-out experiments or
heterologous expression could verify the candidate clusters as being
responsible for the production of chlorflavonin, but this organism is
not currently genetically engineerable, and the gene cluster is too
large to transfer.
We therefore set out to support our prediction by sequencing
and comparing genomes of several closely related species from
section Candidi. A. candidus is a known chlorflavonin producer,
whereas A. taichungensis is not (50). These species were there-
fore whole-genome sequenced to compare the pattern of the
producers with the predicted clusters. A. campestris, A. candidus,
and A. taichungensis each have 48, 45, and 43 predicted clusters.
Based on the backbone,A. campestris and A. candidus share 35 clusters
and A. campestris and A. taichungensis share 31 (BLASTP ≥50%
identity and ≥130% hit+query coverage).
Comparing the genes found in the putative chlorflavonin
cluster in A. campestris with the whole-genome sequences of A.
candidus and A. taichungensis, A. candidus was homologous to
genes in the putative chlorflavonin cluster (Fig. 3E). Moreover,
this cluster is also the only cluster in A. candidus that has three
methyltransferases and three monooxygenases. A. taichungensis,
in contrast, does not have any significant hits of the predicted
biosynthesis genes, as would be expected.
In addition, the chlorinating potential was investigated in
these species. As with A. campestris, there were no BLASTP hits
in A. candidus and A. taichungensis from the known chlorinating
proteins (SI Appendix, Table S5, Part 1) (51–54).
Also, the possible chlorinating InterPro domains were in-
vestigated in the genomes of A. candidus and A. taichungensis.
The number of hits were similar; however, A. campestris had one
more hit for IPR001568, and both A. campestirs and A. candidus
had one more hit for IPR008775, but none of the hits is found in
SMURF-predicted clusters (SI Appendix, Table S5, Part 2).
These investigations further support that the identified cluster in
A. campestris is the best candidate for chlorflavonin biosynthesis.
Conclusion
In this study, high-quality PacBio genome sequence data were
generated for four Aspergillus species (A. campestris, A. novofu-
migatus, A. ochraceoroseus, and A. steynii) and investigated using
comparative genomics. Furthermore, we have prepared draft genome
sequences for two additional species: A. taichungensis and A. candidus.
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These six species are diverse and represent various sections of the
Aspergillus genus, and thereby provide insight into the genomic and
biochemical diversity and potential of the genus.
The four PacBio sequenced species have been compared with
a group of already whole-genome-sequenced Aspergillus species
to determine the level of genetic diversity. A phylogram was
constructed on the basis of the whole-genome proteomes, and
the resulting tree supports the taxonomy of the genus and fits
with a phylogenetic tree constructed by Peterson SW (21) and
Kocsubé S, et al. (22), based on four loci or nine loci (21, 22).
The tree confirms that A. campestris, A. ochraceoroseus, and A.
steynii indeed represent sections of the Aspergillus genus, which
have not been genome sequenced before. Analysis of the ge-
nomes show that these genomes represent a large number of
species-specific genes, particularly within secondary metabolism.
Investigation of the presence of N6-methyldeoxyadenine of
the four presented species shows very low levels of 6mA. More-
over, no 6mA sites were found symmetrically at ApTs, which has
been found to be a characteristic feature of 6mA modification in
early-diverging fungi (18), thus confirming previous suggestions
that 6mA methylation is not significant in Aspergilli.
A. novofumigatus has been compared with a close relative, the
pathogenic species A. fumigatus, to better understand the mecha-
nism of pathogenicity and virulence. The predicted SM gene clusters
were found to be very different for the two close relatives, with A.
novofumigatus containing 65% more clusters than A. fumigatus.
All allergens known from A. fumigatus are also present in A.
novofumigatus, and the majority of the virulence factors are
shared between the two species. The major difference is that A.
novofumigatus lacks the fumitremorgin cluster. However, it has
been suggested that proxy-exometabolites may serve the same
function and A. novofumigatus has an extensive arsenal of additional
SM gene clusters. It is thus highly likely that A. novofumigatus is a
highly capable pathogen.
Furthermore, we have, with multiple examples, demonstrated
that it is possible to identify the respective gene cluster using
whole-genome sequences if one has a well-established structure
of a SM and biological and chemical insights to the pathway. This
way we have reidentified the aflatoxin gene cluster in A. ochraceor-
oseus; the epi-aszonalenins, novofumigatonin, and ent-cycloechinulin
gene clusters in A. novofumigatus; the ochrindol cluster in A. steynii;
and finally, the chlorflavonin cluster in A. campestris, backed by
additional info from sequencing the A. taichungensis and A.
candidus genomes.
In summary, the six genome sequences presented in this study
illustrate the large diversity found in the Aspergillus genus and
highlight the potential for discovery of structurally diverse SMs.
As our project of sequencing +300 species progresses along with
other fungal genome sequencing projects (e.g., the 1K fungal
genomes project 1000.fungalgenomes.org/home/), the potential
for applying comparative genomics to get evolutionary insights
and discover interesting SMs will only increase.
Materials and Methods
The materials include a list of sequenced strains. Methods include strain
cultivation; genome sequencing, assembly, and annotation; DNA-methylation
analysis; details for comparative genomics analysis; phylogeny; and chemical
analysis of secondary metabolism. Details for all methods are found in SI
Appendix, SI Text. In particular, we provide a detailed protocol for efficient,
reproducible, and scalable DNA and RNA extraction from fungi.
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3.2 Manuscript II – Comparative genomics of section Flavi
The Aspergillus section Flavi belongs to subgenus Circumdati. The section con-
tains species extremely important to our society including the industrial workhorse
A. oryzae, the food fermenting A. sojae and the crop spoilers and toxin producers
A. flavus and A. parasiticus. Besides these (in)famous species, the section also
includes at least 19 other less studied species.
We have made a genomic comparisons of 23 members of the section, where we
de novo sequenced 19 species. The species already sequenced were all from the
same clade end hence only covered a small part of the diversity of the section.
With our additional species we have a wide coverage of the section and even more
species from the most studied clade giving an even higher resolution. Our analysis
has shown that section Flavi have certain general characteristics, including large
genomes which is reflected in the high number of predicted secondary metabolite
gene clusters and carbohydrate active enzymes (CAZymes). These features make
the Flavi section highly interesting for future genome mining.
With whole genome sequences covering the entire section, it has been possible
to investigate issues such as phylogeny and toxin production to gain new insights.
The phylogeny was for instance investigated based on 200 genes revealing evo-
lutionary patterns that have not been seen before concerning the relatedness of
species within the extensively studied A. flavus clade. The distribution of sec-
ondary metabolite gene clusters including known toxins such as aflatoxin has been
investigated to show the potential across the section and compared with experi-
mental data.
The findings presented in Manuscript II illustrates even more uses of compar-
ative genomics both in terms of what analysis that can be used and what insights
we can gain.
Manuscript II will be submitted to Genome Biology. The additional files can be
found in Appendix B.
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Friends and foes – A comparative genomics study
of 23 Aspergillus species from section Flavi
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Abstract
Background: Section Flavi encompasses several extremely important species both harmful and beneficial. The
best known are most likely A. oryzae used in food fermentation and enzyme production and A. flavus, a food
and feed spoiler and mycotoxin producer. As part of the whole-genus Aspergillus sequencing project we have
generated 19 genomes de novo spanning the breadth of the Flavi section. We have made comparisons of 31
fungal genomes including 23 species from the Flavi section in order to investigate the genomic diversity of this
important section.
Results: Based on the genomes, we have predicted 13,759 CAZymes and 1,972 secondary metabolite gene
clusters and shown that the Flavi species in general have a high number of both CAZymes and secondary
metabolite gene clusters compared to other Aspergillus species. The CAZy content was compared with growth
experiments on 35 media showing that the genetic variations are not necessarily reflected in the growth
patterns. The secondary metabolite gene clusters were divided into families and coupled to compounds,
allowing predictions of 20 compound families in 31 species. Focusing on the highly toxic aflatoxin gene cluster,
we have shown that it is conserved in 14 section Flavi species and that a very short version is found in A.
caelatus, and most likely a complete loss has happened in A. tamarii. By coupling the cluster predictions to
chemical data of the Flavi species we have been able to identify a putative miyakamide biosynthetic gene
cluster demonstrating one of the versatile possibilities unlocked from this data.
Conclusion: In summary we have generated a highly valuable and versatile resource and used it to
demonstrate the diversity and similarities of the Flavi section both in terms of CAZy content and secondary
metabolite potential.
Keywords: Aspergillus; Comparative Genomics; Secondary Metabolism
Background
Aspergillus section Flavi encompasses a large number
of species, many of whom have a significant impact
on human life: Some species (e.g. A.oryzae and A.
sojae) are extensively used in food fermentation for
the production of sake, miso, soy sauce, and other fer-
mented foods. Moreover, A. oryzae is also used indus-
trially for enzyme and secondary metabolite produc-
tion [36, 46, 65]. In contrast, other Flavi species (e.g.
A. flavus and A. paraciticus) are notorious for produc-
*Correspondence: mr@bio.dtu.dk
1Department of Biotechnology and Bioengineering, Technical University of
Denmark, Søltoft Plads 223, 2800 Kongens Lyngby, Denmark
Full list of author information is available at the end of the article
ing highly toxic fungal compounds, the aflatoxins, in
addition to infecting and damaging crops [25, 34, 83].
Furthermore, A. flavus has the capability of infect-
ing immunocompromised humans, and is now the sec-
ond leading species associated with human aspergillo-
sis [27, 38]
Besides these well-studied species, the section also
includes several less known species that like their
(in)famous relatives includes both beneficial and harm-
ful properties. There are potential positive impacts
from the producers of bioactive compounds (antiinsec-
tant N-alkoxypyridone metabolite, leporin A, from A.
leporis; an antibiotic with antifungal activity, avenaci-
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olide, from A.avenaceus) and enzymes producers (in-
cluding amylases, proteases and xylanolytic enzymes
in A.tamarii and pectin degrading enzymes in A. al-
liaceus). On the harmful side, plant pathogens (A. al-
liaceus on onion bulb, A. nomius on nuts, seeds and
grains) and toxin producers (ochratoxin from A. alli-
aceus, aflatoxin from A. nomius) are also found among
these less studied Flavi species [79].
Given the high impact that species of Section Flavi
have in industrial enzyme production, food fermention,
toxin production and crop disease, it is important to
examine the full potential of the section to assess the
potential alternative species for industrial use, novel
bioactive compound production and as a source of
useful enzymes while also characterizing each genome
for the purpose of mitigating food spoilage, mycotoxin
production and pathogenicity.
At the onset of this project, whole geneome se-
quence was available for five species from section Flavi
(A. oryzae, A. flavus, A. sojae, A. bombycis, and A.
paraciticus) [43, 45, 56, 62, 65]. They all belong to the
A.flavus clade which is closely related and only covers
a small part of the total section. In this study, as part
of the Aspergillus Genus Sequencing Project, we have
generated genome sequence for 18 additional species
plus an additional A. parasiticus isolate, permitting
genomic comparisons across 23 members of Section
Flavi.
Comparing genomes across a section-wide represen-
tation allows for examination of important features
for food fermentation and exploration of enzyme and
bioactive compound potential. We gain insights into
the core attributes of the section as well as the dif-
ferences and diversity across the section, which will
give a better understanding of the widely used species
and an appreciation of the potential of the section with
many unexplored resources. The understanding gained
from this study are useful for 1) exploring novel en-
zymes and secondary metabolites, 2) optimizing food
fermentation and industrial use and 3) improve food
and feed protection and control. We have applied ad-
vanced comparative genomics to identify core, species-
specific and section and clade specific genes. From our
analysis we developed a deeper understanding of the
diversity and similarities within the section and of each
species.
Results and Discussion
Analysis of 19 newly sequenced genomes show large
genome size in section Flavi
In this study we present the whole genome sequences
of 19 species from Aspergillus section Flavi (Figure1
panel B). The analysis of these genomes also include
previously sequenced section Flavi species (A. oryzae,
A.flavus, A. sojae, A. bombycis [45, 56, 62, 65]).
During the time of this project two additional Flavi
genomes have been published, A. nomius and A.
arachidicola [55, 57] which have not been used in
this analysis instead we have used our own sequenced
strains of these species. In order to assess the quality
of the data and generate a picture of the genome di-
versity of the Flavi section we investigated the quality
of the genome assemblies and compared the genome
attributes such as genome size, GC content and num-
ber of predicted proteins. The results are displayed in
Figure 1C.
The genome assemblies generated for this study are
of similar quality with 13 out of the 18 genomes as-
sembled into fewer than 500 scaffolds, Figure 1C (col-
umn 5). A. coremiformiis has the highest number of
scaffolds, 2,728. With such a high number of scaffolds
we were concerned with the quality of the genome.
However the percentage of core genes from BUSCO
(Benchmarking Universal Single-Copy Orthologs) [69]
is 99.78% lacking only a phosphomannomutase, sug-
gesting that the gene content is of appropriately high
quality despite the large number of scaffolds.
The genome sizes of Aspergillus section Flavi are
large with a mean of 37.96 Mbp compared to 31.7 Mbp
for other representative Aspergilli, see Figure 1C (col-
umn 1). Notably, in section Flavi there is one partic-
ular exception — A. coremiformiis — which is only
30.1 Mbp, also reflected in the number of predicted
proteins ranging from 9078 to 14216 for A. coremi-
formiis and A. novoparasiticus respectively. The large
genome sizes compared with other Aspergilli have been
reported for A.oryzae [19] and the data presented here
suggests this is a trait shared by most species in the
Flavi section. Functional annotation covers 68-81% of
the predicted proteins in section Flavi.
From our investigations we confirm that the genomes
are of high quality and that a section Flavi specific
trait is large genomes both in terms of size (Mbp) and
number of predicted proteins (with A. coremiformiis
as one major exception).
Phylogeny of section Flavi
Next we examined the evolutionary relationships and
relatedness of section Flavi based on genome sequences
and predicted proteins. To do this we constructed a
maximum likelihood phylogenetic tree based on 200
monocore genes (genes having exactly one homolog in
each genome), Figure 1A. The tree shows that sec-
tion Flavi is a monophyletic group. The clades within
section Flavi correspond to what has been seen for
a phylogenetic tree based on the β-tubulin gene with
the A. tamarii clade as neighbour to the A. flavus, fol-
lowed by the A. nomius, A. togoensis, A. alliaceus, A.
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leporis and A. avenaceus clade [79]. A. bertholletius
was not included in the study by Varga et al., but
Taniwaki et al. have shown that it falls in between the
A. nomius and A. togoensis clades in its own distinct
clade which is confirmed here [75]. The species from
section Circumdati and Terrei are closest related to
the Flavi section followed by the Nigri, Nidulantes,
and Fumigati section which was also seen by Kocsube
et al. [37].
The support of the branching within the tree is gen-
erally high, with most branch points supported by 100
out of 100 bootstraps. This also includes the distinc-
tion between section Flavi and the neighbouring sec-
tions. Within section Flavi the only branch below 80
bootstraps is between A. flavus and A. sojae. It is in-
deed also surprising that A. sojae is found closest to
A. flavus since A. sojae is perceived as a domesticated
version of A. parasiticus, while A. oryzae, perceived
as a domesticated version of A. flavus is not next to
it in the tree [39, 79, 84]. There have been reports
suggesting that A. oryzae descended from an ances-
tor that was the ancestor of A. minisclerotigenes or
A. parvisclerotigenus based on the region neighbour-
ing the cyclopiazonic acid biosynthetic gene cluster [8]
which may be supported by this tree where A. oryzae
is between A. minisclerotigenes and A. parviscleroti-
genus.
It is worth noting that within the A. flavus clade,
the species are very closely related it can therefore be
difficult to resolve the inter-species relationships. In
an attempt to increase the resolution and resolve the
A. flavus clade we created phylogenetic trees based on
300 and 500 monocore genes, see additional file Fig-
ure B1 and B2. In each of the generated trees only A.
sojae changes position while the other A. flavus clade
species have steady positions. The bootstrap values for
A. sojae are 37 and 32 out of 100 for the tree based
on 300 and 500 sequences respectively. In none of the
trees A. sojae is closest to A. parasiticus, but rather in
between the group with A. flavus and A. parasiticus.
One explanation for the unstable behavior of A. sojae
could be that it is a hybrid species, or that the pro-
cess of domestication has had significant effects and
a different evolutionary pressure. To investigate the
speculation that A. sojae could be a hybrid species,
which would explain why it is so difficult to place in
the phylogenetic tree, we created single gene trees for
18 of the monocore protein families (Additional file
B3). We would expect that some genes are closely re-
lated to one parent while other genes are closely related
to the other parent in a hybrid species. For 6 of the
single gene trees we see that A. sojae is closest related
to A. flavus, for 6 other we see A. sojae is closer to
A. parasiticus, in 2 trees A. sojae is in between and
the final 4 trees are inconclusive due to lack of reso-
lution. This further supports the hypothesis that A.
sojae potentially could be a hybrid species.
In summary, we show that section Flavi is a mono-
phyletic group and that the previously defined clades
are reflected by the groupings in phylogenies built on
200–500 genes. However it is not possible to resolve the
phylogeny within the A. flavus clade based on whole
genome phylogeny based on 200–500 monocore genes.
Examination of core, section-specific and
species-specific genes
In the view of the genome attributes from the previous
section we wanted to investigate the common traits of
section Flavi and the diversity as individual species-
specific characteristics in order to generate an under-
standing of core feature shared by all section Flavi
species and to identify variations and specific features
important for their various uses and purposes such as
food fermentation, plant and human pathogenicity.
To do this we constructed families of homologous
proteins across the species found in Figure 1 using an
existing pipeline [80]. This approach makes it possible
to identify homologs within and across the species, we
use the term homolgs since we are not doing functional
analysis of these genes and therefore we cannot confi-
dentially disticguish between orthologs and paralogs.
Using these homologous protein families we identified
1) the core genome - protein families with at least one
member in all species. This is expected to be essential
functions such as those important for growth and pri-
mary metabolism. 2) Clade and section specific genes -
genes that have homologs in all members of the group
but not with any other species. These genes are ex-
pected to be involved in phenotypical traits specific
for that group, it could be secondary metabolite genes
or specific carbon utilization. 3) Species-specific genes
- genes without homologs in any other species in the
comparison. Species-unique genes are presumed to be
possible gene annotation errors or encompassing phe-
notypical traits unique to one species important for
speciation and adaptation [80].
With regard to core genes, it is important to note
that depending on which species are included in the
construction of the families, the core will change: the
closer related the species are, the bigger the core will be
as those species will have more functions in common.
Thus the core of the set including all 31 species in this
dataset is 2,082 protein families, whereas the core in-
cluding only the 29 Aspergillus species is 3,853 and for
section Flavi alone, it is 4,903 protein families. The
Aspergillus core ranges from 38.04% for A. novopar-
asiticus to 50.83% for A. coremiiformis of the total
genome while the Flavi core ranges from 47.35-63.43%
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for A. novoparasiticus and A. coremiiformis respec-
tively. Hence, about half of the section Flavi genomes
are varied when comparing across the section.
By coupling the protein families to the phylogenetic
tree, it is possible to identify section and clade specific
genes and species unique genes. There are 92 section
Flavi -specific protein families. The number of clade-
specific families ranges from 27 (A. flavus clade), 28
(A. tamarii clade) to 54 for the A. nomius clade which
is low compared with section Nigri examined previ-
ously [80]. The fact that there are few clade-specific
genes could indicate that some clades are closely re-
lated and that species from two different clades in sec-
tion Flavi might share many features. The A. flavus
and A. tamrii clade for instance shares 22 protein fam-
ilies which is nearly as many as the clade specific fam-
ilies they have.
Lastly, the species-specific genes for section Flavi
species ranges from 2,181 to 166 in A. leporis and
A. sojae respectively. The number of species-specific
genes in A. sojae is very low, compared to an earlier
study of section Nigri including 6 different strains of A.
niger where the number of strain-specific genes ranged
from 182 for NRRL3 to 1015 for CBS 513.88 but most
had around 3-400 strain-specific genes [80]. While this
raises the question whether A. sojae is or is not its own
species, it should be noted that the A. sojae genome
was annotated with different gene modeling pipeline
than the genomes we generated for this study and
could therefore influence these numbers. The species
question has been discussed previously concerning the
relationship between A. flavus and A. oryzae and it
seems that the argument of practicality and food safety
is a factor when regarding them as separate species for
regulatory reasons rather than evolutionary or phylo-
gentic reasons [20, 24, 35].
As mentioned above, the species-unique genes are
expected to retain a part of what sets a species apart
from other species [80] making it interesting to inves-
tigate these genes in more detail. We examined the
functions to investigate if they live up to the expec-
tation and the statistical significance to see if there is
an enrichment of specific functional domains in species
unique genes.
We examined the functions of the species unique
genes using InterPro, GO and KOG annotations [18,
22, 23, 76]. The portion of species-specific genes with a
functional annotation was 20, 12 and 9 percent for In-
terPro, GO and KOG respectively. In total, 21% of the
species-specific genes had an annotation. We will focus
on InterPro annotations since it covers the most (most
common GO and KOG annotations, Additional file,
Figure B5 and B6). For InterPro, the most common
functions range from transcription factor, protein ki-
nase, transporter to P450 (Figure Additional file, Fig-
ure B4). These functions fit well with our expectation
of proteins that could be involved in phenotypic traits.
For the most common IPR, GO and KOG domains,
we investigated whether these functions are more of-
ten associated with species-specific genes. We used
Fisher’s exact test to investigate if there is a signifi-
cant association between the annotated functions and
species-specific genes. The majority of the most com-
mon domains have p-values below 0.005 or 0.00001
which are indicated by stars in the figures of Addi-
tional file Figure B4, B5 and B6. Looking at all the
functions found in species unique genes approximately
43% of the InterPro domains are enriched in species
unique genes with p-values below 0.01, indicating that
there is an enrichment of certain functional domains
in species unique genes.
Species-specific and secondary metabolite genes are
localized towards the the subtelomeric regions
In a study by Galagan et al. it was shown that the
subtelomeric sequences are associated with extensively
rearranged regions lacking synteny when comparing A.
nidulans, A. oryzae and A. fumigatus [19]. This phe-
nomenon has also been described for mammals, ne-
matodes and yeasts [15]. A comparative genomic hy-
bridization (CGH) study of A. fumigatus Af293 with
two other A. fumigatus strains and three closely re-
lated species showed that there was a bias towards
sub-telomeric regions for the unique, diverged or miss-
ing genes [61]. Another feature enriched in the sub-
telomeric regions is the presence of predicted sec-
ondary metabolite gene clusters (SMGCs) seen for A.
nidulans and A. fumigatus. It was thus suggested that
the sub-telomeric region promotes species specific evo-
lution of the secondary metabolite genes (SMGs) and
that the SMGs play a role in the ecology [19].
We therefore examined the location of species-unique
genes and predicted secondary metabolite clusters in
order to assess the potential over-representation of
these genes in telomeric regions. We used the nearly
completely assembled genome (distributed on 8 chro-
mosomes plus 3 scaffolds) of A. oryzae as the refer-
ence for analysis of gene location, Figure 3. We cal-
culated the density of the genes across the genome
(Figure 3, black graph), identified the core genes and
mapped them to the genome (grey dots), shown be-
low the chromosomes in Figure 3. The 696 A. oryzae
species-specific genes and the 456 predicted SMG were
identified and mapped to the genome shown above the
chromosomes, Figure 3. Based on the density of the
total number of genes, the percentage of the unique
and the SMG were calculated and plotted above the
chromosome as graphs.
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From our plot it is clear that the core genes are
found spread across all the chromosomes, but with
a lower concentration at the sub-telomeric ends. In
the sub-telomeric ends, unique and SMG are definitely
found but some are also spread across the genome. The
species specific and clade specific genes from A. oryzae
were also mapped to the genome but no clear pattern
was observable. To examine whether or not the pat-
tern of the unique and SMGs is statistically significant
we performed Fisher’s exact test which showed that
both unique (p-value = 7.266e-07) and SMGs (p-value
< 2.2e-16) are enriched towards the sub-telomeric re-
gions (100 kbp from the chromosomal ends) support-
ing previous work by Galagan et al. and Nierman et
al. [19, 61]. The fact that the species-specific genes are
not randomly distributed argues against the possibil-
ity that species-specific genes are simply annotation
or gene modeling errors, therefore indicating that they
are, indeed, legitimate genes. The distribution of the
species-specific genes could indicate the existence of
a mechanism where new genes enter the genome at
telomeric regions with higher frequency, or it could
be an indication of a counter selection preventing new
genes in conserved regions potentially because those
changes kills the host in most cases or it could be a
combination of both.
Analysis of syntenic and non-syntenic regions in section
Flavi
Another factor to consider when analysing genome lo-
cation is syntenic regions and non syntenic regions.
It has been shown that the A. oryzae genome has a
mosaic pattern of syntenic and non syntenic regions
with more non-syntenic regions proximal to telomeric
ends [36, 46]. We examined the synteny across the
Flavi section using A. oryzae as reference and com-
pared with the section Flavi genomes plus A. nidulans
and A. fumigatus. The number of syntenic genes and
the percentage of the A. oryzae genome can be seen
in Table 1. A. oryzae shares the highest synteny with
A. minisclerotigenes with 75.59% of the genes being
syntenic followed by 72.20% to A. flavus. This is an-
other indication that A. oryzae is closest related to A.
minisclerotigenes and not A. flavus.
Shared syntenic genes are illustrated on Figure 4,
where the genes syntenic in all species in a group (A.
flavus clade; A. flavus and A. tamarii ; A. flavus, A.
tamarii and A. nomius; Flavi section; Flavi section,
A. nidulans and A. fumigatus) are shown. The species
within the A flavus clade shares a high degree of syn-
teny which is conserved across most of the genome.
When more distantly related species are included the
syntenic regions are reduced.
In general, there are fewer regions of synteny towards
the telomeric ends corresponding with earlier studies
made with three species from different clades (A. nidu-
lans, A. fumigatus and A. oryzae) [36, 46] . The more
distant the compared species, the more pronounced the
trend. We also observe that some chromosomes (espe-
cially chromosome 1 and 2) has a very high degree
of conserved synteny across all the species compared,
while others (such as chromosome 6 and 8) have a
much lower syntenic conservation.
A. oryzae genes that are non-syntenic in all the
species in this study are marked below the chromosome
in black, Figure 4. They are as expected based on the
analysis above and previous studies found in a higher
density towards the telomeric ends. More surprisingly
there are some blocks of non-syntenic genes found with
very high density at some specific regions, one on chro-
mosome 4, 6 and 8. One explanation for these non syn-
tenic blocks could be horizontal gene transfer (HGT),
another explanation could be gene shuﬄing or de novo
gene formation of A. oryzae specific genes potentially
by a major event of gene duplication followed by di-
vergence.
HGT was investigated using BLASTp to examine the
best hits in the NCBI non-redudant database. Recent
HGT are expected to have high identity with another
group of species where it would have been transferred
from, and not be found in the closely related species.
None of the genes within these blocks showed sign of
recent HGT (data not shown). The non-syntenic block
genes were compared with the identified A. oryzae
unique genes. Only 23 of the 80 genes in the non-
syntenic blocks were A. oryzae unique genes. It thus
seems likely that these non-syntenic blocks are caused
by significant rearrangements and the emergence of A.
oryzae unique genes.
Taken together, these observations — some very con-
served chromosome and some highly rearranged non
syntenic blocks — could indicate an evolutionary pres-
sure for stability in some regions while other regions
are frequently subject to gene shuﬄing and rearrange-
ments, i.e. rearrangement hot spots.
Section Flavi is a rich source of Carbohydrate Active
Enzymes
Carbohydrate-Active enZymes (CAZymes) are essen-
tial for what carbon sources a species can degrade and
utilize. The Aspergillus genus is known to have a high
number of these enzymes and a wide span and hence
the ability to degrade and convert a broad range of
plant biomass [13]. Aspergilli are considered general-
ists concerning carbon utilization since they are capa-
ble of degrading various plant biomass and are thus
not specialized on one thing [4, 12]. Within section
Flavi this is mainly described for A. oryzae [3, 36, 46]
and to a lesser extent for A. flavus [4, 31, 47, 59, 70]
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and A. sojae [29, 51], while only incidental stud-
ies have been performed with other species of this
group [11, 28, 49, 58, 64, 66, 68], often describing pro-
duction or characterization of certain CAZyme activity
or protein, respectively.
To investigate the genomic diversity and enzyme po-
tential of section Flavi, we used the Carbohydrate-
Active Enzymes database (CAZy) to predict the
CAZyme content in each of the genomes. A total of
13,759 CAZymes were predicted within the 23 Flavi
species with an average of 598 per species which is
higher than the other Aspergilli in the set having an
average of 508 per species, Figure 5A. A. parasiticus
has the highest CAZyme content with 663 while A.
coremiformiis has the lowest with 383.
Each of the identified CAZymes belongs to one
of the seven classes of enzyme activity. The most
common CAZyme class is composed of the Glyco-
side hydrolases (GH) with more than 250 proteins
per species followed by Glycosyltransferases, Auxiliary
activities, Carbohydrate-binding molecules, Carbohy-
drate esterases, Polysaccharide lysases and Distant
plant expansins. Comparing the number of proteins
within each CAZyme class for the clades within sec-
tion Flavi, glycoside hydrolases has a higher number of
proteins in clade A. flavus followed by A. tamarii and
A. nomius, Figure 5B. The similar pattern is found for
Auxiliary activities where the highest number is found
in A. flavus followed by A. nomius and A. tamarii. For
Glycosyltransferases the highest number of proteins is
found in clade A. nomius with slightly lower but simi-
lar number of proteins in the rest of section Flavi. For
carbohydrate esterases the number of proteins is very
similar across the groupings.
Comparing the diversity, the number of subgroups
across the CAZyme classes it is quite similar across
clades for most of the classes except Glycoside hydro-
lases where the A. flavus, A. tamarii and A. nomius
clades had higher diversity compared to the rest, Fig-
ure 5B. Polysaccharide lysases have a slightly higher
diversity for the A. flavus and A. tamarii clade.
The different clades of section Flavi contain variable
CAZyme gene content, but this does not seem to
specifically effect their ability to degrade plant biomass
To evaluate the actual carbon utilization ability across
section Flavi and compare it to other fungal species,
we performed growth profiling of 31 species (29 As-
pergilli, including 23 species from section Flavi) on 35
plant biomass-related substrates, Figure 6 (Additional
file Figure B7 and Table B1) and compared this to the
CAZy gene content prediction related to plant biomass
degradation (Additional file Table B2). D-Glucose re-
sulted in the best growth of all monosaccharides for
all species and was therefore used as an internal ref-
erence for growth, Additional Figure B7. Growth on
other carbon sources was compared to growth on D-
glucose and this relative difference was compared be-
tween the species. While in a previous study the vari-
ation in growth between distantly related Aspergilli
could be linked to differences in CAZy gene content
in their genomes [13], this was not the case in a re-
cent study addressing species of the section Nigri of
Aspergillus [80]. The CAZyme sets of section Flavi re-
lated to plant biomass degradation are overall highly
similar (Figure 6), especially when comparing species
of the same clades, but there are some noteworthy ex-
ceptions. A. coremiiformis has a strongly reduced gene
set compared to all other members of section Flavi, in-
cluding its closest relatives (A. leporis and species of
the A. alliaceus clade), as well as to the other As-
pergilli, and is similar in CAZyme content to Penicil-
lium digitatum.
The A. alliaceus and A. nomius clades together with
A. bertholletius are highly similar in CAZyme con-
tent, but contain a somewhat lower number than the
A. tamarii and A. flavus clades (Figure 6). The A.
tamarii and A. flavus clades are also highly similar,
with the exception of A. coelatus (A. tamarii clade)
that has even lower number of CAZymes than the A.
nomius clade. When looking more closely at number of
genes in individual CAZy families in section Flavi, Ad-
ditional file Table B2, some differences can be observed
that may affect their hydrolytic abilities. A. alliaceus
is expanded in specific xylanolytic (GH11 endoxy-
lanase) and xyloglucanolytic (GH12 xyloglucan-active
endoglucanase) genes, while expansion of the number
of genes in the cellulolytic family GH45 in this species
is shared with another members of the A. flavus clade
(A. parasiticus) as well as A. coremiiformis (clade
A. togoensis). Differences are also observed between
the clades of section Flavi (Additional file Table B2).
Clade A. togoensis has a reduced set of xylanolytic and
xyloglucanolytic genes, but this is not reflected in the
growth of these species on xylan. Two xyloglucanolytic
families (GH29 α-fucosidase and GH74 xyloglucan-
active endoglucanase) were absent in all species of
section Flavi, but present in other Aspergilli. In con-
trast, expansion of several xylanolytic families was
observed in specific clades. GH115 (α-glucuronidase)
is expanded in clades A. flavus, A. tamarii and A.
nomius. Accordingly, xylanolytic enzymes or activity
have been reported from several species from these
clades [17, 28, 32, 49, 54, 64, 68, 71, 72]. GH62 (ara-
binoxylan arabinofuranohydrolase) was expanded in
clade A. leporis. Clades A. leporis and A. avenaceus
were the only clades from section Flavi that had genes
of CE15 (glucuronoyl esterase), which were also found
in Aspergillus species outside section Flavi.
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The galactomannan degrading ability was nearly
fully conserved in section Flavi, but interestingly
growth on guar gum that consists mainly of galac-
tomannan was variable between the species. We re-
cently demonstrated that guar gum contains small
amounts of other sugars that can trigger the produc-
tion of enzymes with preferred activity towards other
polysaccharides than galactomannan (R.P. de Vries,
personal communication, manuscript in preparation),
suggesting that the variation on growth is more likely
due to regulatory differences in gene expression. Sim-
ilarly, the reduced amylolytic ability of clades A. to-
goensis and A. avanaceus did not result in reduced
growth on starch or maltose.
Large variation of the presence of inulinolytic genes
(GH32) was observed among the species. Endoinuli-
nase encoding genes were only present in clade A. al-
liciaceus, and two species of clade A. flavus. These
species also contained an exoinulinase that was oth-
erwise only found in three species from clade A.
tamarii. The presence on endoinulinase resulted in bet-
ter growth on inulin for most of those species, but sur-
prisingly good growth was also observed for A. coremi-
iformis and A. leporis, which only contain invertases.
Variation was also observed in the number of pecti-
nolytic genes. The most pronounced differences were
the absence of PL11 (rhamnogalacturonan lyase) genes
from most species of section Flavi, except for A. ave-
naceus and the expansion of GH78 (α-rhamnosidase)
in clades A. flavus and A. tamarii. However, these
differences and the smaller ones in other families did
not result in large variation in growth on pectin. In-
terestingly though, some species, e.g. A. oryzae, A.
parasiticus, A. pseudonomius and A. sojae, showed
reduced growth on apple pectin compared to citrus
pectin, but whether this is due to subtle changes in
the pectinolytic ability or sensitivity to possible im-
purities in apple pectin is unclear at this point. Sim-
ilarly, growth on different crude substrates was sim-
ilar for most species, but variable for A. oryzae, A.
pseudonomius and A. sojae. This variation may also
be due to sensitivity to impurities in the substrates
or to fine-tuning of gene expression resulting variably
efficient enzyme mixtures.
As mentioned above, A. coremiiformis had a strong
reduction in CAZyme content. While this was due
to reduced numbers in some families, this species
also specifically lacked a number of families related
to pectin (GH54, GH88, PL1-PLY, PL4, PL9), xylan
(GH62, GH67) and xyloglucan (GH31-AXL, GH95)
degradation. Interestingly, this species showed better
relative growth on xylan than most other species, while
growth on other polysaccharides was mainly similar to
that of the other species of section Flavi. This indi-
cates that the reduced gene set of A. coremiiformis
has not reduced its ability to degrade plant biomass.
This could suggest that plant biomass degradation ap-
proach of A. coremiiformis is more similar to that
found for T. reesei rather than A. niger, as T. ree-
sei also has a reduced CAZy gene set, but produces
the corresponding enzymes at very high level [50].
Growth on monosaccharides was largely similar be-
tween the species of section Flavi Figure 6 (additional
file Figure B7 and Table B1). Growth of all species
was equally good on D-glucose, D-fructose, D-mannose
and D-xylose. This was also the case for L-ribose, ex-
cept for A. parvisclerotigenus, A. pseudotamatii, A.
sergii and A. sojae. Growth on L-arabinose was a
slightly slower, and even more reduced on L-rhamnose
and D-galacturonic acid, but also relatively similar
across the species. Growth was poor on D-galactose,
which is likely due to similar problems with uptake of
D-galactose during germination as has been demon-
strated for A. niger [16].
More obvious differences were present during growth
on cellobiose and lactose. Except for A. albertensis,
A. alliaceus and A. pseudonomius, most species grew
poorly on cellobiose despite similar numbers of β-
glucosidase encoding genes in most species Additional
file Table B2. Similarly, only A. arachidicola, and to a
lesser extent A. albertensis grew well on lactose, while
the number of β-galactosidases in these species is sim-
ilar to that of the other species.
Genomically the CAZy potential is largely conserved
with some variations in copy numbers, but comparing
with for instance the diversity found within secondary
metabolism, the variation in CAZy potential is much
smaller. The genomic potential and variations are not
necessarily reflected in the growth. One explanation
could be that that additional copies have evolved new
functions or that the conditions tested does not trig-
ger the expression of the enzymes. In conclusion, the
CAZyme gene sets of section Flavi is largely conserved,
with the exception of A. cremiiformis, but variation of
growth in plant biomass related oligo- and polysaccha-
rides was observed between them. It is therefore likely
that as suggested previously [13], these differences are
largely at the regulatory level.
Investigation of selected CAZy families important for
food fermentation
We were particularly interested in enzymes belonging
to the GH28 and GH13 families, as these are impor-
tant for the food fermentation process and the quality
of the product [77]. We were therefore interested in in-
vestigating these families and comparing the number
and the relatedness of members of specific CAZyme
subfamilies across the Flavi section. A phylogenetic
tree was created of all members of GH28 from section
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Flavi, Additional file Figure B8. The tree consists of
429 proteins, on average 18.7 per species. The most is
found in A. sergii and A. sojae with 25 and 24 mem-
bers respectively.
Within the tree there are different groupings. Five
have members from all the 23 species (marked with
blue squares). There are nine groupings missing one
to four species (usually A. coremiformiis and A. cae-
latus), two groups have members of all A. flavus, A.
tamarii and A. nomius clades. Lastly there are eight
groupings containing two to 13 species which does not
follow the phylogeny. It seems that the groupings con-
taining all species are distributed throughout the tree
often surrounded by groups missing some a few species
and groupings with some species not following the phy-
logeny. In general species from clade A. flavus has a
high number of GH28 members. A. sojae is known to
have a high number of GH28 which is also seen here,
but A. sergii has even higher. It could be interesting
to investigate and see if this could be exploited either
using A. sergii as a new species in food fermentation
or as a source of novel enzymes.
Secondary Metabolism
Secondary metabolites (SMs) are important source of
beneficial bioactive compounds and harmful toxins. In
additon, SMs are thought to be involved in specia-
tion [80]. The Aspergillus genus is known to produce
a large number of SMs and the number of predicted
secondary metabolite gene clusters (SMGCs) is even
higher. The majority of predicted SMGCs are unchar-
acterized and therefore have the potential to produce
a diversity of novel, bioactive compounds.
We examined the diversity and potential for SM pro-
duction in section Flavi, both quantitatively in terms
of numbers of clusters, and qualitatively in terms of the
compounds these clusters could potentially produce.
We utilized a SMURF-like SMGC prediction, followed
by the creation of SMGC families (expected to pro-
duce the same compound or a derivative) and cluster
dereplication [78].
High diversity of section Flavi secondary metabolism
To quantitatively assess the potential for SM produc-
tion, SMGCs were predicted using a SMURF-like pre-
diction tool [30] for all species except N. crassa and
A. sojae since these were not sequenced and/or anno-
tated by JGI and thus have not the required generated
data and dissimilar gene calling methods.
An overview of the predicted main enzyme responsi-
ble for the formation of the core chemical structure of
the resulting compound (backbone enzyme) for each
species can be seen in Figure 7C. Within the 28 As-
pergillus species, there is a total of 1,972 predicted
SMGCs and for the 22 section Flavi species the total
is 1606 SMGCs with an average of 73 per species. The
maximum of SMGCs is 84 and is found in A. leporis
while the minimum is 37 for A. coremiformiis.
Similar gene clusters (based on sequence similarity
of backbone and tailoring enzymes) are expected to
code for proteins producing compounds with a simi-
lar chemical core structure, therefore, creating fami-
lies of gene clusters allows us to investigate the SM
production potential, evaluate SM diversity and pres-
ence/absence patterns across the section. These fam-
ilies of SMGCs were constructed using the method
described in Theobald et al. [78, 80] (a table of the
predicted clusters and SMGC families can be found
in Additional file B3). For the entire dataset with pre-
dicted SM 477 cluster families were constructed, where
the section Flavi SMGCs belong to 308 cluster fami-
lies. Several cluster families only contain one member
of the section Flavi species 150 clusters have no ’sim-
ilar’ cluster in the other species in the dataset. The
singlet SMGC families are expected to produce com-
pounds specific to one species in the set, or alterna-
tively be incorrectly identified gene clusters or clusters
with aberrantly predicted gene models. Families with
members in more than one species are expected to be
characteristic for a larger group of organisms, as such,
90 SMGC families are found in more than 5 organisms.
There are 3 SMGC families found in all the species, 1
family found in all the Aspergilli and 2 section Flavi
specific cluster families. There are also clade specific
SMGC families, the A. flavus clade shares 1 while A.
tamarii and A. nomius has 0 and 2 families respec-
tively indicating that the A. flavus and A. nomius
clade are closely related groups of species. The num-
ber of unique cluster families ranges from 1-3 within
the A. flavus clade with A. minisclerotigenes as an
exception with 6 unique families. These numbers are
rather low compared with the other species supporting
that this clade is very closely related. For species not
in the A. flavus, A. tamarii or A. nomius clade the
number of unique cluster families is mainly above 10
showing high diversity and a large potential for novel
compounds.
Within section Nigri 2,717 SMGCs were identified
in 37 species, distributed in 455 SMGC families giving
73.43 clusters per species and 5.97 clusters pr fam-
ily [80]. Comparing across all the species in this study,
the number of clusters per species was 70.42 with 4.13
clusters per family. The number of clusters per species
in this study is slightly lower however the number of
members per SMGC family is also lower, which indi-
cates a greater diversity in secondary metabolism in
section Flavi compared to section Nigri.
In the Nigri study [80] it was shown that 82% of
cluster families were found in less than 10 organisms
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and 49% were only found in one species with an av-
erage of 8.75 unique clusters per species comparing to
section Flavi the numbers are 88% for cluster families
found in less than 10 organisms, 61% found only in one
species and 10.31 unique clusters per species. These
results further supports that the species in this study
are more diverse than in the Nigri study. This diver-
sity is mirrored by the number of species included from
a section. The more species from a section the closer
related they are and the more likely they are to share
SMGCs, thus resulting in a lower diversity. Focusing
only on the section Favi species there are on average
6.8 unique SMGCs per species.
Dereplication of secondary metabolism in section
Flavi
To asses the potential for SM production qualita-
tively, we used a pipeline of dereplication, Figure
7B [78] where predicted clusters are associated with
verified known clusters (from the MIBiG database [53])
in a guilt-by-association method. Known gene clus-
ters were coupled to SMGC families making it pos-
sible to predict the compounds or derivates thereof a
species can potentially produce. Cluster families con-
taining one cluster highly similar to a known com-
pound cluster are labelled after the known compound
but further manual inspection of the cluster fam-
ily is needed in order to evaluate these predictions.
Using the dereplication approach 20 cluster families
were coupled to a compound family. Clusters simi-
lar to the Naphthopyrone [52] cluster were found in
all Flavi species and so was the nidulanin A [2] clus-
ter family except for A. leporis. Clusters similar to
Azanigerone [86], 4,4’-piperazine-2,5-diyldimethyl-bis-
phenol and aflavarin [6]/ endocrocin [5, 41] were iden-
tified in all Flavi species except A. coremiiformis, A.
avenaceus; A. avenaceus; and A. coremiiformis, A.
avenaceus and A. leporis respectively. Clusters simi-
lar to Alternariol [1] and aspirochlorine [9] are found
in all clade A. flavus and A. tamarii species plus A.
bertholletius and A. avenaceus. These SMGC families
follow the phylogenetic groups with a few exceptions.
Clusters similar to the Asperfuranone [10] cluster does
not follow the phylogenic groups but is found in A.
tamarii, A. pseudotamarii, A. nidulans and A. terreus.
Likewise clusters similar to the pseurotin A [48] or Fu-
magillin [42] cluster were found in a pattern of species
not following the phylogeney (A. caelatus, A. pseudo-
caelatus, A. steynii, A. avenaceus, A. leporis and A.
fumigatus).
Using the dereplication pipeline we have been able
to identify 20 cluster families similar to known biosyn-
thetic clusters. We have thus been able to identify
potential producers of known toxins such as aflatoxin
and aspirochlorine. Notably, some cluster families mir-
ror the species phylogeny and have representatives in
all species within a certain grouping while others are
found in multiple species discontinuously across the
breadth of the phylogenetic tree possibly indicating
different evolutionary paths.
Linking secondary metabolites to clusters by
combining chemical and genome analysis
We were interested in linking compounds and clusters
based on presence absence pattern of produced com-
pounds and predicted clusters. We therefore created a
heatmap of all the cluster families found in at least 5
species, added the predicted compound families from
the MIBiG dereplication plus manually curated com-
pound families from a literature survey (Additional
files B9). In addition, we created chemical data of the
Flavi species grown on CYA (Additional file Table B4)
to see what compounds are produced by which species
and use this to identify the gene cluster responsible for
the production.
One compound family, miyakamides, were found
to be produced by A. sojae, A. nomius, parasiti-
cus, A. novoparasiticus and A. transmontanensis.
Miyakamides have been isolated from an A. flavus
species and have been shown to have antibiotic prop-
erties [67]. The biosynthetic gene cluster producing
miyakamides is not known, but from the chemical
structure we performed retro-biosynthesis and pre-
dicted that the biosynthetic gene cluster should be
contain a NRPS with three adenylation domains (or
potentially two since two of the amino acids are highly
similar), an N-methyltransferase, an acetyltransferase
and potentially a decarboxylase/dehydrogenase, ad-
ditional file Figure B10A. Holding this information
together we searched for cluster families with mem-
bers in all the miyakamide producing species having
NRPS backbones with 3 or 2 adenylation backbones
and a methyltransferase domain. With these criteria,
only one cluster family met the requirements. The
cluster family has has a NRPS backbone with three
predicted A domains in A. transmontanensis and two
predicted in A. parasiticus, A. novoparasiticus and A.
nomius. The NRPS contains a methyltransferase do-
main, hence two of the required activities are found
in one predicted gene. The size of the predicted clus-
ters in these species varies from one to nine genes,
the difference are most likely caused by SMGC pre-
dictions errors. The predicted functions are also vary-
ing. We took sequences for the predicted gene clus-
ters and neighbouring genes and created synteny plots
of all the clusters belonging to the cluster family to
see which parts are conserved and shared among the
species. This conservation gives an indication of which
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genes are involved in the biosynthesis, additional Fig-
ure B10B. Of the predicted clusters and surrounding
genes there are several genes only conserved among
some of the species and a small part, containing the
NRPS and two small genes with unknown function,
widely conserved. These conserved genes are most
likely involved in the miyakamide biosynthesis. The
clusters ofA. transmontanensi and A. parviscleroti-
genus are located at the end of a scaffold, and do not
have the two conserved genes in the clusters. In both
cases the NRPS is located at the end of a scaffold and
homologs of the conserved genes are found the end
of another scaffold with high similarity (≥ 94% iden-
tity to A. nomius genes). Based on the presented data
and performed analysis we propose that the identified
NRPS along with the two conserved genes of unknown
function are involved in the miyakamide biosynthesis.
The aflatoxin biosynthetic gene cluster is highly
conserved in the A. flavus, A. nomius and partly in
the A. tamarii clade
Perhaps the best known secondary metabolite in sec-
tion Flavi is the highly carcinogenic aflatoxin molecule.
Aflatoxins are known to be produced by many sec-
tion Flavi species (A. arachidicola, A. bombycis, A.
flavus, A. minisclerotigenes, A. nomius, A. parvis-
clerotigenus, A. pseudocaelatus, A. pseudonomius, A.
pseudotamarii and some A. oryzae species [79]). We
examined the number of species that had the genetic
potential to produce aflatoxin, and compared the afla-
toxin cluster across the section to assess its variabil-
ity. From the dereplication analysis, we identified a
SMGC family predicted to be involved in sterigmato-
cystin, aflatoxin or cyclopiazonic-acid, Figure 7B. The
first notable observation from the predicted SMGC
was that the cluster is found in all the species in the
A. flavus, A. nomius and A. tamarii clade except for
A. tamarii. A synteny plot of the cluster family (easy-
fig [74], Additional file Figure B11) shows that the clus-
ter is extremely well conserved with no rearrangements
and a high alignment identity for the aflatoxin genes.
Only A. caelatus seems to have a different version of
the cluster where only the aflB, aflC, aflD genes are
found.
The length of the predicted aflatoxin clusters varies
and in A. parvisclerotigenus, A. arachidicola, A.
minisclerotigenes and A. sergii there are several ad-
ditional genes not known to be involved in aflatoxin
biosynthesis included in the clusters. Several of these
additional genes have similarity to genes associated
with a known cluster responsible for producing cyclop-
iazonic acid, explaining why two different biosynthetic
pathways end up in the same cluster family. Since the
clusters are located in very close proximity it is not
possible with our prediction method to distinguish and
therefore they end up in one large predicted cluster.
The biosynthesis of aflatoxin requires the aflP and
aflQ genes which are responsible for the last steps
of the biosynthetic pathway. In most of the predicted
clusters these genes were not found. In order to clarify
if this was due to cluster prediction errors or if they
were not there we used the A. flavus genes as query
and searched for similar genes using BLASTp. The
aflP protein has hits (over 89% identity) for all the
species with the predicted aflatoxin cluster, however
the query and hit coverage is only around 50%. We
made a multiple alignment of the aflP from A. flavus
and the hits in the other Flavi species with the cluster
(Additional file Figure B12) to investigate this.
From the alignment it is evident that the A. flavus
protein has an earlier 5’ start site and a gap in the
middle compared with the other sequences. We inves-
tigated the gene predictions, and the RNA coverage in
search of explanations of this (Additional file Figure
B13). The RNA coverage (based on transcriptomics)
clearly follows the gene predictions and supports the
gene prediction in the species sequenced for this study
showing that this region is likely to be transcribed in
the predicted manner. The A. flavus genome was a se-
quenced previously and annotated with different gene
modeling software, which could explain the annotation
differences. The genomes in our study were all anno-
tated with gene models supported from next genera-
tion sequencing technology RNA-seq giving high qual-
ity predictions. The aflQ gene has hits with >85%
identity and nearly 100% coverage. Lastly the location
of the aflQ and aflP genes were determined relative to
the aflatoxin cluster. All aflQ genes were 5-10 genes
from the predicted aflatoxin gene clusters while the
aflP genes were 3-8 genes from the predicted aflatoxin
clusters. The high similarity and the proximity to the
predicted cluster indicate that the genes should be in-
cluded in the clusters and that all the species do have
the aflP and aflQ genes required required for complete
aflatoxin biosynthesis.
As mentioned A. tamarii is missing in this cluster
family. Since all the other species have the cluster, a
possible explanation is a deletion event in A. tamarii.
To identify a possible genomic locus of the loss, we
compared the cluster and surrounding genes from the
closest relative A. pseudotamarii, A. pseudocaelatus
and A. caelatus to A. tamarii. In A. pseudotamarii
only the last gene in the predicted cluster is found in
A. tamarii with high identity (above 90%, marked by
blue ring in Additional file Figure B11). In A. pseudo-
caelatus the last and third to last genes have good hits
in A. tamarii and in A. caelatus five of the genes in
the right end of the predicted cluster have hits in A.
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tamarii (marked in Additional file Figure B11). The
hits in A. tamarii are all found on scaffold 131 close to
the end of the scaffold. Comparing the rest of the scaf-
fold 131 from A. tamarii with A. caelatus the hits are
not on the same scaffold as the aflatoxin-like clusters.
It indicates that the aflatoxin cluster has undergone
similar changes as in A. caelatus and even more se-
vere.
Conclusions
We de novo sequenced species representing various
parts of the Flavi section which allowed a section
wide comparison illustrating the similarities and di-
versity within the section. Members of the Flavi sec-
tion has a large genome size compared to other As-
pergilli. The large genome is reflected in the high num-
ber of secondary metabolite gene clusters (SMGCs)
and Carbohydrate-Active enZymes (CAZymes) which
could be a source of novel compounds and enzymes in
the future.
We have shown that the aflatoxin cluster is highly
conserved both concerning identity and synteny in the
A. flavus, A. nomius clade and partly in the A. tamarii
clade where the cluster is partly lost in A. caelatus and
completely lost in A. tamarii.
The number of species unique proteins is varying but
even with the very closely related A. flavus clade, most
species have above 700 unique proteins illustrating the
diversity.
Localization analysis of A. oryzae have shown the
distribution of unique and SMGC across the genome
but with a higher density in the sub-telomeric ends.
Synteny analysis have highlighted some tendencies of
some highly conserved chromosomes and a few dense
non syntenic blocks which could represent rearrange-
ment hot-spots.
Methods
Fungal strains
The species examined in this study were from the IBT
Culture Collection of Fungi at the Technical University
of Denmark (DTU), unless otherwise noted.
DNA and RNA preparation, sequencing and assembly
The procedure for fungal DNA and RNA prepara-
tion, sequencing and assembly has previously been de-
scribed [33, 80].
Genome annotation
The genomes were annotated using the JGI annotation
pipeline [26] as previously described in [33, 80].
Homologous protein families
All predicted proteins from the 31 genomes used in this
study were aligned using the BLASTp function from
the BLAST+ suite version 2.2.27 with an e− value ≥
1010). The 961 whole-genome BLAST tables were anal-
ysed to identify homologous proteins and group them
into families as describes in [80]. Protein families con-
taining at least one protein from all species were de-
fined as core families while species-unique families were
defined as families containing one or more protein(s)
from only one species.
Functional annotation
Functional domains were identified in all the proteins
using InterPro [18], GO [22] and KOG [76].
Phylogeny
Monocore gene were identified as protein families hav-
ing exactly one member in each species. Each protein
family was aligned using MUSCLE version 3.8.31 (de-
fault settings) and then trimmed using gblocks ver-
sion 0.91b (-t=p -b4=5 -b5=h). Following 200 of these
monocore sequences (with length between 150 and
1000 AA) were selected randomly and concatenated
and used to construct a phylogentic tree using RaxML
version 8.2.8 using PROTGAMMAWAG substitution
model and 1000 bootstrapping.
Prediction of Carbohydrate-Active Enzymes
Carbohydrate-Active enZymes (CAZymes) were pre-
dicted using the Carbohydrate-Active Enzymes database
(CAZy; www.cazy.org, [44]) and the method described
by Vesth et al. [80].
Prediction of secondary metabolite gene clusters
Secondary metabolite gene clusters (SMGCs) and
SMGC families were predicted based on the SMURF
algorithm [30] and the method described in Vesth et
al. [80].
Annotation of SMGC families using MIBiG
SMGC families were annotated based on the MIBiG
database [53] using the method described in Theobald
et al. [78].
Genome synteny analysis
Orthologs were defined as a pair of genes found be-
tween two genomes from different species by bidirec-
tional best hits using BLASTP with E−value ≥ 1010).
When two genes within 10 kbp on the 1st genome
have corresponding orthologs within 10 kbp on the
2nd genome, the region between the two genes was de-
fined as a syntenic block. The distance between the two
genes was calculated by the formula, |PC1 − PC2| −
1/2(LN1 +LN2), where PCn and LNn are nucleotide
position of the center and nucleotide length of gene
“n” (n = 1 or 2), respectively. -
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Analysis of chromosomal localization
For visualization of chromosome, chromosomal loca-
tion and gene density the R package karyoploteR was
used [21].
Secondary metabolite gene cluster synteny analysis and
visualization
For visulization of cluster synteny and similarity Easy-
Fig was used [74]. The parameters minimum length
and meninmum identity was set to 50 bp and 50% re-
spectively.
Competing interests
The authors declare that they have no competing interests.
Author’s contributions
Text for this section . . .
Acknowledgements
Text for this section . . .
Author details
1Department of Biotechnology and Bioengineering, Technical University of
Denmark, Søltoft Plads 223, 2800 Kongens Lyngby, Denmark. 2US
Department of Energy Joint Genome Institute, YYY, XXX Walnut Creek
CA USA. 3Kikkoman Corporation, YYY, XXX Noda Japan. 4 US
Department of Energy Joint BioEnergy Institute, YYY, XXX Emeryville CA
USA. 5 Kanazawa Institute of Technology, YYY, XXX Kanazawa Japan.
6 Fungal Physiology, Westerdijk Fungal Biodiversity Institute Fungal
Molecular Physiology, Utrecht University, Uppsalalaan 8, 3584 CT Utrecht
The Netherlands. 7 Department of Microbiology, Faculty of Agriculture
and Forestry, University of Helsinki, Viikinkaari 9, Helsinki Finland. 8
Architecture et Fonction des Macromole´cules Biologiques, (CNRS UMR
7257, Aix-Marseille University, , 13288 Marseille France. 9 Environmental
Molecular Sciences Division, Earth and Biological Sciences Directorate,
Pacific Northwest National Laboratory, , Richland WA USA. 10
Department of Plant and Microbial Biology, University of California, ,
Berkeley CA USA.
References
1. Ahuja, M., Chiang, Y.M., Chang, S.L., Praseuth, M.B., Entwistle,
R., Sanchez, J.F., Lo, H.C., Yeh, H.H., Oakley, B.R., Wang, C.C..
Illuminating the diversity of aromatic polyketide synthases in
aspergillus nidulans. Journal of the American Chemical Society
2012;134(19):8212–8221.
2. Andersen, M.R., Nielsen, J.B., Klitgaard, A., Petersen, L.M.,
Zachariasen, M., Hansen, T.J., Blicher, L.H., Gotfredsen, C.H.,
Larsen, T.O., Nielsen, K.F., Mortensen, U.H.. Accurate prediction of
secondary metabolite gene clusters in filamentous fungi. Proceedings
of the National Academy of Sciences 2013;110(1):E99–E107.
3. Barbesgaard, P., Heldt-Hansen, H.P., Diderichsen, B.. On the safety
of Aspergillus oryzae: a review. Applied Microbiology and
Biotechnology 1992;36:569–572.
4. Benoit, I., Culleton, H., Zhou, M., DiFalco, M., Aguilar-Osorio, G.,
Battaglia, E., Bouzid, O., J M Brouwer, C.P., O El-Bushari, H.B.,
Coutinho, P.M., Gruben, B.S., Hilde´n, K.S., Houbraken, J., Alexis
Jime´nez Barboza, L., Levasseur, A., Majoor, E., Ma¨kela¨, M.R.,
Narang, H., Trejo-Aguilar, B., van den Brink, J., VanKuyk, P.A.,
Wiebenga, A., McKie, V., McCleary, B., Tsang, A., Henrissat, B.,
de Vries, R.P.. Closely related fungi employ diverse enzymatic
strategies to degrade plant biomass. Biotechnology for Biofuels
2015;8:107.
5. Berthier, E., Lim, F.Y., Deng, Q., Guo, C.J., Kontoyiannis, D.P.,
Wang, C.C., Rindy, J., Beebe, D.J., Huttenlocher, A., Keller, N.P..
Low-Volume Toolbox for the Discovery of Immunosuppressive Fungal
Secondary Metabolites. PLoS Pathogens 2013;9(4):e1003289.
6. Cary, J.W., Han, Z., Yin, Y., Lohmar, J.M., Shantappa, S.,
Harris-Coward, P.Y., Mack, B., Ehrlich, K.C., Wei, Q.,
Arroyo-Manzanares, N., Uka, V., Vanhaecke, L., Bhatnagar, D., Yu,
J., Nierman, W.C., Johns, M.A., Sorensen, D., Shen, H., De
Saeger, S., Diana Di Mavungu, J., Calvo, A.M.. Transcriptome
analysis of Aspergillus flavus reveals veA-dependent regulation of
secondary metabolite gene clusters, including the novel aflavarin
cluster. Eukaryotic Cell 2015;14(10):983–997.
7. Castresana, J.. Selection of Conserved Blocks from Multiple
Alignments for Their Use in Phylogenetic Analysis. Mol Biol Evol
2000;17(4):540–552.
8. Chang, P.K., Ehrlich, K., Fujii, I.. Cyclopiazonic Acid Biosynthesis of
Aspergillus flavus and Aspergillus oryzae. Toxins 2009;1:74–99.
9. Chankhamjon, P., Boettger-Schmidt, D., Scherlach, K., Urbansky,
B., Lackner, G., Kalb, D., Dahse, H.M., Hoffmeister, D., Hertweck,
C.. Biosynthesis of the halogenated mycotoxin aspirochlorine in koji
mold involves a cryptic amino acid conversion. Angewandte Chemie -
International Edition 2014;53(49):13409–13413.
10. Chiang, Y.M., Szewczyk, E., Davidson, A.D., Keller, N., Oakley,
B.R., Wang, C.C.. A gene cluster containing two fungal polyketide
synthases encodes the biosynthetic pathway for a polyketide,
asperfuranone, in aspergillus nidulans. Journal of the American
Chemical Society 2009;131(8):2965–2970.
11. Civas, A., Eberhard, R., Le Dizet, P., Petek, F.. Glycosidases
induced in Aspergillus tamarii . Mycelial α-d-galactosidases. Technical
Report; 1984.
12. Coutinho, P.M., Andersen, M.R., Kolenova, K., Vankuyk, P.A.,
Benoit, I., Gruben, B.S., Trejo-Aguilar, B., Visser, H., Van Solingen,
P., Pakula, T., Seiboth, B., Battaglia, E., Aguilar-Osorio, G., De
Jong, J.F., Ohm, R.A., Aguilar, M., Henrissat, B., Nielsen, J.,
St˚albrand, H., De Vries, R.P.. Post-genomic insights into the plant
polysaccharide degradation potential of Aspergillus nidulans and
comparison to Aspergillus niger and Aspergillus oryzae. Fungal
Genetics and Biology 2009;46:S161–S169.
13. De Vries, R.P., Riley, R., Wiebenga, A., Aguilar-Osorio, G., Amillis,
S., Uchima, C.A., Anderluh, G., Asadollahi, M., Askin, M., Barry,
K., Battaglia, E., Bayram, O¨., Benocci, T., Braus-Stromeyer, S.A.,
Cerqueira, G.C., Chen, F., Chen, W., Choi, C., Clum, A., Correˆa,
R.A., Santos, D., De Lima Dama´sio, R., Diallinas, G., Emri, T.,
Fekete, E., Flipphi, M., Freyberg, S., Gallo, A., Karaffa, L.,
Kara´nyi, Z., Krasˇevec, N., Kuo, A., Kusch, H., Labutti, K.,
Lagendijk, E.L., Lapidus, A., Levasseur, A., Lindquist, E., Lipzen,
A., Logrieco, A.F., Maccabe, A., Molna´r, A´.P., Mule´, G., Ngan,
C.Y., Orejas, M., Orosz, E., Ouedraogo, J.P., Overkamp, K.M.,
Ram, A.F.J., Ramo´n, A., Rauscher, S., Record, E., Rian˜o-Pacho´n,
D.M., Robert, V., Ro¨hrig, J., Ruller, R., Salamov, A., Salih, N.S.,
Samson, R.A., Sa´ndor, E., Sanguinetti, M., Schu¨tze, T., Sepcˇic´, K.,
Shelest, E., Sherlock, G., Sophianopoulou, V., Squina, F.M., Sun,
H., Susca, A., Todd, R.B., Tsang, A., Unkles, S.E., Van De Wiele,
N., Van Rossen-Uffink, D., Velasco De Castro Oliveira, J., Vesth,
T.C., Visser, J., Yu, J.H., Zhou, M., Andersen, M.R., Archer, D.B.,
Baker, S.E., Benoit, I., Brakhage, A.A., Braus, G.H., Fischer, R.,
Frisvad, J.C., Goldman, G.H., Houbraken, J., Oakley, B., Po´csi, I.,
Scazzocchio, C., Seiboth, B., Vankuyk, P.A., Wortman, J., Dyer,
P.S., Grigoriev, I.V.. Comparative genomics reveals high biological
diversity and specific adaptations in the industrially and medically
important fungal genus Aspergillus. Genome Biology 2017;18(1):28.
14. Edgar, R.C.. MUSCLE: multiple sequence alignment with high
accuracy and high throughput. Nucleic Acids Research
2004;32(5):1792–1797.
15. Eichler, E.E., Sankoff, D.. Structural dynamics of eukaryotic
chromosome evolution. Science 2003;301(45):793–797.
16. Fekete, E., De Vries, R.P., Seiboth, B., VanKuyk, P.A., Sa´ndor, E.,
Fekete, E´., Metz, B., Kubicek, C.P., Karaffa, L.. d-galactose uptake
is nonfunctional in the conidiospores of Aspergillus niger. FEMS
Microbiology Letters 2012;329(2):198–203.
17. Ferreira, G., Boer, C.G., Peralta, R.M.. Production of xylanolytic
enzymes by Aspergillus tamarii in solid state fermentation. FEMS
Microbiology Letters 1999;173:335–339.
18. Finn, R.D., Attwood, T.K., Babbitt, P.C., Bateman, A., Bork, P.,
Bridge, A.J., Chang, H.Y., Dosztanyi, Z., El-Gebali, S., Fraser, M.,
Gough, J., Haft, D., Holliday, G.L., Huang, H., Huang, X., Letunic,
I., Lopez, R., Lu, S., Marchler-Bauer, A., Mi, H., Mistry, J.,
Natale, D.A., Necci, M., Nuka, G., Orengo, C.A., Park, Y.,
3.2. Manuscript II – Comparative genomics of section Flavi 58
D
R
A
FT
Kjærbølling et al. Page 13 of 24
Pesseat, S., Piovesan, D., Potter, S.C., Rawlings, N.D., Redaschi,
N., Richardson, L., Rivoire, C., Sangrador-Vegas, A., Sigrist, C.,
Sillitoe, I., Smithers, B., Squizzato, S., Sutton, G., Thanki, N.,
Thomas, P.D., Tosatto, S.C.E., Wu, C.H., Xenarios, I., Yeh, L.S.,
Young, S.Y., Mitchell, A.L.. InterPro in 2017––beyond protein family
and domain annotations. Nucleic Acids Research 2017;45:D190–D199.
19. Galagan, J.E., Calvo, S.E., Cuomo, C., Ma, L.J., Wortman, J.R.,
Batzoglou, S., Lee, S.I., Bas¸tu¨rkmen, M., Spevak, C.C.,
Clutterbuck, J., Kapitonov, V., Jurka, J., Scazzocchio, C., Farman,
M., Butler, J., Purcell, S., Harris, S., Braus, G.H., Draht, O.,
Busch, S., D’Enfert, C., Bouchier, C., Goldman, G.H.,
Bell-Pedersen, D., Griffiths-Jones, S., Doonan, J.H., Yu, J.,
Vienken, K., Pain, A., Freitag, M., Selker, E.U., Archer, D.B.,
Pen˜alva, M.A., Oakley, B.R., Momany, M., Tanaka, T., Kumagai,
T., Asai, K., Machida, M., Nierman, W.C., Denning, D.W.,
Caddick, M., Hynes, M., Paoletti, M., Fischer, R., Miller, B., Dyer,
P., Sachs, M.S., Osmani, S.A., Birren, B.W.. Sequencing of
Aspergillus nidulans and comparative analysis with A. fumigatus and
A. oryzae. Nature 2005;438(7071):1105–15.
20. Geiser, D.M., Pitt, J.I., Taylor, J.W.. Cryptic speciation and
recombination in the aflatoxin-producing fungus Aspergillus flavus
(population genetics mycotoxin biological species microbial evolution).
PNAS 1998;95(1):388–393.
21. Gel, B., Serra, E.. KaryoploteR: An R/Bioconductor package to plot
customizable genomes displaying arbitrary data. Bioinformatics
2017;33(19):3088–3090.
22. Gene Ontology Consortium, T.. Expansion of the Gene Ontology
knowledgebase and resources. Nucleic Acids Research
2017;45:D331–D338.
23. Gene Ontology Consortium, T., Ashburner, M., Ball, C.A., Blake,
J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski,
K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver,
L., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E.,
Ringwald, M., Rubin, G.M., Sherlock, G.. Gene Ontology: tool for
the unification of biology. Nature Genetics 2000;25:25–29.
24. Gibbons, J.G., Salichos, L., Slot, J.C., Rinker, D.C., Mcgary, K.L.,
King, J.G., Klich, M.A., Tabb, D.L., Mcdonald, W.H., Rokas, A..
The Evolutionary Imprint of Domestication on Genome Variation and
Function of the Filamentous Fungus Aspergillus oryzae. Current
Biology 2012;22(15):1403–1409.
25. Gourama, H.. Aspergillus flavus and Aspergillus parasiticus:
Aflatoxigenic fungi of concern in foods and feeds: A review. Journal of
Food Protection 1995;58(12):1395–1404.
26. Grigoriev, I.V., Martinez, D.A., Salamov, A.A.. Fungal genomic
annotation. Applied Mycology and Biotechnology 2006;6(C):123–142.
27. Hedayati, M.T., Pasqualotto, A.C., Warn, P.A., Bowyer, P.,
Denning, D.W.. Aspergillus flavus: human pathogen, allergen and
mycotoxin producer. Microbiology 2007;153:1677–1692.
28. Heinen, P.R., Bauermeister, A., Ribeiro, L.F., Messias, J.M.,
Almeida, P.Z., Moraes, L.A., Vargas-Rechia, C.G., de Oliveira,
A.H., Ward, R.J., Filho, E.X., Kadowaki, M.K., Jorge, J.A., Polizeli,
M.L.. GH11 xylanase from Aspergillus tamarii Kita: Purification by
one-step chromatography and xylooligosaccharides hydrolysis
monitored in real-time by mass spectrometry. International Journal of
Biological Macromolecules 2018;108:291–299.
29. Ichishima, E.. Development of enzyme technology for <i>Aspergillus
oryzae</i>, <i>A. sojae</i>, and <i>A. luchuensis</i>, the
national fungi of Japan. Bioscience, Biotechnology and Biochemistry
2016;80(9):1681–1692.
30. Khaldi, N., Seifuddin, F.T., Turner, G., Haft, D., Nierman, W.C.,
Wolfe, K.H., Fedorova, N.D.. SMURF: Genomic mapping of fungal
secondary metabolite clusters. Fungal Genetics and Biology
2010;47:736–741.
31. Kim, J.d.. Production of Xylanolytic Enzyme Complex from
Aspergillus flavus using Agri- cultural Wastes. Mycobiology
2005;33(2):84–89.
32. Kimura, I., Sasahara, H., Tajima, S.. Purification and
characterization of two xylanases and an arabinofuranosidase from
Aspergillus sojae. Journal of Fermentation and Bioengineering
1995;80(4):334–339.
33. Kis-Papo, T., Weig, A.R., Riley, R., Perˇsoh, D., Salamov, A., Sun,
H., Lipzen, A., Wasser, S.P., Rambold, G., Grigoriev, I.V., Nevo,
E., Kholodny, M.G.. Genomic adaptations of the halophilic Dead Sea
filamentous fungus Eurotium rubrum. Nature communications
2014;5:3745.
34. Klich, M.A.. Aspergillus flavus: the major producer of aflatoxin.
Molecular Plant Pathology 2007;8(6):713–722.
35. Klich, M.A., Pitt, J.I.. DIFFERENTIATION OF ASPERGILLUS
FLAVUS FROM A. PARASITICUS AND OTHER CLOSELY
RELATED SPECIES. Transactions of the British Mycological Society
1988;91(1):99–108.
36. Kobayashi, T., Abe, K., Asai, K., Gomi, K., Juvvadi, P.R., Kato,
M., Kitamoto, K., Takeuchi, M., Machida, M.. Genomics of
Aspergillus oryzae. Bioscience, Biotechnology, and Biochemistry
2007;71(3):646–670.
37. Kocsube´, S., Perrone, G., Magista`, D., Houbraken, J., Varga, J.,
Szigeti, G., Hubka, V., Hong, S.B., Frisvad, J.C., Samson, R.A..
Aspergillus is monophyletic: Evidence from multiple gene phylogenies
and extrolites profiles. Studies in Mycology 2016;85:199–213.
38. Krishnan, S., Manavathu, E.K., Chandrasekar, P.H.. Aspergillus
flavus : an emerging non- fumigatus Aspergillus species of significance.
Mycoses 2009;52(3):206–222.
39. Kurtzman, C.P., Smiley, M.J., Robnett, C.J., Wicklow, D.T., Wickl,
D.T.. DNA Relatedness among Wild and Domesticated Species in the
Aspergillus flavus Group. Mycologia 1986;78(6):955–959.
40. Lebar, M.D., Cary, J.W., Majumdar, R., Carter-Wientjes, C.H.,
Mack, B.M., Wei, Q., Uka, V., De Saeger, S., Diana Di Mavungu,
J.. Identification and functional analysis of the aspergillic acid gene
cluster in Aspergillus flavus. Fungal Genetics and Biology
2018;116:14–23.
41. Lim, F.Y., Hou, Y., Chen, Y., Oh, J.H., Lee, I., Bugni, T.S.,
Keller, N.P.. Genome-based cluster deletion reveals an endocrocin
biosynthetic pathway in Aspergillus fumigatus. Applied and
Environmental Microbiology 2012;78(12):4117–4125.
42. Lin, H.C., Chooi, Y.H., Dhingra, S., Xu, W., Calvo, A.M., Tang,
Y.. The fumagillin biosynthetic gene cluster in Aspergillus fumigatus
encodes a cryptic terpene cyclase involved in the formation of
β-trans-bergamotene. Journal of the American Chemical Society
2013;135(12):4616–4619.
43. Linz, J.E., Wee, J., Roze, L.V.. Aspergillus parasiticus SU-1 Genome
Sequence, Predicted Chromosome Structure, and Comparative Gene
Expression under Aflatoxin-Inducing Conditions: Evidence that
Differential Expression Contributes to Species Phenotype. Eukaryotic
cell 2014;13(8):1113–1123.
44. Lombard, V., Ramulu, H.G., Drula, E., Coutinho, P.M., Henrissat,
B.. The carbohydrate-active enzymes database (CAZy) in 2013.
Nucleic Acids Research 2014;42(Database issue):D490–D495.
45. Machida, M., Asai, K., Sano, M., Tanaka, T., Kumagai, T., Terai,
G., Kusumoto, K.I., Arima, T., Akita, O., Kashiwagi, Y., Abe, K.,
Gomi, K., Horiuchi, H., Kitamoto, K., Kobayashi, T., Takeuchi,
M., Denning, D.W., Galagan, J.E., Nierman, W.C., Yu, J., Archer,
D.B., Bennett, J.W., Bhatnagar, D., Cleveland, T.E., Fedorova,
N.D., Gotoh, O., Horikawa, H., Hosoyama, A., Ichinomiya, M.,
Igarashi, R., Iwashita, K., Juvvadi, P.R., Kato, M., Kato, Y., Kin,
T., Kokubun, A., Maeda, H., Maeyama, N., Maruyama, J.I.,
Nagasaki, H., Nakajima, T., Oda, K., Okada, K., Paulsen, I.,
Sakamoto, K., Sawano, T., Takahashi, M., Takase, K., Terabayashi,
Y., Wortman, J.R., Yamada, O., Yamagata, Y., Anazawa, H., Hata,
Y., Koide, Y., Komori, T., Koyama, Y., Minetoki, T., Suharnan,
S., Tanaka, A., Isono, K., Kuhara, S., Ogasawara, N., Kikuchi, H.,
The, . Genome sequencing and analysis of Aspergillus oryzae. Nature
2005;438:1157–1161.
46. Machida, M., Yamada, O., Gomi, K.. Genomics of Aspergillus
oryzae: Learning from the History of Koji Mold and Exploration of Its
Future. DNA Research 2008;15:173–183.
47. Mahmoud, M., Al-Othman, M., Abd-El-Aziz, A., Metwaly, H.,
Mohamed, H.. Expression of genes encoding cellulolytic enzymes in
some Aspergillus species. Genetics and Molecular Research
2016;15(4):15048913.
48. Maiya, S., Grundmann, A., Li, X., Li, S.M., Turner, G..
Identification of a hybrid PKS/NRPS required for pseurotin A
59 Chapter 3. Exploring genomic diversity and linking compounds to clusters
D
R
A
FT
Kjærbølling et al. Page 14 of 24
biosynthesis in the human pathogen Aspergillus fumigatus.
ChemBioChem 2007;8(14):1736–1743.
49. Makhuvele, R., Ncube, I., van Rensburg, E.L.J., La Grange, D.C..
Isolation of fungi from dung of wild herbivores for application in
bioethanol production. Brazilian Journal of Microbiology
2017;48:648–655.
50. Martinez, D., Berka, R.M., Henrissat, B., Saloheimo, M., Arvas,
M., Baker, S.E., Chapman, J., Chertkov, O., Coutinho, P.M.,
Cullen, D., Danchin, E.G., Grigoriev, I.V., Harris, P., Jackson, M.,
Kubicek, C.P., Han, C.S., Ho, I., Larrondo, L.F., De Leon, A.L.,
Magnuson, J.K., Merino, S., Misra, M., Nelson, B., Putnam, N.,
Robbertse, B., Salamov, A.A., Schmoll, M., Terry, A., Thayer, N.,
Westerholm-Parvinen, A., Schoch, C.L., Yao, J., Barbote, R.,
Nelson, M.A., Detter, C., Bruce, D., Kuske, C.R., Xie, G.,
Richardson, P., Rokhsar, D.S., Lucas, S.M., Rubin, E.M.,
Dunn-Coleman, N., Ward, M., Brettin, T.S.. Genome sequencing
and analysis of the biomass-degrading fungus Trichoderma reesei (syn.
Hypocrea jecorina). Nature Biotechnology 2008;26(5):553–560.
51. Mata-Go´mez, M.A., Heerd, D., Oyanguren-Garc´ıa, I., Barbero, F.,
Rito-Palomares, M., Ferna´ndez-Lahore, M.. A novel pectin-degrading
enzyme complex from Aspergillus sojae ATCC 20235 mutants. Journal
of the Science of Food and Agriculture 2015;95:1554–1561.
52. Mayorga, M.E., Timberlake, W.E.. The developmentally regulated
Aspergillus nidulans wA gene encodes a polypeptide homologous to
polyketide and fatty acid synthases. Molecular and General Genetics
1992;235(2-3):205–212.
53. Medema, M.H., Kottmann, R., Yilmaz, P., Cummings, M., Biggins,
J.B., Blin, K., de Bruijn, I., Chooi, Y.H., Claesen, J., Coates, R.C.,
Cruz-Morales, P., Duddela, S., Du¨sterhus, S., Edwards, D.J., Fewer,
D.P., Garg, N., Geiger, C., Gomez-Escribano, J.P., Greule, A.,
Hadjithomas, M., Haines, A.S., Helfrich, E.J.N., Hillwig, M.L.,
Ishida, K., Jones, A.C., Jones, C.S., Jungmann, K., Kegler, C.,
Kim, H.U., Ko¨tter, P., Krug, D., Masschelein, J., Melnik, A.V.,
Mantovani, S.M., Monroe, E.A., Moore, M., Moss, N., Nu¨tzmann,
H.W., Pan, G., Pati, A., Petras, D., Reen, F.J., Rosconi, F., Rui,
Z., Tian, Z., Tobias, N.J., Tsunematsu, Y., Wiemann, P., Wyckoff,
E., Yan, X., Yim, G., Yu, F., Xie, Y., Aigle, B., Apel, A.K.,
Balibar, C.J., Balskus, E.P., Barona-Go´mez, F., Bechthold, A.,
Bode, H.B., Borriss, R., Brady, S.F., Brakhage, A.A., Caffrey, P.,
Cheng, Y.Q., Clardy, J., Cox, R.J., De Mot, R., Donadio, S.,
Donia, M.S., van der Donk, W.A., Dorrestein, P.C., Doyle, S.,
Driessen, A.J.M., Ehling-Schulz, M., Entian, K.D., Fischbach,
M.A., Gerwick, L., Gerwick, W.H., Gross, H., Gust, B., Hertweck,
C., Ho¨fte, M., Jensen, S.E., Ju, J., Katz, L., Kaysser, L., Klassen,
J.L., Keller, N.P., Kormanec, J., Kuipers, O.P., Kuzuyama, T.,
Kyrpides, N.C., Kwon, H.J., Lautru, S., Lavigne, R., Lee, C.Y.,
Linquan, B., Liu, X., Liu, W., Luzhetskyy, A., Mahmud, T., Mast,
Y., Me´ndez, C., Metsa¨-Ketela¨, M., Micklefield, J., Mitchell, D.A.,
Moore, B.S., Moreira, L.M., Mu¨ller, R., Neilan, B.A., Nett, M.,
Nielsen, J., O’Gara, F., Oikawa, H., Osbourn, A., Osburne, M.S.,
Ostash, B., Payne, S.M., Pernodet, J.L., Petricek, M., Piel, J.,
Ploux, O., Raaijmakers, J.M., Salas, J.A., Schmitt, E.K., Scott, B.,
Seipke, R.F., Shen, B., Sherman, D.H., Sivonen, K., Smanski,
M.J., Sosio, M., Stegmann, E., Su¨ssmuth, R.D., Tahlan, K.,
Thomas, C.M., Tang, Y., Truman, A.W., Viaud, M., Walton, J.D.,
Walsh, C.T., Weber, T., van Wezel, G.P., Wilkinson, B., Willey,
J.M., Wohlleben, W., Wright, G.D., Ziemert, N., Zhang, C.,
Zotchev, S.B., Breitling, R., Takano, E., Glo¨ckner, F.O.. The
Minimum Information about a Biosynthetic Gene cluster. Nature
Chemical Biology 2015;11(9):625–631.
54. Mellon, J.E., Cotty, P.J., Callicott, K.A., Abbas, H.. Identification
of a Major Xylanase from Aspergillus flavus as a 14-kD Protein.
Mycopathologia 2011;172:299–305.
55. Moore, G.G., Mack, B.M., Beltz, S.B.. Genomic sequence of the
aflatoxigenic filamentous fungus Aspergillus nomius. BMC Genomics
2015;16:551.
56. Moore, G.G., Mack, B.M., Beltz, S.B., Gilbert, M.K.. Draft
Genome Sequence of an Aflatoxigenic Aspergillus Species, A.
bombycis. Genome Biology and Evolution 2016;8(11):3297–3300.
57. Moore, G.G., Mack, B.M., Beltz, S.B., Puel, O.. Genome sequence
of an aflatoxigenic pathogen of Argentinian peanut, Aspergillus
arachidicola. BMC Genomics 2018;19:189.
58. Moreira, F.G., Lenartovicz, V., Peralta, R.M.. A thermostable
maltose-tolerant α-amylase from Aspergillus tamarii. Journal of Basic
Microbiology 2004;44:29–35.
59. Ma¨kela¨ MR DiFalco M, M.E.N.T.W.A.H.K.P.M.G.I.T.A.d.V.R..
Genomic and exoproteomic diversity in plant biomass degradation
approaches among Aspergilli 2018;xx(X):x–xx.
60. Nicholson, M.J., Koulman, A., Monahan, B.J., Pritchard, B.L.,
Payne, G.A., Scott, B.. Identification of two aflatrem biosynthesis
gene loci in Aspergillus flavus and metabolic engineering of Penicillium
paxilli to elucidate their function. Applied and Environmental
Microbiology 2009;75(23):7469–7481.
61. Nierman, W.C., May, G., Kim, H.S., Anderson, M.J., Chen, D.,
Denning, D.W.. What the Aspergillus genomes have told us. Medical
Mycology Supplement 2005;43:S3–S5.
62. Nierman, W.C., Yu, J., Fedorova-Abrams, N.D., Losada, L.,
Cleveland, T.E., Bhatnagar, D., Bennett, J.W., Dean, R., Payne,
G.A.. Genome Sequence of Aspergillus flavus NRRL 3357, a Strain
That Causes Aflatoxin Contamination of Food and Feed. Genome
Announcements 2015;3(2):e00168–15.
63. Paradis, E., Claude, J., Strimmer, K.. APE: Analyses of
Phylogenetics and Evolution in R language. BIOINFORMATICS
APPLICATIONS NOTE 2004;20(2):289–290.
64. Saroj, P., P, M., Narasimhulu, K.. Characterization of thermophilic
fungi producing extracellular lignocellulolytic enzymes for
lignocellulosic hydrolysis under solid-state fermentation. Bioresources
and Bioprocessing 2018;5:31.
65. Sato, A., Oshima, K., Noguchi, H., Ogawa, M., Takahashi, T.,
Oguma, T., Koyama, Y., Itoh, T., Hattori, M., Hanya, Y.. Draft
Genome Sequencing and Comparative Analysis of Aspergillus sojae
NBRC4239. DNA Research 2011;18:165–176.
66. Sen, S., Ray, L., Chattopadhyay, P.. Production, purification,
immobilization, and characterization of a thermostable β-galactosidase
from aspergillus alliaceus. Applied Biochemistry and Biotechnology
2012;167:1938–1953.
67. Shiomi, K., Hatae, K., Yuichi Yamaguchi, O˜., Mas Hiroshi Tomoda,
R., Kobayashi, S., Omura, S.. New Antibiotics Miyakamides
Produced by a Fungus. JOURNAL OF ANTIBIOTICS
2002;55(11):952–961.
68. da Silva, A.C., Soares de Franc¸a Queiroz, A.E., Correiab, P.C.,
Branda˜o-costaa, R., Moreira, K.A., Porto, A.L.F., de Medeiros,
E.V.. Production and Characterization of Xylanase from Aspergillus
parasiticus URM 5963 Isolated from Soil of Caatinga. Technical
Report 2; 2016.
69. Sima˜, F.A., Waterhouse, R.M., Ioannidis, P., Kriventseva, E.V.,
Zdobnov, E.M.. BUSCO: assessing genome assembly and annotation
completeness with single-copy orthologs. Bioinformatics
2015;31(19):3210–3212.
70. de Siqueira, F.G., de Siqueira, A.G., de Siqueira, E.G., Carvalho,
M.A., Peretti, B.M.P., Jaramillo, P.M.D., Teixeira, R.S.S., Dias,
E.S., Fe´lix, C.R., Filho, E.X.F.. Evaluation of holocellulase
production by plant-degrading fungi grown on agro-industrial residues.
Biodegradation 2010;21(5):815–824.
71. de Souza, C.G.M., Girardo, N.S., Costa, M.A.F., Peralta, R.M..
Influence of growth conditions on the production of xylanolytic
enzymes byAspergillus flavus. Journal of Basic Microbiology
1999;39(3):155–160.
72. de Souza, D.F., de Souza, C.G.M., Peralta, R.M.. Effect of easily
metabolizable sugars in the production of xylanase by Aspergillus
tamarii in solid-state fermentation. Process Biochemistry
2001;36:835–838.
73. Stamatakis, A.. RAxML version 8: a tool for phylogenetic analysis and
post-analysis of large phylogenies. Bioinformatics
2014;30(9):1312–1313.
74. Sullivan, M.J., Petty, N.K., Beatson, S.A.. Easyfig: a genome
comparison visualizer. BIOINFORMATICS APPLICATIONS NOTE
2011;27(7):1009–101010.
75. Taniwaki, M.H., Pitt, J.I., Iamanaka, B.T., Sartori, D., Copetti,
M.V., Balajee, A., Helena, M., Fungaro, P., Frisvad, J.C..
Aspergillus bertholletius sp. nov. from Brazil Nuts. PLoS ONE
2012;7(8):e42480.
3.2. Manuscript II – Comparative genomics of section Flavi 60
D
R
A
FT
Kjærbølling et al. Page 15 of 24
76. Tatusov, R.L., Fedorova, N.D., Jackson, J.D., Jacobs, A.R.,
Kiryutin, B., Koonin, E.V., Krylov, D.M., Mazumder, R.,
Mekhedov, S.L., Nikolskaya, A.N., Rao, B.S., Smirnov, S., Sverdlov,
A.V., Vasudevan, S., Wolf, Y.I., Yin, J.J., Natale, D.A.. The COG
database: an updated version includes eukaryotes. BMC Bioinformatics
2003;4:41.
77. Terada, M., Hayashi, K., Mizunuma, T.. Distinction between
Aspergillus oryzae and Aspergillus sojae by the productivity of some
hydrolytic enzymes. Nihon shoyu kenkyusho zasshi 1980;6:75–81.
78. Theobald, S., Vesth, T.C., mmer Rendsvig, J.K., Nielsen, K.F.,
Riley, R., de Abreu, L.M., Salamov, A., Frisvad, J.C., Larsen, T.O.,
Andersen, M.R., Hoof, J.B.. Uncovering secondary metabolite
evolution and biosynthesis using gene cluster networks and genetic
dereplication. Manuscript in review ;.
79. Varga, J., Frisvad, J., Samson, R.. Two new aflatoxin producing
species, and an overview of Aspergillus section Flavi. Studies in
Mycology 2011;69:57–80.
80. Vesth, T.C., Nybo, J.L., Theobald, S., Frisvad, J.C., Larsen, T.O.,
Nielsen, K.F., Hoof, J.B., Brandl, J., Salamov, A., Riley, R.,
Gladden, J.M., Phatale, P., Nielsen, M.T., Lyhne, E.K., Kogle,
M.E., Strasser, K., McDonnell, E., Barry, K., Clum, A., Chen, C.,
LaButti, K., Haridas, S., Nolan, M., Sandor, L., Kuo, A., Lipzen,
A., Hainaut, M., Drula, E., Tsang, A., Magnuson, J.K., Henrissat,
B., Wiebenga, A., Simmons, B.A., Ma¨kela¨, M.R., de Vries, R.P.,
Grigoriev, I.V., Mortensen, U.H., Baker, S.E., Andersen, M.R..
Investigation of inter- and intra-species variation through genome
sequencing of Aspergillus section Nigri. Nature Genetics
2018;Accepted -.
81. Watanabe, K.. Effective use of heterologous hosts for characterization
of biosynthetic enzymes allows production of natural products and
promotes new natural product discovery. Technical Report 12; 2014.
82. Wollenberg, R.D., Saei, W., Westphal, K.R., Klitgaard, C.S.,
Nielsen, K.L., Lysøe, E., Gardiner, D.M., Wimmer, R., Sondergaard,
T.E., Sørensen, J.L.. Chrysogine Biosynthesis Is Mediated by a
Two-Module Nonribosomal Peptide Synthetase. Journal of Natural
Products 2017;80(7):2131–2135.
83. Yu, J., Nierman, W.C., Fedorova, N.D., Bhatnagar, D., Cleveland,
T.E., Bennett, J.W.. What can the Aspergillus flavus genome offer to
mycotoxin research? Mycology 2011;2(3):218–236.
84. Yuan, G.F., Liu, C.S., Chen, C.C.. Differentiation of Aspergillus
parasiticus from Aspergillus sojae by Random Amplification of
Polymorphic DNA. Applied and Environmental Microbiology
1995;61(6):2384–2387.
85. Yun, C.S., Motoyama, T., Osada, H.. Biosynthesis of the mycotoxin
tenuazonic acid by a fungal NRPS-PKS hybrid enzyme. Nature
Communications 2015;6:8758.
86. Zabala, A.O., Xu, W., Chooi, Y.H., Tang, Y.. Characterization of a
silent azaphilone gene cluster from Aspergillus niger ATCC 1015
reveals a hydroxylation-mediated pyran-ring formation. Chemistry and
Biology 2012;19(8):1049–1059.
Tables
Table 1 Percentage of genome syntenicly conserved. .
Species # Syntenic genes % of A. oryzae
A. parasiticus 8199 68.15%
A. transmontanensis 8238 68.48%
A. arachidicola 8817 73.29%
A. novoparasiticus 8102 67.35%
A. sergii 8091 67.26%
A. flavus 8686 72.20%
A. parvisclerotigenus 9094 75.59%
A. oryzae – –
A. minisclerotigenes 8498 70.64%
A. caelatus 7411 61.60%
A. pseudocaelatus 7503 62.37%
A. pseudotamarii 7494 62.29%
A. tamarii 7471 62.10%
A. pseudonomius 7179 59.68%
A. nomius 7269 60.42%
A. bombycis 7863 65.36%
A. bertholletius 6801 56.53%
A. alliaceus 6021 50.05%
A. albertensis 5998 49.86%
A. coremiiformis 5425 45.10%
A. leporis 5800 48.21%
A. avenaceus 5351 44.48%
A. nidulans 4272 35.51%
A. fumigatus 4876 40.53%
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Figure 1 Phylogeny and genome statitics of section Flavi plus 8 other Aspergillus, Penecillium and Neurospora species. A)
Phylogenetic tree constructed using RAxML [73], MUSCLE [14], and Gblock [7] based on 200 monocore genes. The red star
indicates uncertain/unresolved branches. B) The colors illustrates the clades found within section Flavi and the cross indicates
species sequenced in this study. C) Seven bubble plots illustrating key genome numbers and sequencing quality parameter. The
bubble sizes have been scaled to each panel and are not comparable across panels.
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Figure 2 Core, section, clade specific and species unique genes A) A dendrogram representing the phylogenetic relationship
between the 31 Aspergilli. The black boxes in the nodes represent the homologous protein families shared among the species
branching from that node. The white boxes at the tips represent the protein families unique to that individual species. B) A barplot
showing the number of total (green), core (turquoise), and species-unique (orange) proteins for each species. The dark shading
illustrates the number of proteins with a least one functional annotation based on InterPro [18].
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Figure 3 Location of species unique and secondary metabolite genes in the A. oryzae genome The grey bars represent the A.
oryzae genome. Above the chromosome the unique (turquoise) and secondary metabolite genes (orange) are mapped to the genome,
each line represents a gene. The curve shows the percentage of the density calculated from the total number of genes within 30 kbp
in steps of 5 kb. Below the genome the core genes are mapped by the grey dots and the density of the total number of genes are
shown by the black graph (with a window of 30 kbp).
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Figure 4 Syntenic genes mapped to the A. oryzae genome The grey bars represent the A. oryzae genome. Syntenic genes were
found using A. oryzae as reference comparing all the other species to this genome. Above the chromosomes syntenic genes shared
with all species in a certain group is shown. Dark turquoise - A. flavus clade; light turquoise - A. flavus and A. tamarii clade; yellow -
A. flavus, A. tamarii and A. nomius clade; blue - Flavi section; orange - Flavi section, A. nidulans and A. fumigatus. Below the
chromosome the non-syntenic genes, found to be non syntenic in all the species, are shown in black.
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Figure 5 Carbohydrate active enzymes in section Flavi A) The total number of Carbohydrate-Active enZymes (CAZymes) in each
species distributed on 7 categories of enzyme activity; auxiliary activities, carbohydrate-binding molecules, carbohydrate esterases,
distant plant expansins, glycoside hydrolases, glycosyltransferases, and polysaccharide lysases. B) Boxplot representing the diversity
of CAZymes amount and content among clade A. flavus (light blue), A. tamraii (yellow), A. nomius (dark blue), A. alliaceus (light
turquoise), the rest of the Flavi section (orange), other Aspergilli (dark turquoise), non-Aspergillus species (grey). For each CAZyme
class the total number of CAZymes (top row) and the number of unique CAZyme families (bottom row) are displayed.
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Figure 6 Carbohydrate active enzymes in section Flavi A) Heatmap representing the growth profiles of 23 Flavi species and 8
addition species on 35 different media. B) Comparison of the CAZyme sets related to plant biomass degradation in the genomes of
species from Aspergillus section Flavi, and some other fungi. The colours reflect the polysaccharides the enzymes are active on. The
blue line indicates the species of section Flavi.
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Figure 7 Dereplikation of known compound and predicted secondary metabolite gene backbone genes per species. A) A
dendrogram representing the phylogenetic relationship between the species. The black boxes in the nodes represent the secondary
metabolite gene cluster (SMGC) families shared among the species branching from that node. If there is no black box there are zero
clusters shared. The grey boxes at the tips shows the number of unique SMGC families only found in one species. B) Matrix
indicating the presence and absence of SMGC families coupled to known clusters from the MIBiG database [53] for each species. C)
Predicted secondary metabolite genes for each species divided by the backbone enzyme. DMAT: Dimethylallyltransferase (Prenyl
transferases), HYBRID: A backbone gene containing domains from NRPS and PKS backbones, NRPS: Non-ribosomal peptide
synthetase, NRPS-like: Non-ribosomal peptide synthetase like, containing at least two NRPS specific domains and another domain or
one NRPS A domain in combination with NAD binding 4 domain or short chain dehydrogenase, PKS: Polyketide synthase, PKS-like:
Polyketide synthase like, containing at least two PKS speci
c domains and another domain, TC: Terpene cyclase
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Table B1 Growth section Flavi quantitatively. Growth analysis of 23 Flavi species plus 8 additional species on 35 different growth
media, quantitated by growth from 0-10, normalized based on growth on 1% glucose
Table B2 CAZy content in section Flavi. Overview of the CAZy content and plant degradation related CAZy content
Table B3 Secondary metabolite gene clusters section Flavi. Long format table with all the predicted clusters in the species and the
cluster family they belong to. Column 1 - Species, column 2 - JGI protein id of the predicted backbone, column 3 - cluster family number.
Table B4 Compounds produced by Flavi species after growth on CYA 7 days.
Figure B1 Phylogenetic tree based on 300 monocore genes. Phylogenetic tree constructed using RAxML [73], MUSCLE [14], and
Gblock [7] based on 300 monocore genes.
Figure B2 Phylogenetic tree based on 500 monocore genes. Phylogenetic tree constructed using RAxML [73], MUSCLE [14], and
Gblock [7] based on 200 monocore genes.
Figure B3 Single genes phylogenetic trees of 18 monocore families. Phylogenetic trees constructed using RAxML [73] and
MUSCLE [14] of 18 single gene tress from monocore families.
Figure B4 Most common InterPro domains in species unique proteins. Bar plot showing the number of species unique proteins
with an InterPro domain per species, shown for the most common InterPro annotations [18]. Light grey star indicates p-values below
0.005 and dark grey star indicates p-value below 0.00001 of enrichment in the species unique genes for the specific functional domain.
Figure B5 Most common GO domains in species unique proteins.Bar plot showing the number of species unique proteins with a
GO domain per species, shown for the most common GO annotations [22]. Dark grey star indicates p-value below 0.00001 of
enrichment in the species unique genes for the specific functional domain.
Figure B6 Most common KOG domains in species unique proteins.Bar plot showing the number of species unique proteins with an
KOG domain per species, shown for the most common KOG annotations [76]. P-values indicates enrichment of a certain KOG term
in the species unique genes for the specific functional domain. The p-values are indicated by stars of light to dark grey the lightest
star indicates p-values below 0.05, followed by p-values below 0.005 and the darkest stars indicates p-value below 0.00001.
Figure B7 Growth section Flavi.Growth analysis of 23 Flavi species plus 8 additional species on 35 different growth media.
Figure B8 Phylogenetic tree of GH28. Phylogenetic tree of all proteins assigned to the GH28 CAZy catagory. The GH28 family
consits of polygalacturonase. Alignment of the members of GH28 CAZy family found in all section Flavi species was created using
clustalo. The ML phylogenetic tree was created using the ape package in R [63].
Figure B9 Heatmap cluster families. Cluster families with members in at least 5 species are illustrated by a heatmap. The top rows
indicate the backbone enzymes found within the cluster family. Compounds with similar clusters are added from the dereplication
using MIBiG marked by orange boxes and black text in addition to manually curated compounds (marked by black boxes and blue
text). Aspergillic acid [40], aflatrem [60], chrysogine [82], tenuazonic acid [85], ditryptophenaline [81].
Figure B10 Miyakamide and putative clusters. A) Miyakamide B1 showing the three amino acid parts (organge line), the
acetylation (purple circle), the decarboxylation (green circle) and the N-methylation (blue circle). B) Syntenic plot of the putative
miyakamide cluster family plus surrounding genes. The syntney plot was generated using EasyFig [74] with the minimum length 50
bp and the minimum identity to 50%. The genes potentially involved in miyakamide production are marked by orange.
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Figure B11 Synteny of aflatoxin cluster family. Syntenic plot of the predicted clusters belonging to the ’sterigmatocystin - aflatoxin
- cyclopiazonic-acid’ cluster family. The syntney plot was generated using EasyFig [74] with the minimum length 50 bp and the
minimum identity to 50%. The genes are color coded based on known pathways; aflatoxin (orange), cyclopiazonic-acid (turquoise)
and unknown (blue).
Figure B12 Investigation of aflP and aflQ. The aflP gene is important for the last steps in the biosynthesis of aflatoxin, but it is
missing in most of the predicted aflatoxin clusters. Here is an alignment of the aflP protein against the best hits in the other Flavi
species.
Figure B13 Geneprediction of aflP. An overview of the gene prediction in the aflP gene in A. paraciticus and the RNA coverage
from JGI at Mycocosm.
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4 Resistance gene-directed genome
mining
There are thousands of predicted secondary metabolite gene clusters and it takes a
significant effort to identify the compounds and test them for bioactivity etc. The
idea behind Fungal ResIstance Gene-directed Genome mining (FRIGG) is that we
can select for bioactive clusters and knowing the Resistance mechanism we can
have an idea of the possible uses of the compound such as fungicides, cholesterol
lowering and so on.
In this chapter we will first introduce a pipeline we have developed for iden-
tifying putative resistance genes and bioactive biosynthetic gene clusters (section
4.1) followed by experimental investigation of an identified cluster (section 4.2).
4.1 Manuscript III - Pipeline for resistance gene-directed
genome mining
We have developed a pipeline for Fungal ResIstance Gene-directed Genome mining
(FRIGG) based on the hypothesis of a duplicated essential gene functioning as a
resistance gene.
As mentioned in the background (Section 2.3), there are many self-resistance
mechanisms. In this pipeline we are targeting a very specific self-resistance mecha-
nism — the duplication of an essential target gene which is inhibited by a secondary
metabolite, but the duplicated resistance gene is not and can thus still function.
The duplicated resistance gene is found with the biosynthetic gene cluster produc-
ing the secondary metabolite. This knowledge is used to identify resistance genes
and bioactive clusters and it allows for the identification of novel drug targets.
Whole-genome sequencing and comparative genomics are both prerequisites for
the development of this pipeline and will briefly be introduced here. Whole genome
sequencing of filamentous fungi have reveal an enormous biological diversity, which
was evident from the first whole genomes [25, 23, 24] and have been confirmed with
sequencing projects such as the 1000 fungal genomes (http://1000.fungalgenomes.
org) and Aspergillus sequencing project [92, 93].
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Comparative genomics paves the way of finding new insights and patterns from
whole genome sequences and have been developed and used extensively in bacteria
for many years [94, 95] and these methods are now becoming more extensively used
for fungi [96].
Comparative genomics can be used to identify similarities across many species
such as orthologous proteins and differences such as specific traits only found in a
few species. It is also extensively used to annotate newly sequenced genomes based
on knowledge from well studied genomes and from sequence similarity identified
using tools such as Basic Local Alignment Search Tool (BLAST) [97]. Other tools
have been developed inferring the functional domains from the sequences such as
Gene Ontology (GO) [98, 99], eukaryotic orthologous groups (KOG) [100] and
InterPro [101, 102].
When the first fungal genomes were sequenced and revealed a large number of
putative secondary metabolite gene clusters, combined with comparative genomic
tools, the idea of genome mining simply emerged — predicting and identifying
natural products based on the genetic information. Genome mining has been
extensively used in fungal genomes to identify secondary metabolite gene clusters
using sequence similarity of synthase/synthetase genes and predictive tools such
as SMURF [66] and antiSMASH (including the fungal version https://fungismash.
secondarymetabolites.org/#!/start) [103].
Today the challenge is not only to identify the biosynthetic clusters but to se-
lect the most promising clusters and prioritize the experimental effort. We wanted
to create a method overcoming the challenge of data overload by exploiting the bi-
ological diversity, wealth of whole genome sequences and the opportunities created
by comparative genomics. To do this, we created a pipeline identifying biosynthetic
gene clusters containing putative self-resistance genes. The developed pipeline is
based on comparative genomics, which is extreme powerful, when one has many
genomes available. Orthologs are identified in the species based on BLASTp and
secondary metabolite gene clusters are predicted using SMURF [66] and this in-
formation is coupled and then filtered based in a hypothesis driven approach. The
method is described in detail the following manuscript (Manuscript III).
Manuscript III will be submitted to the journal: Fungal Biology and Biotechnol-
ogy. The additional files to the manuscript can be found in Appendix C. The
scripts and data can be found at the Github page: https://github.com/ingek-1/
FRIGG pipeline and this repository: https://files.dtu.dk/u/ox6SPjaekiyxHpI8/
Data tables FRIGG?l.
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Abstract
Background: Fungal secondary metabolites are a rich source of valuable natural
products. Genome sequencing have revealed an enormous potential from
predicted biosynthetic gene clusters. It is however currently a time consuming
task and an unfeasible task to characterize all biosynthetic gene cluster and to
identify possible uses of the compounds. A rational approach is needed to identify
promising gene clusters responsible for producing valuable compounds. Several
valuable bioactive clusters have been shown to include a resistance gene which is
a paralog of the target gene inhibited by the compound. This mechanism can be
used to design a rational approach selecting those clusters.
Results: We have developed a pipeline FRIGG (Fungal ResIstance Gene-directed
Genome mining) identifying putative resistance genes found in biosynthetic gene
clusters based on homology patterns of the cluster genes. The FRIGG pipeline
has been run using 51 Aspergillus and Penicillium genomes, identifying 72 unique
protein families with putative resistance genes using various settings in the
pipeline. The pipeline was also able to identify the characterized resistance gene
inpE from the Fellutamide B cluster thereby validating the approach.
Conclusion: We have successfully developed an approach identifying putative
valuable bio-active clusters based on a specific resistance mechanism. This
approach will be highly useful as an ever increasing amount of genomic data
becomes available — the art of identifying and selecting clusters producing novel
valuable compounds will only become more crucial.
Keywords: secondary metabolism; resistance; genome mining; Aspergillus
Background
Fungal secondary metabolites are a rich source of bio-active compounds including
important pharmaceuticals such as penicillin, cyclosporin and statin [1]. When the
first fungal genomes were sequenced, it became clear that the genomes harbour a
higher number of secondary metabolite gene clusters than the number of charac-
terized secondary metabolites thus revealing a much larger potential [2, 3, 4, 1].
The number of sequenced genomes is ever increasing mainly due to large sequenc-
ing efforts such as the 1000 Fungal Genomes Project of the Department of Energy
Joint Genomes Initiative (http://1000.fungalgenomes.org/home/) and the 300 As-
pergillus genome project [5, 6] and therefore the number of predicted secondary
metabolite gene clusters is steadily increasing.
Despite progress in molecular tools and methods for characterization of secondary
metabolite gene clusters, it is still a time-consuming task, making it unfeasible to
investigate all predicted secondary metabolite gene clusters. Therefore only a small
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fraction of the predicted clusters are characterized and investigated experimentally.
With the plethora of predicted secondary metabolite gene clusters (clusters) and
the aim of discovering novel bio-active compounds useful as drugs, the question
emerges: How do we select the most interesting predicted clusters producing po-
tential valuable drugs such as anti-fungicides, anti-cancer drugs and anti-microbial
compounds? To meet this need we have created a pipeline FRIGG (Fungal ResIs-
tance Gene-directed Genome mining) identifying clusters producing likely bio-active
compounds based on resistance genes.
Many bio-active compounds are toxic compounds also impairing the organism that
synthesize them by inhibiting essential functions, therefore a self-resistance mech-
anism is needed in order to survive [7, 8, 9]. One known self-resistance mechanism
is the duplication of the target gene, where the second version is resistant towards
the compound and this second resistant version is most often found as part of the
biosynthetic gene cluster producing the toxic compound. This mechanism has been
seen in several bacterial instances such as novobiocin [10] and pentalenolactone
[11, 12].
More recently this resistance mechanism has also been identified in fungi. My-
cophenolic acid (MPA) is produced by Penicillium brevicompactum and it inhibits
inosine-5’- monophosphate dehydrogenase (IMPDH) which is the rate limiting step
in guanine synthesis. The biosynthetic cluster of MPA revealed an additional copy
of IMPDH which is insensitive to MPA thus conferring resistance, Figure 1A
[13, 14, 15]. Another example is Fellutamide B produced by A. nidulans which
is a proteasome inhibitor. Within the biosynthetic gene cluster a gene, inpE, en-
coding a proteasome subunit is located and it was shown that this gene confers
resistance, Figure 1B [16].
An illustration of the general mechanism can be seen on Figure 1C, where two ver-
sions of an enzyme is present and one version is affected by the secondary metabolite
(the target) whereas the other version is slightly different, but still with the same
function, is not inhibited by the secondary metabolite (the resistance gene). Even
though only a few examples of this mechanism have been identified and verified in
filamentous fungi so far [13, 16, 17, 18], it is possible that this resistance mechanism
is more widely distributed. We have therefore developed a Fungal ResIstance Gene-
directed Genome mining (FRIGG) pipeline identifying putative bio-active clusters
with resistance genes. The aim of the pipeline is to identify bio-active clusters in a
targeted manner thus providing a way of selecting the most interesting predicted
clusters producing potential valuable drugs from whole genome sequences.
The immediate advantage of the FRIGG pipeline is that highly likely bioactive
clusters are identified. Another major advantage of using this approach is that
the target of the compound is inherently known and hence the mode of action.
Knowing the target saves a lot of time since linking the compound to the target is
extreme difficult and time consuming and several regular drug discovery steps can
be eliminated since possible uses of the compound are known from the beginning.
Results
Pipeline set-up and Input data
We were interested in creating a pipeline identifying secondary metabolite gene clus-
ters (clusters) containing possible resistance genes from whole genome sequencing
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data. In order to do this we based the pipeline on the assumption that the resistance
gene is found within a cluster and is a copy – a paralog – of an essential gene. This
pattern and the resulting resistance mechanism has previously been described in
two different cases in fungi [13, 16].
We have used complete and draft quality whole genome sequences, mainly from
the 300 Aspergillus sequencing project [5, 6]. The input for the pipeline was chosen
to consists of three different types of data derived from the whole genome sequence
data: 1) predicted genes/proteins and functionally annotated proteins, for the func-
tional annotation we used InterPro [19, 20]. 2) Predictions of secondary metabolite
gene clusters, for this purpose we used a re-implementation of SMURF [21] as de-
scribed in Vesth et al. [6]. 3) Groups of homologous protein sequences. We used a
pipeline designed for Aspergillus data creating homologous protein families based
on single linkage of bidirectional BLASTp hits (as described in [6]). It is assumed
that proteins with similar, although not necessarily identical, function will be clus-
tered into the same protein family. For our purpose this is useful, as resistance and
target genes will be grouped into one family.
Using the described input the pipeline consists of a number of filtration steps de-
signed to identify the most likely candidate clusters containing potential resistance
genes, Figure 2. Several steps in the pipeline are designed to deal with and/or min-
imize the effect of possible errors in assembly and annotation due either to inherent
errors in sequencing technologies or errors caused by the assembly and sequence
quality of draft genomes. Several options have been added to the pipeline to allow
the user to set the filters to allow for more or less noise caused by errors. Besides
mitigating errors the filtering steps are also implemented to deal with biological
diversity and differences.
Here we present the results of the pipeline using an extensive test dataset of 51
Penicillium and Aspergillus species containing a total of 3,276 predicted clusters and
26,551 secondary metabolite genes. The goal of the pipeline is to identify clusters
containing resistance genes, assuming that the resistance genes are copies of essential
genes. In this context, an essential gene is defined as a gene that has homologs in
all the species included in the analysis.
Homolog count and ’Strict’ cluster selection
The first step in the pipeline is to couple the homologous protein families to the pre-
dicted cluster genes, Figure 2 step 1. Following, the number of homologs – homology
count – for each secondary metabolite gene in each organism/genome is identified.
In addition, the number of homologs found in predicted clusters are recorded.
Next, clusters with potential resistance genes are selected based on a specific
pattern of homology counts, Figure 2 step 2. In this step the user can select various
levels of stringency for the selection pattern.
The most strict and simple selection pattern (Figure 2 step 2 left) identifies clus-
ters where only one of the genes have a homolog in the genome, it can have only one
such homolog, and this homolog must not be part of another cluster. The gene with
the homolog is the presumed resistance gene and the homolog outside the cluster
is the presumed target gene. Using this selection criteria on our test dataset, 262
clusters are identified, divided into 141 potential resistance genes protein families,
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Figure 3A (dark turquoise). This corresponds to 8% of the total clusters in the
data set.
This ’strict’ selection pattern is very restrictive: if any one of the other cluster
genes have a homolog anywhere in the genome, the cluster will be filtered away.
Many clusters contain tailoring enzymes with common functions such as P450 or
methyltransferases, these can be thought of as ”household” functions in secondary
metabolism. Clusters with common tailoring functions will therefore frequently have
several homologs resulting in high homology counts and the cluster will therefore
fall out of the ’strict’ selection pattern. Another effect of the filtering is that the
selected clusters often contain fewer genes (average size 6.4 genes vs. 8.2 for the
total data set). The bigger the cluster, the more likely it is that there are several
genes with homologs in the genome. It is likely that clusters containing potential
resistance genes are missed due to the strict selection criteria. Conversely, the share
of bioactive clusters is increased after the selection.
’Alternative’ cluster selection pattern
To increase the number of selected clusters with potential resistance genes, we
wanted to create an alternative selection pattern allowing the presence of more tai-
loring enzymes and larger cluster sizes. In order to generate reasonable alternative
selection criteria, the cluster genes in the dataset were investigated. The most com-
mon InterPro domains (annotated in at least 1000 cluster genes) were selected, the
protein families belonging to each InterPro domain was identified and the size of
the protein families were noted. In the additional file C1 a violin plot illustrates the
selected InterPro domains on the x-axis and the sizes of the protein families with
at least one protein with this domain are on the y-axis. There are many protein
families belonging to each InterPro domain ranging in size from 1 to 475 proteins.
Protein families with more than 100 members will most likely have several ho-
mologs in each organism and every time they appear in a cluster, the cluster will be
discarded using the ’strict’ selection pattern. To avoid this, an ’alternative’ selec-
tion pattern was created disregarding large protein families as potential resistance
genes and instead allowing the proteins belonging to large protein families to have
homologs in the organism, Figure 2 step 2 ’alternative’ pattern.
The size of the protein families will change depending on the data (e.g. the number
of genomes included and how closely related the species are). The selection was
therefore designed to be dependent on the number of organisms in the data set. In
order to determine this, we defined a metric: If the protein family is larger than the
total number of organisms in the dataset multiplied by X, where X is a user input,
then the gene is not considered as a potential resistance gene. Instead it is allowed
to have homologs and the cluster can still be selected, if another gene meets the
requirements for a resistance gene and the rest of the genes either have no homologs
or belong to a large protein family. The alternative pattern under step 2 in Figure
2 illustrates the copy number pattern.
In the less strict selection method, the potential resistance gene is thus still only
allowed to have one homolog outside the cluster and there is only one gene that can
have this pattern, however the other genes in the cluster are allowed to have more
homologs if their protein family is larger than: XInput × Number of organisms.
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If X is set to 2 then the cutoff in the illustration (step 2 in Figure 2) would be
2*5 organisms and the protein family illustrated has 11 members and hence would
be allowed in the pattern. If 3 is selected instead the cutoff would be 12 and the
illustrated protein family is not big enough and this cluster would fall out.
We have used two and three as input thereby disregarding protein families with
more than 102 or 153 members respectively. With this selection criteria 482 and 388
clusters are identified respectively which corresponds to an 84% and 48% increase
compared to the initial ’strict’ selection criteria, Figure 3A. Of these clusters there
are 255 and 202 different potential resistance gene families, corresponding to an
increase of 81% and 43% respectively, showing that the ’strict’ measurement is
indeed sensitive to large protein families.
Filtering
As mentioned above, genome data contains multiple types of errors such as incom-
plete genomes, gene calling and secondary metabolite gene cluster prediction errors.
Incomplete genomes and gene calling errors are likely to casue false negatives in our
pipeline while cluster prediction errors can cause both false positives and negatives
depending on if the prediction algorithm over or under predicts the size of the clus-
ter. Even with the current rate of technological advancement, data errors will most
likely be a problem for some time to come and therefore we have created filtering
steps to deal with these shortcomings in the data. Another reason for filtering is
to identify the most likely resistance genes and hence filtering steps have also been
implemented to decrease false positives.
Step 3 – Filtering the number of clusters. A filtering step is implemented in or-
der to mitigate secondary metabolite prediction errors (Figure 2 step 3). With the
assumption that if two of the selected clusters have potential resistance genes be-
longing to the same protein family, then it is less likely that it is an error and more
likely that the resistance gene belongs to the cluster. The filtering step selects only
the clusters where at least one other identified cluster has a potential resistance
gene belonging to the same protein family. As such, the members of the potential
resistance gene protein family have to be found in at least two selected clusters.
Using these filtering criteria, 45, 88, and 67 of the previous identified potential
resistance genes protein families are left for the ’strict’, ’alternative’ Xinput 2 and 3
which correspond to 32-35% of the initial selected potential resistance gene cases,
Figure 3B. As such about a third of the initially identified clusters share resistance
gene with another identified cluster and these are therefore more likely not to be
prediction errors.
Step 4 – Filtering the number of organisms with homologs. The assumption behind
this step is that the resistance genes should preferentially belong to a protein family
with an essential function, and thus it should have protein members in all the
species. The filtering step has two purposes, first it makes it more likely that it is
a resistance gene if there are homologs in all species and second it will be a more
widely useful bioactive compound if the target is conserved in many species.
This filtering step removes clusters where the putative resistance gene have ho-
mologs in less than a certain percentage of the organisms, Figure 2 step 4. The user
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can select percentages from 100 to 90 to select the most likely resistance genes and
best targets. The possibility of choosing lower than 100% was implemented to allow
for some data and prediction errors such as incomplete genomes and imperfect gene
annotations. Another reason for choosing lower than 100% is to allow some species
to have a different mechanism and thus not the target gene. Here we show the ef-
fect of selecting 98% and 90% of the organism on the number of cases selected. If
selecting the most restrictive setting where the homologs of the resistance gene has
to be found in 98% of the organism, then there are 14, 25 and 22 potential resis-
tance gene cases of the ’strict’, ’alternative’ Xinput 2 and 3 respectively, Figure 3C.
While setting the percentage of organisms to 90% there are 19, 38 and 32 potential
resistance gene cases, Figure 3C.
If one chooses not to use step 3 (based on at least two selected clusters having the
potential resistance gene), but only employ step 4 (based on the number of organ-
isms homologs of the potential resistance gene should be found in) more clusters
are selected, see Figure 3D. Using the setting of potential resistance genes having
homologs in 98% of the organisms 43, 57 and 54 cases are identified based on the
homology count pattern of ’strict’, ’alternative’ Xinput 2 and 3, respectively. While
employing only 90% of the organisms should have homologs of the potential resis-
tance genes, 70, 99 and 89 are cases were detected for ’strict’, ’alternative’ Xinput
2 and 3.
Step 5 – Filtering the number of organisms with single copies. The final filtering
step is again related to the organisms in which the putative resistance gene have
homologs. The assumption here is that the target gene should be one essential gene
and therefore the majority of the species should only have one copy.
This filtering step therefore removes protein families where more than 50% of the
organisms have more than one homolog of the putative resistance gene, Figure 2
step 5. This step is optional and can be employed or not as the user sees fit. The
effect of adding this selection criteria can bee seen in Figure 3E and F.
Pipeline output The primary output of this pipeline is a list of protein families with
potential resistance genes and fasta files containing all the proteins belonging to the
identified family. The header of each entry includes the name of the organism, the
section it belongs to, the protein id, the number of copies found in the organism and
if it is in a selected cluster (StrictClust), a predicted cluster (Clust) or somewhere
else in the genome (0) which is followed by the amino acid sequence. The cases that
come out of the pipeline depends on the different settings and each identified case
is independent of the others. If a high experimental capacity is available one option
is to test all these cases, if the experimental capacity is limited further analysis is
needed to evaluate and select which cases to work with.
In this example with 51 species, we get 12 different outputs after step 5 using each
of the various settings. Narrowing down from 3,276 clusters we have identified 72
unique putative resistance gene families using all the various settings (Table C2).
Of these 4 potential resistance gene families are found every time independent on
which setting, while 19 are found only once using a specific set of variables.
With each filtering step, the number of clusters and putative resistance genes de-
creases, but the share of likely bioactive clusters and true resistance genes increases.
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Identifying potential bioactive clusters
Even with the described selection criteria, the pipeline still produces more candi-
date clusters than it would be feasible for most academic labs to verify experimen-
tally. Once the pipeline has been run and potential resistance gene cases have been
identified, further analysis is needed to select the most promising candidates for
experimental verification.
In order to do this efficiently, we use a combination of principal component analysis
(PCA), phylogenetic analysis, functional annotation, and comparison to the NCBI
database using BLASTp in order to gain more knowledge about the potential cases
(examples of the PCA and phylogenetic trees can be seen in Figure 4 and additional
Figure C2 and C2).
The functional annotation and BLAST analysis are included to add to the under-
standing of the potential resistance genes; to examine if it has a known function, if
the function is essential, and if it would be a good drug target.
The PCA and phylogenetic trees are used to illustrate the evolutionary relation-
ship between the proteins in the protein family. Resistance genes are expected to
be a duplication of a target gene which is essential. Essential genes are under sim-
ilar evolutionary pressure in all the species and are therefore closely related. The
resistance gene however, is under a different pressure, potentially expressed under
a different subset of conditions, which is expected to be reflected in the sequence
and hence the analysis where resistance genes should form a separate group com-
pared to the target genes. To perform these two analysis the protein sequences from
the protein families were aligned using clustalo [22] and trimmed using Gblocks
[23, 24].
As mentioned in the introduction, there are some known clusters containing a
verified resistance gene, this includes the mycophenolic acid cluster in P. brevicom-
pactum and the fellutamide B cluster from A. nidulans. Both clusters were included
in this study as validation controls to check if the known resistance genes would be
identified using our pipeline.
The Fellutamide B cluster is identified in all the outputs where step 3 was skipped,
since this was the only cluster with this resistance gene and the selected homology
count pattern. Thus when filtering for more reliable cluster predictions it falls out
of the analysis.
The potential resistance and target genes are exposed to different evolutionary
pressure. This is expected to be reflected in the evolutionary pattern where the
essential target genes (under high pressure) will be closely related whereas the re-
sistance genes will show more variation. To investigate if this is the case a phyloge-
netic tree and a principal component (PCA) analysis was performed for the protein
family containing the fellutamide B resistance gene (596635), Figure 4. The PCA
shows a clear distinction between the resistance genes found in clusters and the
other essential target genes, Figure 4B. The phylogenetic tree (Figure 4A) shows
two clear groupings: one big closely related group with all the target genes (having
0 at the end of the label), and one small containing the resistance gene. The target
genes are ordered in their phylogenetic groups, so species from the same section
cluster together. The resistance gene from A. nidulans is clustered with a protein
from A. sydowii and A. versicolor, which both are found in clusters, indicating
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that these most likely also function as resistance genes and potentially can produce
Fellutamide B or a derivative or a different compound attacking the same target.
A. versicolor is known to produce fellutamide C and F [25, 26], whereas A. sydowii
to our knowledge has not been reported to produce derivatives of fellutamide. The
clusters in A. versicolor and A. sydowii are similar to the A. nidulans fellutamide
B cluster with similar backbone enzymes (≥ 70%) and tailoring enzymes, but the
A. versicolor and A. sydowii predicted clusters are bigger consisting of 19 genes, 7
more than the A. nidulans cluster. Three of the extra genes have homologs in the
genome and belong to small protein families which is why these clusters are not
identified in the first steps of the pipeline.
Near the resistance genes in the phylogenetic tree, there are also three other genes
found in A. homomorphus, A. tachungensis and A. candidus which are extra copies
of the target genes, but they are not predicted to be in clusters. One explanation
for the extra copies not found in clusters could be cluster prediction errors. We
therefore investigated if A. homomorphus, A. tachungensis and A. candidus had
a cluster similar to the A. nidulans fellutamide B cluster, but no BLASTp hits
of the backbone genes had identity above 37% indicating that they most likely
cannot produce any derivatives of fellutamide. Another explanation for the extra
copy could be that it functions as a defence mechanism protecting against other
species producing fellutamide, which could be useful if the species naturally grow
near fellutamide producing species.
The cluster of mycophenolic acid did not turn up in our outputs, so we investigated
the cluster further to understand why. The predicted cluster containing the PKS
responsible for producing the core compound of mycophenolic acid consists of four
genes; The PKS, a P450, a methyltransferase and the resistance gene. The PKS and
p450 are only found in one copy and the resistance gene has one identified homolog
as expected. The methyltransferase however also has a homolog in the genome.
As the size of this protein family is only 23 members, it is not disregarded in the
alternative pattern and the cluster is therefore filtered away in step 2. This shows
that we do loose some good cases along the steps in the pipeline which illustrates the
importance of running the pipeline with multiple settings and inspecting the output
carefully. The pipeline is highly sensitive to the number of organisms included and
the settings should be used keeping this limitation in mind.
Novel putative resistance gene
In addition to the known clusters with resistance genes, several uncharacterized
clusters were also identified containing putative resistance genes. We will here focus
on one example where the potential resistance gene is found in clusters in A. oryzae
and A. flavus (protein family 597268). The PCA analysis showed a very clear picture
of the resistance genes falling outside the group of target genes, the same is seen
in the phylogenetic tree, where the target genes also follow the expected phylogeny
with species from the same section grouping together, Additional Figure C2 and C3.
Besides the identified putative resistance genes in A. oryzae and A. flavus several
other species (A. wentii, A. piperis, A. candidus, A. taichungensis, A. campestris,
A. novofumigatus and P. brevicompactum) have an additional gene but these are
not found in predicted clusters. The backbone genes from A. oryzae and A. flavus
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have no hits in those species which could mean that the species carries the resistance
gene but do not produce the compound.
The predicted clusters in A. oryzae and A. flavus both consists of four genes:
an acetyltransferase (IPR000182, IPR016181), the predicted reistance gene, a
NRPS-like synthetase and a gene belonging to the major facilitator superfamily
(IPR011701, IPR007114). The putative resistance gene has annotations involved
in ’Signal transduction response regulator, receiver region’ and ’Signal transduc-
tion histidine kinase, core’ (IPR001789, IPR005467). Using BLASTp to investigate
the function of the putative resistance gene, the top hits have functions like: ’two-
component osmosensing histidine kinase (Bos1)’ (RAQ55620.1). Based on this infor-
mation it seem likely we have identified a cluster containing a previously unidentified
resistance gene where the compound inhibits a histidine kinase. In order to fully
determine this, this will have to be experimentally validated in the future.
Discussion
The pipeline was designed to identify secondary metabolite gene clusters (clusters)
containing potential resistance genes. It is a delicate balance of filtering away as
many clusters as possible to narrow down the field to the best candidates, while
keeping as many clusters with potential resistance gene as possible.
We have chosen an approach, where we make no assumptions about the function
or makeup of resistance genes besides being homologs of a gene shared by most
organisms in the data set. Another approach could be to screen for specific classes
of essential genes or resistance targets within predicted clusters. This approach was
used in another study where 86 bacterial Salinispora genomes were mined for du-
plicated genes involved in central metabolism co-localizing with clusters. Clusters
containing putative fatty acid synthase resistance genes were identified and these
were shown to be involved in the biosynthesis of thiotetronic acid natural products,
including thiolactomycin which is a well-known fatty acid synthase inhibitor [27].
This approach builds on knowledge of house-keeping genes thus requiring extensive
knowledge of the primary metabolism. In filamentous fungi there is still a lot of
primary processes which are not characterized, therefore there is a risk of missing
interesting resistance genes using that approach. To avoid this, we chose to use
a wider approach based only on the homology copy number pattern of predicted
secondary metabolism genes and not based on the functions. The underlying as-
sumption is that our pipeline identifies conserved household genes with a homolog
in a cluster. Using our approach, we avoid limiting the search space to only known
mechanisms thereby making it possible to find new essential mechanisms and drug
targets. Our non-functional-impelled approach can be used both on organisms with
little knowledge and extensive knowledge of the primary metabolism. In well char-
acterized species our approach is also useful since it is likely both to identify known
household genes but also new uncharacterized household genes. Finally, the setup
makes it possible to search the identified clusters afterwards with a criterion such
as the presence of primary metabolism genes.
The pipeline has been designed for a specific data set-up but it is also possible to
apply the method and the approach to other data-sets using the same ratiocination.
In each of the steps in the pipeline various parameters affect the output and
identified putative resistance genes, which parameters to use and tweak depends
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on the data and the aim of the analysis. The first thing is therefore to select the
input data carefully. Data with distantly related species might not give meaningful
homologous protein families using our cut-offs since proteins with similar function
might be more different than our cut-offs allow. Step 1 in the pipeline combines the
input data and creates a tables with homology count of all the cluster genes, in this
step no filtering or selection is done and hence there is no parameters to tweak.
In step 2 selecting clusters with a specific homology count pattern, the strict or
alternative patterns can be selected. Using the strict selection criteria, only 8% of
the clusters meets the criteria. When using too restrictive selection patterns, there
is a risk of creating false negatives, thus filtering away good cases. As mentioned
earlier, many common secondary metabolite genes are likely to have homologs and
belong to large protein families. Of the cluster genes belonging to this test dataset
12 and 6% belong to protein families larger than 102 and 153 proteins respectively,
and these are found in 51% and 37% of the total clusters. Therefore using the
’strict’ selection pattern, up to half of the clusters are likely to be discarded due to
the homology count pattern of standard cluster genes, which causes a lot of false
negatives. We therefore recommend using the alternative selection pattern. If the
species in the dataset are distantly related the size of the protein families might be
smaller and therefore a lower Xinput is recommended. The lowest reasonable value
of Xinput we recommend is 1.5; going lower the risk of disregarding true resistance
gene families becomes too big.
Filtering based on more clusters having the putative resistance gene (step 3) was
designed to avoid false positives due to cluster prediction errors. This step is useful
for data including closely related species likely to have similar clusters. If the data
consists mainly of distantly related species, it is less likely that similar clusters will
be found in more species and hence the risk of filtering away good cases increases
thereby making false negatives. In the test data, about two-thirds of the cases are
filtered away in this step, if running the pipeline and even more than two-tirds are
filtered away, we suggest skipping this step.
The 4th filtering step was made to avoid false positives, in this step the percentage
of organisms that should have a homolog of the putative resistance gene is selected
and this parameter can be tweaked depending on the data. If the species are dis-
tantly related, it is more likely that some species have a different essential household
mechanism and hence does not have a copy the household / target gene. A lower
percentage of organisms that should have a homolog is thus recommended in this
case. Another reason for choosing a lower percentage of organisms with a homolog
is if the quality of the genome sequence data is low, with incomplete genomes or if
the data includes novel species distantly related to model organisms where the gene
prediction algorithms might not work as efficiently.
The last filtering step was also made to avoid false positives, in this step at
least 50% of the species should only have a single homolog. This filtering step
is independent of the quality of the data and the relatedness of the species, and
we therefore recommend using this at all times. Here 30-60% of the cases are left
after this filtering, significantly decreasing the number but leaving highly promising
resistance cases.
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Conclusions
In this study, we have created a method identifying clusters responsible for produc-
ing bioactive compounds. The approach we have developed is based on a specific
resistance mechanism and paves the way for rationally selecting promising bioac-
tive clusters from whole genome data. The FRIGG pipeline was designed in con-
nection with the Aspergillus sequencing project however several filtering steps and
paramters can be tweaked to fit different kinds of data and to deal with the most
likely errors from predictions and draft genomes.
We have tested the developed pipeline on 51 Aspergillus and Penicillium genomes
identifying 72 unique putative resistance genes and clusters in the most strict con-
figuration of the pipeline. In addition, the characterized Fellutamide B resistance
gene inpE was successfully identified with this pipeline confirming the accuracy and
applicability of the pipeline to such cases of resistance mechanisms.
As more and more genomes are sequenced, the relevance of this approach will
increase and it will become a useful method for selecting which clusters to focus
on in the hunt for novel drugs such as anti-fungicides, anti-cancer drugs and anti-
microbial compounds.
Methods
Fungal species
The data consisted of 50 Aspergillus and 1 Penicillium species with available whole
genome sequencing data which was downloaded from JGI. Species information can
be found in Additional Table C1.
Input data
The data used in the pipeline was organized in a MySQL database, an overview
of the input data can be found in the file: Input data pipeline.txt and the data
can be found as sql/csv files on https://github.com/ingek-1/FRIGG pipeline. A
few of the data files were too big for Github and can be found in this repository
instead https://files.dtu.dk/u/ox6SPjaekiyxHpI8/Data tables FRIGG?l. The data
includes predicted secondary metabolite gene clusters based on an implementation
of the SMURF [21] pipeline described elsewhere [6]. Homologous protein families
were created with Aspergillus optimized parameters based on single linkage of bidi-
rectional BLASTp hits with identity ≥ 50% and sum of query and hit coverage ≥
130% as described in [6]. InterPro annotations of the proteins were also used [19, 20]
and gff information.
Pipeline
The pipeline was created using Python and the investigation of specific protein
families was conducted in R [28]. The versions and packages used can be seen in
version info files on the github page. For alignment and trimming of the protein
families clustalo and Gblocks was used in a Python script, also included on the
github page. All the scripts and files are available at Github: https://github.com/
ingek-1/FRIGG pipeline.
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Figure 1 Resistance mechanism. A) Mycophenolic acid chemical structure and biosynthetic
cluster with known resistance gene mpaF (highligted in red) which is a Inosine-5’-monophosphate
dehydrogenase (IMPDH) inhibitor. B) Chemical struture of Fellutamide B and overview of the
biosynthetic cluster including the resistance gene inpE (highlighted in red) which is a proteasome
inhibitor. C) Illustration of the resistance mechanism used by some toxin producers. The secondary
metabolite is a toxin which inhibits an essential enzyme - the target of the compound. Within the
cluster responsible for producing the toxin a copy of the target gene is found, this version is still
functioning despite the compounds pressence and hence makes the organism self-resistant.
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Figure 2 Overview of the pipeline. Overview of the pipeline illustrating the initial data of
predicted secondary metabolite gene clusters and homologous protein families. Step 1 – The initial
data is combined to generate counts of how many homologs are found in each organisms andhow
many are within predicted clusters. Step 2 – Clusters are selected based on specific homology
count patterns, either ’strict’ where only one gene can have a homolog outside the cluster or
’Alternative’ where genes belonging to large protein families are allowed. Step 3 – Filtering of the
selected clusters based on other clusters having a homologous resistance gene, this step is
optional. Step 4 – Filtering based on the majority of the organisms should have a homolog of the
resistance/target genes. Step 5 – Filtering based on the number of organism that should only have
a single homolog.
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Figure 3 Number of cases after each filtering step using various settings. A) the number of
cluster selected for each of the selections patterns and the number of resistance cases. B) The
number of resistance cases after step 3 - the resistance protein family has to be found in two
selected clusters. C) The number of resistance cases after step 4 - the resistance protein family
have to have homologs in 90 or 98% of the organisms in the dataset. D) The number of
resistance cases after step 4 but having skipped step 3, again both for 90 and 98% of the
organisms. E) The number of resistance cases after step 5 - the resistance protein family have to
be found as single copy in 50% of the species. F) The number of resistance cases after step 5 but
having skipped step 3.
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Figure 4 Phylogenetic tree and principal component analysis of protein family 596635 including
the Fellutamide B resistance gene. A) Phylogenetic tree of the the protein family (596635)
containing the Fellutamide B resistance gene, (protein id 2700) from A. nidulans. The
phylogenetic tree is a maximum likelihood tree and was created with 500 bootstraps. The
identified resistance gene is highlighted with red, the corresponding target is in green, other
cluster genes are in yellow and gene not found in clusters are in blue. B) Principal component
analysis of the protein family 596635 containing the Fellutamide B resistance gene, (protein id
2700) from A. nidulans. The panels to the left is colored based on the sections the proteins belong
to while the panels to the right is colored based on if the protein if found in a a selected cluster
(StrictClust- red), a predicted cluster (Clust-yellow), not in a cluster (0-blue) and the homolg to
the ones found in selected clusters (outsideSC-green).
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1 Additional Files
Figure C1 Common InterPro domains in secondary metabolism. Visualization of the most
common InterPro annotations of secondary metabolite genes (found in more than 1000 secondary
metabolite proteins) and the size of the protein families. Two horizontal lines indicate the
recommended protein family size cut-offs where XInput is 2 (102) and 3 (153).
Figure C2 Principal component analysis of the protein family 597268. Principal component
analysis of the protein family 597268 containing two potential resistance genes (protein id 11595
and 32200) found in A. oryzae and A. flavus. The panels to the left are colored based on the
sections the proteins belong to while the panels to the right are colored based on if the protein if
found in a a selected cluster (StrictClust- green), not in a cluster (0-blue), and the homolg to the
ones found in selected clusters (outsideSC-yellow).
Figure C3 Phylogenetic tree of the the protein family (597268). Phylogenetic tree of protein
family 597268 containing two potential resistance genes (protein id 11595 and 32200) found in A.
oryzae and A. flavus. The node labels shows bootstraps values based on 500. The tip labels have
the species name, the section, protein id, number of homologs in the species and an indication if
it is found in a selected cluster (StrictClust), a predicted cluster (Clust), not in a cluster (0) and
the homolg to the ones found in selected clusters (outsideSC)
Table C1 Species used in this study, showing species name, section, and link to the JGI pages with
the genomes.
Table C2 Overview of the 72 identified putative resistance genes families and the parameters where
they were identified.
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4.2 Identified and investigated resistance case
4.2.1 Introduction
Using the pipeline described in section 4.1, several clusters with putative resistance
genes were identified. Out of these, one cluster was selected for further experimen-
tal analysis in order to verify that the putative resistance gene truly is a resistance
gene and to identify the compound produced by the cluster. The additional files
can be found in Appendix D.
Investigation of an A. oryzae predicted cluster
The selected putative resistance gene belongs to protein family (597268) also men-
tioned in section 4.1, Manuscript III. It is found in clusters in A. flavus and A.
oryzae (no homolog of the cluster is found found in A. nidulans or A. aculeatinus).
The predicted cluster consists of four genes in both species. The illustration in
Figure 4.1 shows a representation of the A. oryzae cluster, but the cluster in A.
flavus is syntenic. The predicted functions in the cluster: a major facilitator su-
perfamily (IPR007114, IPR011701, IPR016196, JGI protein ID 11593), an NRPS-
like protein (JGI protein ID 11594), a signal transduction histidine kinase /Signal
transduction response regulator, receiver region (IPR001789/IPR005467, JGI pro-
tein ID 11595) which is the putative resistance gene, and an N-acetyltransferase/
Acyl-CoA N-acyltransferase (IPR000182, IPR016181, JGI protein ID 11596). It
is expected that the NRPS-like and the N-acetyltransferase are involved in the
biosynthesis of the secondary metabolite. The function of the major facilitator is
not known, it could be responsible for transporting precursors or intermediates to
the right compartments, or transporting the final compound out of the cell and
potentially helping in self-protection as mentioned in section 2.3.
11593 11594 11595 11596
Major facilitator superfamily NRPS-like
N-acetyltransferaseSignal transduction histidine kinase
5,000 10,000 15,000
Putative resistance 
gene
Figure 4.1 Selected cluster in A.oryzae with putative resistance gene. The genes
are represented by arrows and the JGI protein id is shown above, while the func-
tions are illustrated by the colors.
In order to investigate the cluster we have used several different strategies, I)
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Gene deletion in the native host using classical gene targeting and CRISPR based
deletion, II) Heterologous expression in A. nidulans by targeted integration, and
III) random integration in A. aculeatinus.
As mentioned in the review in Section 2.4, the main advantage of using the na-
tive host is that clear changes can be observed in the chemical profile if the cluster
is active. Classical gene targeting is dependent on the homologous recombination
efficiency which in filamentous fungi can be low. More recently, CRISPR-Cas9 has
been used to increase gene targeting efficiency by creating double stranded breaks
in the locus of interest which then need to be repaired either by non-homologous
end joining or homologous recombination using a plasmid or oligo as repair tem-
plate [104, 105]. If the strain used is deficient in non-homologous end joining
(NHEJ) the strain is forced to repair the breaks by homologous recombination
(HR) thereby significantly increasing the gene targeting efficiency.
Heterologous expression in filamentous fungi can be used if it is not possible
to use the native host, this strategy is laborious and have the challenges that the
host can be affected by the inserted cluster affecting the chemical profile or the
host can make cross-chemistry with the compound of interest making it difficult
to identify the compound of interest.
4.2.2 Results and discussion
Strategy I: gene deletion in A. oryzae
Similar clusters were identified in both A. flavus and A. oryzae, but since we
had more information and tools available for A. oryzae we chose to perform the
experiments in that species.
From available transcriptomic data, it was evident that the cluster genes are
expressed under standard laboratory conditions [106, 107]. We therefore decided
to use a strategy of gene deletion of the cluster genes. We expected that we
would be able to identify the compound produced by the cluster by comparing
the chemical profile of the wild type (WT) and deletion mutants. In addition,
we anticipated that we would be able to test if the putative resistance gene truly
confers resistance to a yet unknown compound.
An available strain of A. oryzae engineered for molecular manipulation was
used; A. oryzae A1560 (∆pyrG, ∆ku70 ). This strain has the pyrG gene, coding
for orotidine 5’-phosphate decarboxylase deleted, which is used as an auxotrophic
marker, and it is deficient in non-homologous end-joining thus forcing the DNA
repair to be done using homologous recombination (HR).
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Vectors designed to delete cluster genes were constructed with A. flavus pyrG
flanked by approximately 1000-base pairs targeting sequences complementary to
up- and downstream regions of either the NRPS-like (plasmid pFC873), putative
resistance alone (plasmid pFC874), or of both genes together (plasmid pFC963),
overview of plasmids in appendix D Table D.3. Transformation of the A. oryzae
A1560 (∆pyrG, ∆ku) with linearized vector pFC874, which should delete the pu-
tative resistance gene, resulted in extremely small colonies not viable and therefore
unable to verify correct transformation. The transformants with linearized pFC873
and pFC963 were tested by analytical tissue PCR, but none had the correct dele-
tions.
After several transformation attempts using classical gene targeting strategy, a
method based on CRISPR-Cas9 was employed in order to increase the efficiency of
homologous recombination (HR) [104, 105]. With HR, double-stranded breaks are
induced at the target site forcing the fungi to repair the breaks either by NHEJ
or HR if a repair template is given. NHEJ deficient strains must use a repair
template and HR which should increase the efficiency of gene targeting.
The efficiency of the methods were tested by targeting the spore pigment color
gene, fwnA, which when deleted gives white colonies instead of fawn. The efficiency
of both standard gene targeting and CRISPR-based methods were tested in two
strains A. oryzae A1560 ∆pyrG, ∆ku and A. oryzae A1560 ∆pyrG. This study
showed that gene targeting in A. oryzae A1560 ∆pyrG, ∆ku was unsuccessful,
since no colonies grew, while the same strategy resulted in one big white colony in
the A. oryzae A1560 ∆pyrG strain which is not what we expected (Figure 4.2).
The strain with the ku deletion should be more efficient in HR than the strain
with the wild-type ku. Co-transformation of a CRISPR-Cas9 plasmid carrying
2 gRNAs targeting the pigment gene in each end, with 90 bp oligo nucleotide
repair fragment complementary to up- and downstream sequences of the cut sites,
worked well in both strains giving several white colonies, Figure 4.2, column 3.
Encouraged by these results confirming that the method is efficient in A. oryzae,
new CRISPR-Cas9 vectors were designed to create two double-stranded breaks in
each end of the gene for the NRPS-like and in one end of the NRPS-like and the
other end of the putative resistance gene (to delete two genes at the same time).
As repair templates, both 90 bp oligo were designed and the previously created
plasmids were used. Both strains of A. oryzae A1560 ∆pyrG, ∆ku and ∆pyrG
were transformed with either an oligo or plasmid, but only transformants in the
A. oryzae A1560 ∆pyrG strain were obtained. These were tested using analytical
tissue PCR with multiplexing primers, however none gave the desired results. In
4.2. Identified and investigated resistance case 94
Figure 4.2 Overview of transformants of A. oryzae. The top row shows transfor-
mants of the A. oryzae A1560 ∆pyrG strain while the bottom row shows transfor-
mants of the A. oryzae A1560 ∆pyrG, ∆ku. First column positive control AMA1
(autonomous maintenance in Aspergillus). Second column negative control no
DNA transformed. Third column, using CRISPR and 90 bp oligo as repair tem-
plate. Fourth column classical gene targeting using homologous recombination –
transformation with linearized plasmid.
the oligo version, the genes were not deleted and in the plasmid version pyrG was
not inserted instead of the targeted gene.
The initial plan of deleting the cluster genes in the native host was not fulfilled.
Based on the results and test made it seems that there might be a problem with
the strain used A. oryzae A1560 ∆pyrG, ∆ku since it was very difficult to get
transformants using HR, and the CRISPR based method did not give a higher
efficiency as expected. Instead of trying to fix this problem, we decided to use a
different strategies of heterologous expression in A. nidulans.
Strategy II: Heterologous expression in A. nidulans
Many studies of secondary metabolite gene clusters have been conducted in het-
erologous hosts. A. nidulans has been used extensively [108, 109, 110, 111, 112],
and was chosen as host for heterologous expression of the A. oryzae cluster. An
available A. nidulans strain (IBT 29539) NID1, which is easy to work with and
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has an extensive range of genetic tools (pyrG and argB as auxotrophic marker and
is deficient in non-homologous end joining (NHEJ)) [113].
A) B)
Figure 4.3 Overview of plasmids created for heterologous expression in A.
nidulans, both plasmids contain origin of replication for propagation in E. coli
and a gene conferring resistance to ampicillin. A) Plasmid pAC1560(short pro-
moter)/pAC1562 targeting insertion site 4 [114] in A. nidulans, containing the
NRPS-like gene (protein ID 11594) and the N-acetyltransferase (protein ID 11595)
separated by a dual promoter originating from A. flavus between histone 3 and
4. The native terminators of the genes have been used by including 300-400 bp
downstream of the genes. The selection marker is pyrG originating from A. fumi-
gatus. B) Plasmid pAC1561 targeting insertion site 1 in A. nidulans contains the
putative resistance gene (protein ID 11595) and the major facilitator (protein ID
11593) separated by a dual promoter originating from A. terreus between histone
3 and 4. The native terminators of the genes have been used by including 300-400
bp downstream of the genes. The selection marker is argB originating from A.
oryzae.
The goal was to heterologously express all four cluster genes in A. nidulans.
Two vectors were made: one targeting insertion site 4 [114] containing the NRPS-
like and the N-acetyltransferase genes under the control of bidirectional histone
promoter from A. flavus [115] and using A. fumigatus pyrG as the selection marker
(pAC1560), Figure 4.3A. The other targeted insertion site 1 [114], used A. oryzae
argB as the selection marker and contained the transporter and putative resistance
gene under the control of bidirectional histone promoter from A. terreus [115]
(pAC1561), Figure 4.3B.
Transformants with the NRPS-like and the N-acetyltransferase genes inserted
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in insertion site 4 were created first, A. nidulans (argB2, pyrG89, veA1, nkuA∆,
IS4::T11594-11594-AflaPh3/h4-11596-T11596::pyrG. Unfortunately, it was later
discovered that a too short version of the dual histone promoter from A. flavus
had been used, which resulted in a reduction of the promoter strength in one end
equalling about 10% of the original strength. The N-acetyltransferase gene was at
this end and is thus only expected to be expressed 1/10th compared to the NRPS-
like gene. This version with the short promoter is denoted: A. nidulans (argB2,
pyrG89, veA1, nkuA∆, IS4::T11594-11594-AflaPh3*s/h4-11596-T11596::pyrG. A
new version was constructed with the NRPS-like and the N-acetyltransferase genes
inserted in insertion site 4 and this time with the full length of the dual promoter
(pAC1562).
Figure 4.4 Transformations with argB as selection marker. The transforma-
tions were conducted in the strain A. nidulans (argB2, pyrG89, veA1, nkuA∆,
IS4::T11594-11594-AflaPh3/h4-11596-T11596::pyrG A) Positive control AMA1
plasmid with argB from A. nidulans. B) Control of the backbone plasmid con-
taining only argB from A. oryzae but no cluster genes linearized for insertion
with homologous recombination (HR) into IS1. C) Control of the backbone plas-
mid containing only argB from A. nidulans, insertion with HR in IS1. D) The
plasmid with the cluster genes (11593 and 11595) under the control of the dual hi-
stone promoter from A. terreus with argB from A. oryzae as the selection marker
linearized for insertion in IS1 using HR.
The strain with the two genes inserted and the correct dual promoter was
transformed in order to insert the rest of the cluster in insertion site 1. Several
attempts were made, but no transformants grew. A suspicion of the selection
marker led to investigation of transformations with various methods and argB
genes, Figure 4.4. The positive control with argB from A. nidulans as selection
marker on AMA1 plasmid showed highly successful transformation with many
colonies growing (Figure 4.4A). This shows that the protoplasts are competent
and the selection works. Transformation of linearized plasmid containing argB
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from A. nidulans for integration into insertion site 1 also showed clear colony
formations (4.4C), illustrating that the method with homologous recombination
and integration works. No growth was observed on both the transformation plate
with linearized version of only the backbone plasmid with argB from A. oryzae
(4.4B) and the transformation plate with linearized version of the same backbone
plasmid with the cluster genes (4.4D), which shows that it is not the cluster genes
causing the problem, but the plasmid backbone and hence most likely the selection
marker argB from A. oryzae. Unfortunately we did not have enough resources to
redo the construct with the argB from A. nidulans instead.
The created strains of A. nidulans (argB2, pyrG89, veA1, nkuA∆, IS4::T11594-
11594-AflaPh3/h4-11596-T11596::pyrG both with the short and correct promoter
were used for further chemical analysis (section 4.2.2). Furthermore the created
plasmids, for targeted insertion into A. nidulans with the cluster genes, were also
used for another strategy of heterologous expression in A. aculeatinus elucidated
below (section 4.2.2).
Strategy III: Heterologous expression in A. aculeatinus by random
integration
Heterologous expression can be affected by the host, so the construct (pAC1560
AND pAC1562) with the NRPS-like and the N-acetyltransferase genes were also
inserted randomly into A. aculeatinus ∆pyrG to investigate, if the novel compound
could be found here. The vectors created for targeted insertion in A. nidulans were
linearized and transformed randomly into the genome of A. aculeatinus ∆pyrG
using pyrG as the selection marker, A. aculeatinus ∆pyrG::11594-11596::pyrG.
Both versions with the short and the correct promoter were created and used
for chemical analysis by ultra-high performance liquid chromatography – diode
array detection – quadrupole time-of-flight mass spectrometry (UHPLC-DAD-
QTOFMS).
Chemical analysis of the generated mutants
Firstly, chemical analysis was performed on the A. nidulans (argB2, pyrG89, veA1,
nkuA∆, IS4::T11594-11594-AflaPh3*s/h4-11596-T11596::pyrG and the A. ac-
uleatinus ∆pyrG:11594-11596::pyrG strains with the short promoter. The chem-
ical analysis of the A. nidulans strain was performed for the control (A. nidulans
argB2, pyrG89, veA1, ∆nkuIS4:pyrG) and for one mutant, while chemical analysis
of the A. aculeatinus strains was performed for the wild type and four mutants
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since the genes are integrated randomly and the expression and effect therefore
might vary. The strains were grown for 7 days on MM and YES media in the dark
at 37◦C for A. nidulans and 30◦C for A. aculeatinus and the chemical analysis
was performed in triplicates.
From these strains we expected that the NRPS-like compound should be pro-
duced and potentially part of it N-acetylated. From the A. nidulans strain, the
only significant difference in the chromatograms compared to the wild type was
the production of several stress-response related compounds previously identified
in other A. nidulans mutants (data not shown).
The hypothesis behind the selection of this cluster is that it should be bioactive
producing a toxic compound and the putative resistance gene should rescue the
producer. We would therefore expect an effect on the heterologous host expressing
the cluster, if no resistance gene is included. The insertion of the biosynthetic
cluster genes in A. nidulans caused the production of stress-related compounds,
indicating an effect and a response in the heterologous producer. However, no new
compound was detected in A. nidulans; one explanation for this could be, if the
compound is highly active and toxic to A. nidulans, then very low concentrations
not detected by our analytical methods could be causing the stress. This could
therefore suggest that the cluster truly is bioactive.
Figure 4.5 Overview of Group Abundance Comparison plot of mutants versus
control from Agilent Mass profiler to show the differences and similarities in chem-
ical profiles between the mutants A. aculeatinus ∆pyrG,::11594-11596::pyrG and
the control (WT) to help identify differential compounds of interest. Two com-
pounds were found to significantly differentiate with retention time (RT) of 1.7
and 2.2 minutes and mass to charge (m/z ) for [M+H]+ 189.0869 and 173.1285
respectively.
From the A. aculeatinus ∆pyrG,::11594-11596::pyrG strain with the genes in-
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serted randomly, four mutants were analyzed and compared to the wild type (all in
triplicates) using the program Agilent Mass Profiler, Figure 4.5. Two compounds,
with mass to charge (m/z ) for [M+H]+ 189.0869 and 173.1285 and retention time
(RT) 1.7 and 2.2 minutes respectively, were identified in all the mutants and not
in the wild type (WT), suggesting they are related to the inserted genes. The
compound at RT 1.7 min with [M+H]+ 189.0869 was tentatively identified as N-
acetyl-glutamine based on the HRMS and MS/HRMS data. This was verified by
comparison of HRMS, MS/HRMS and retention time to the commercially avail-
able standard, appendix D Figure D.1. One possible hit for the compound with RT
2.2 minutes and [M+H]+ 173.1285 was be N-acetyl-valine methylamide supported
by the HRMS and MS/HRMS data, appendix D Figure D.2.
In summary, heterologous expression in A. nidulans revealed no new com-
pounds which had not been identified in A. nidulans before, but a changed metabo-
lite profile seen before in stressed A. niudlans strains. Instead, heterologous ex-
pression in A. aculeatinus revealed two differential compounds found in all four
mutants in triplicate with the genes randomly inserted and not in the wild type.
These results clearly shows that there is a difference depending on what host is
chosen. It could therefore generally be a good idea, when identifying a new cluster,
to test a few different hosts in order to identify the best for expression of the given
cluster.
It is highly probable that the two identified compounds (m/z for [M+H]+
189.0869 and 173.1285 and RT 1.7 and 2.2 minutes respectively) are produced by
the inserted biosynthetic genes, since they are found in all A. aculeatinus mutants
and not in the wild type. However the relationship between the compounds, if
they are steps in a biosynthetic pathway or the result of promiscuous enzymes,
is not clear with the current results. It could be that one of the enzymes is not
efficient and potentially needs help from anther enzyme in the conversion.
Strains with the NRPS-like and N-acetyltransferase genes and the correct,
non-truncated, promoter were subsequently analyzed. Here, we expected even
more compound to be acetylated as the promoter should be strong in both ends.
However, the chemical analysis did not show this. For the A. nidulans (argB2,
pyrG89, veA1, nkuA∆, IS4::11594-11596::pyrG mutants, no significant differences
were found between the mutants and control. Using the Agilent Mass Profiler, no
significant differences were seen when comparing the A. aculeatinus ∆pyrG :11594-
11596 mutants and the wild type, Figure 4.6A. If only looking at the features
unique to the A. aculeatinus mutants, Figure 4.6B, a compound was identified,
which was the same as the compound identified in the first experiment with RT
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Figure 4.6 Overview from Agilent Mass Profiler showing the differences in chem-
ical profiles between the mutants A. aculeatinus ∆pyrG :11594-11596 with the
correct promoter and the wild type. A) Group Abundance Comparison plot of all
the mutants (four mutants in triplicates) versus the wild type (triplicates), no sig-
nificant differences were observed. B) Plot showing the features that are unique to
the mutants. One feature has the retention time 2.2 minutes and m/z for [M+H]+
173.1285.
2.2 minutes and m/z for [M+H]+ 173.1285, but the abundance is much lower than
in the previous experiment with the short promoter, appendix D Figure D.3. The
compound with RT 1.7 min m/z for [M+H]+ 189.0869 (N-acetyl-glutamine) was
not identified in these mutants.
The chemical analysis was repeated for the A. aculeatinus ∆pyrG :11594-11596::pyrG
mutants with the short promoter in order to verify the previous findings and secure
reproducibility. In these analyses, the abundance of the two compounds observed
to differentiate in previous experiments is much lower than in the first analysis
(50-75% lower in mutant 1 and 2 while only trace amounts are found in mutant 3
and 4) and a shift in the most abundant compound is seen, with more compound
being produced of m/z for [M+H]+ 173.1285 than m/z 189.0869 opposite to the
first analysis. The decrease in abundance of the compounds observed in the re-
peating experiment could be due to change in the expression of the genes — for
instance caused by epigenetic regulation — which might have had time to down
regulate the inserted genes for the second analysis. This explanation could be
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tested by expression analysis using qPCR. The observed shift from one compound
to the other as the most abundant is puzzling. It is seen for both the repeated
experiment with the short promoter, but also in the transformants with the long
promoter. One explanation could be a slight shift in the available pre-cursors af-
fected by the small changes in the media (which could happen since the plates are
from different batches of MM) combined with promiscuous enzymes able to use
different substrates. In the first analyses as well as in the repetition, A. aculeati-
nus ∆pyrG :11594-11596::pyrG mutant 1 had the highest production of the novel
compounds compared to the other mutants, this could be due to a good insertion
site or more copies inserted. The same is the case for the other mutants. As
such, this experiment did not reproduce the first experiment with the truncated
promoter nor the experiment with the complete promoter.
Lastly A. oryzae (where the investigated cluster originates from) was investi-
gated by chemical analysis in order to see if any of the identified compounds are
produced by the native host. N-acetyl glutamine was detected from A. oryzae
grown on CYA after 3 days, but only in trace amounts and could not be repro-
duced. This is a small indication supporting that the compounds produced by the
cluster genes have been identified, although the cluster may be regulated differ-
ently in the host, or N-acetyl glutamine is an intermediate in another pathway.
The two compounds identified in the A. aculeatinus mutants are produced
without the presence of the resistance gene which could suggest that the com-
pounds are not bioactive, they could potentially be intermediates which most
often are not bioactive and the cluster could be part of a super cluster or more of
the sourrounding genes are involoved. Another possibility is that the compound
does not affect A. aculeatinus under the grown conditions or that the concentra-
tion is too small. From a literature search it is evident that N-acetyl-glutamine
have shown to have some bioactivity, it is used as a psycostimulant and in a com-
plex with aluminium as an anti-ulcer agent [2, 3, 4]. To test the bioactivity as an
antifungal compound, one possibility could be to test the toxicity of the compound
on other fungi to see if the growth is impaired and what concentration is needed to
get an effect. It could also be very interesting to investigate if the mode of action
is on a histidine kinase as predicted by the resistance gene.
4.2.3 Conclusion
We have used three strategies to investigate the A. oryzae cluster containing a
putative resistance gene: I) gene deletion in the native host, II) heterologous ex-
pression in A. nidulans, and III) heterologous expression in A. aculeatinus. We
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have not been able to conclusively characterize the cluster and identify the final
biosynthetic compound using any of these strategies. The deletion in A. oryzae
failed, most likely due to a problem with the background strain, heterologous ex-
pression in A. nidulans did not give rise to new compounds, expression in A. ac-
uleatinus identified two new compounds (N-acetyl-glutamine and N-acetyl-valine
methylamide) but the amount and ratio of these compounds varied. The results in-
dicates that the cluster genes are involved in the production of N-acetyl-glutamine
and N-acetyl-valine methylamide. Further analysis is needed to characterize the
cluster and investigate the resistance hypothesis. One way of doing this could be to
express the entire cluster in A. aculeatinus, which has shown to be a suitable host
of this cluster, to see if the same compounds are produced and if more compound
is produced if the resistance gene is present. It would also be interesting to have
the resistance gene under an inducible promoter which should show whether the
putative resistance gene is required for survival while the cluster is expressed. An-
other strategy could be to express the cluster genes in yeast both individually and
in combination to characterize the biosynthesis and show whether the resistance
gene is required in this host.
4.2.4 Methods
Strains and media
A list of all strains used and constructed in this study is provided in supple-
mentary Table D.1. Gene deletion in A. oryzae was performed using A. oryzae
A1560 ∆pyrG, ∆ku and A. oryzae A1560 ∆pyrG. Heterologous expression was
performed in A. nidulans argB2, pyrG89, veA1, ∆nku (NID1), while heterologous
expression in A. aculeatinus was performed in a ∆pyrG strain. Escherichia coli
strain DH5alpha was used for plasmid propagation. The background strains of A.
oryzae A1560, A. nidulans and A. aculeatinus were obtained from the in house
strain collection.
Aspergillus solid and liquid minimal medium (MM) and transformation medium
(TM) were prepared as described by Nødvig et al. [104] and yeast extract sucrose
(YES) medium was prepared as described by Samson et al. [116]. The medium
was supplemented with 10 mM uridine and 10 mM uracil or 4 mM arginine when
necessary. E. coli was grown on solid and liquid Luria-Betrani (LB) medium con-
taining 10 g/l tryptone (Bacto), 5 g/L yeast extract (Bacto), 10 g/l NaCL (pH
7.0) supplemented with 100 µg/ml ampicillin.
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Vector and strain construction
All DNA fragments used for cloning were amplified in 35 cycles using PfuX poly-
merase [117] and touch-down PCR programme with the annealing temperature
from 65-56◦C. The standard reaction used included 200 µM dNTPs, 1x Phusion
HF buffer (New England Biolabs, USA), 0.4 µM primers (purchased from Inte-
grated DNA technologies, Belgium), 1 U PfuX7, ≤ 10 ng gDNA with a total
volume of 50 µl. The primers used for amplification are listed in Supplementary
Table D.2. Genomic DNA (gDNA) was extracted from A. oryzae A1560 using the
FastDNA SPIN Kit for soil DNA extraction (MP Biomedicals, USA) and used as
template with ≤ 10 ng/µl.
Plasmids were constructed using Uracil-Specific Excision Reagent (USER) cloning
or fusion [118], Supplementary Table D.3. All constructed plasmids contained an
origin of replication for propagation in E. coli and the ampicillin resistance gene.
Plasmids for gene deletion were constructed by introducing the PCR-amplified up
and downstream fragments into two specific USER casettes on each side of the A.
flavus pyrG selection marker.
Plasmids were purified using the GenElute Plasmid Miniprep Kit (Sigma-
Aldrich) and were linearized with SwaI/NotI (New England Biolabs) prior to
transformation when using homologous recombination.
Protoplastation and transformation
In order to make protoplasts, spores from one or two agar plates were harvested
and filtered through sterile Miracloth (EMD Milipore) into a shakeflask with 100
mL of appropriate media with supplements (MM for A. nidulans and YDP for A.
oryzae). The shakeflasks were incubated at appropriate temperature (37◦C for A.
nidulans and 30◦C for A. oryzae) for 4-5 hours (the spores should just have started
to germinate, so when looking in the microscope a few have started to “bud”, while
the majority still looks like spores). The culture was then spun down at 5,000g for
10 min, and the medium was discarded. Subsequently the spores in the pellet were
digested in a 20 ml sterile solution of 40 mg/ml Glucanex (Novozymes) dissolved
in APB. The spore Glucanex solution was incubated for digestion at 30◦C 150
rpm for 1-1.5 hour. Following digestion the solution was spun down at 1500 g for
10 min and the APB supernatant solution was removed. The spores were washed
1-2 times in ST buffer (1 M sorbitol; 50mM Tris; pH 8) and spun at 1500 g for 10
min each time. Finally the washed spores were resuspended in 2-5 ml STC (1 M
sorbitol; 50mM Tris; 50mM CaCl2; pH 8) for a final concentration of 1.2 × 107.
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The protoplasts were stored at -80◦C.
Transformation was performed as described by Nødvig et al. [104]. All candi-
date transformants were purified by streaking on agar plates prior to verification.
All strains were verified by tissue-PCR analysis using mycelium as the source of
DNA and including wild type gDNA as control. The primers can be found in Sup-
plementary Table D.2. Primers for gene- deletion analysis were designed to bind
up- and downstream outside the region eliminated by the gene-targeting substrate.
Primers for gene insertions were designed to bind up and downstream of the inser-
tion site and in each end of the inserting genes, four primers were included in one
reaction giving one large band if the insertion was unsuccessful and two smaller
bands if the insertion is successful.
Chemical analysis
The mutants and wild types were grown on MM and YES agar plates for 7 days,
subsequently 5 plugs were taken across the colony, 800 µl isopropanol:ethyl acetate
(1:3 v/v) with 1% formic acid was added and ultrasonicated for 1 hour. The liquid
sample was transferred to another tube and evaporated, following 300 µL methanol
was added to redissolve the pellets and the samples were ultrasonicated 20 minutes.
Samples were then centrifuged at max g-power for 2-3 minutes, and afterwards 150
µL of the supernatant was transferred to HPLC vials.
Ultra-high performance liquid chromatography – diode array detection – quadrupole
time-of-flight mass spectrometry (UHPLC-DAD-QTOFMS) was performed on an
Agilent Infinity 1290 UHPLC system equipped with a diode array detector. Sep-
aration was obtained on a 250 × 2.1 mm i.d., 2.7 µm, Poroshell 120 Phenyl Hexyl
column (Agilent Technologies, Santa Clara, CA) held at 60 ◦C. The sample, 1
µL, was eluted with a flow rate of 0.35 mL/min using A: a linear gradient 10%
acetonitrile in Mili-Q water buffered with 20 mM formic acid increased to 100%
in 15 min., staying there for 2 min. before returning to 10% in 0.1 min., held for 3
min. before the following run. Mass spectrometry (MS) detection was performed
on an Agilent 6545 QTOF MS equipped with an Agilent dual jet stream electro
spray ion (ESI) source with a drying gas temperature of 160 ◦C, gas flow of 13
L/min, sheath gas temperature of 300 ◦C, and flow of 16 L/min. Capillary voltage
was set to 4000 V, and nozzle voltage, to 500 V in positive mode. MS spectra were
recorded as centroid data, at an m/z of 100 to 1,700, and auto MS/HRMS frag-
mentation was performed at three collisions energies (10, 20, 40 eV), on the three
most intense precursor peaks per cycle. The acquisition was 10 spectra/s. Data
was handled in the software Agilent MassHunter Mass Profiler and MassHunter
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Qualitative Analysis (Agilent Technologies, Santa Clara, CA).
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5 Conclusion
With the increasing number of fungal whole genome sequences, exciting opportu-
nities emerge but also challenges. Both of which are addressed in this thesis. The
opportunities include gaining new insights and creating knowledge-based hypoth-
esis, whereas the main challenges are how to use the data, what to focus on with
the unprecedented amount of data, and — post-data analysis — which projects
to initiate based on the data.
An important discovery from the first Aspergillus whole genome sequences was
the large potential of secondary metabolite biosynthesis. This initiated opportu-
nities in genome mining, but it still remains a challenge to link biosynthetic gene
clusters to the compounds they produce. I have addressed this challenge both in
terms of presenting state-of-the-art in Chapter 2 and by predicting biosynthetic
gene clusters for aflatoxin, chlorflavonin, novofumigatonin and ochrindol based
on the genome sequences in Section 3.1, thereby addressing aim 1. Chapter 3
also addresses two other aims, publishing genomes and investigating the biologi-
cal and chemical diversity within Aspergillus species (aim 2 and 3). With Paper
I and Manuscript II, we will publish 6 and 19 genomes respectively, moreover
we have characterized the genomes and used them to investigate the diversity.
In Manuscript II (section 3.2, I focused on the important Flavi section. With
genome sequences covering the entire section, we had a unique opportunity to
explore the diversity and similarities across the Flavi section. From this work we
have shown that section Flavi has a very high potential for secondary metabo-
lite production and carbohydrate active enzymes. We have, through phylogenetic
analyses, shown differences in the evolutionary pattern compared to the common
theories, and from synteny analysis shown potential patterns of genome evolution
with highly conserved regions and variable blocks.
The first whole genome sequencing data of Aspergillus species revealed a large
number of predicted secondary metabolite gene clusters. With the current molecu-
lar methods, it is unfeasible to investigate all the predicted clusters in the search for
novel bioactive compounds, which is why a targeted method is needed to identify
which clusters to elucidate. We have addressed this need using a hypothesis-driven
approach based on duplicated self-resistance genes and comparative genomics, pre-
sented in Chapter 4, Manuscript III. We chose to attack the challenge by develop-
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ing a pipeline identifying putative resistance genes in biosynthetic gene clusters.
Applying the pipeline to 51 Aspergillus and Penicillium genomes, we were able
to validate the method by identification of a known cluster with a verified self-
resistance gene as well as the identification of 71 other protein families containing
unverified resistance genes. We have investigated a selected cluster with a putative
resistance gene in an attempt to verify the identified cluster and with a hope of
finding a novel bioactive compound. The efforts have so far only produced incon-
clusive results. In the future the pipeline or the rationale behind it can be used
to direct experimental efforts in natural product discovery in the quest to identify
novel anti-fungals and meet the desperate need.
The work presented in this thesis will function as a reference for future work
both within research in section Flavi and within the field of linking compounds
and gene clusters. Our work has provided reference genomes and an overview of
the potential of section Flavi and other researchers can build on this and create
new insights. We have shown various ways of identifying biosynthetic gene clusters
from compounds which hopefully will inspire other researchers to use the strategies
and resources to link their favorite cluster genes and compounds. Finally, we
have provided the natural product discovery field with a new targeted method of
identifying likely bioactive compounds and gene clusters. The identified resistance
genes, targets and clusters will hopefully be examined and tested in the near future
to provide much needed new antifungals.
In the future we are likely to see an increasing number of studies using compara-
tive genomics to create knowledge-based hypothesis. Genome sequencing projects
such as the Aspergillus whole genus project and the 1000 fungal genomes pro-
vide an enormous resource to the scientific community not seen before within the
fungal field, opening for exciting opportunities in a variety of fields including ba-
sic research in the evolution and adaptation and applied research in metabolic
engineering, and enzyme and drug discovery.
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Figure S1 LC-MS analysis of the metabolites from Aspergillus novofumigatus IBT 16806 cultivated on 
YES agar medium. (A) Total and (B) extracted ion chromatograms, and mass spectra of (C) ent-cy-
cloechinulin, (D) epi-aszonalenin A, (E) novofumigatonin, and (F) epi-aszonalenin A. 
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SI	Text	
Part	1:	Materials	and	Methods	
Strains:	
A.	 campestris	 (CBS	348.81	=	 IBT28561,	NCBI	 Taxonomy	 ID:	 1392248)	was	 first	 isolated	 in	1979	 from	 soil	
collected	in	northern	North	Dakota.	Initially	is	was	placed	in	the	ochraceus	group	(section	Circumdati)	[1].	
This	was	however	only	based	on	morphology.	In	2000	Rahbæk	et	al.	suggested	that	A.	campestris	should	be	
placed	in	section	Candidi	based	on	chemotaxonomical	evidence	[2].	In	an	investigation	of	section	Candidi	it	
was	 further	 consolidated	 that	A.	 campestris	 belongs	 to	 this	 section	 based	 on	 among	 other	 phylogenetic	
studies	of	the	calmodulin	and	b-tubulin	genes	[3].	A.	campestris	is	known	to	produce	a	range	of	interesting	
chemical	compounds	including,	candidusin	C,	terphenyllin	and	chlorflavonin	[2,	3].	
A.	novofumigatus	(CBS	117520	=	IBT16806,	NCBI	Taxonomy	ID:	1392255)	was	originally	isolated	Californian	
chamise	 chaparral	 soil	 collected	 in	1965.	 It	 is	 closely	 related	 to	 the	pathogenic	 species	A.	 fumigatus	 and	
belongs	to	the	section	Fumigati.	It	was	initially	suggested	to	be	a	separate	species	in	2005,	this	was	mainly	
based	on	phylogenetic	studies	of	the	beta-tubulin,	calmodulin	and	actin	genes	and	on	the	extrolite	profile	
[4].	A.	novofumigatus	has	been	 recorded	 in	one	 instance	of	 aspergillosis	 along	with	another	 species	 in	a	
patient	with	leukaemia	[5].	
A.	ochraceoroseus	(IBT	24754	=	CBS	550.77,	NCBI	Taxonomy	ID:	1392256)	was	first	isolated	from	soil	from	
the	Taï	national	Park	in	the	Ivory	Coast	in	1978	and	based	on	the	morphology	it	was	assigned	to	ochraceus	
group	(section	Circumdati)	 [6].	Looking	at	 the	phylogeny	of	several	housekeeping	genes	and	the	extrolite	
profile	A.	ochraceoroseus	it	is	more	closely	related	to	subgenus	Nidulantes	and	Veriscolores	[7].	Currently	it	
is	believed	to	be	a	member	of	section	Ochraceorosei	[8,	9].		
A.	steynii	(IBT	23096	=	CBS	112812,	NCBI	Taxonomy	ID:	1392250)	has	been	isolated	from	Arabica	green	coffee	
bean	from	India.	It	belongs	to	section	Circumdati	and	is	closely	related	to	A.	elegans.	A.	steynii	is	important	
in	food	spoilage	since	it	is	known	to	produce	ochratoxin	A	in	addition	to	several	other	extrolites	[10,	11].	
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A.	candidus	(CBS	102.13	=	IBT	13984)	was	isolated	in	Japan	and	belongs	to	section	Candidi	[2,	3].	
A.	 taichungensis	 (NCBI	 482145	=IBT19404,	NCBI	 Taxonomy	 ID:	 482145)	was	 isolated	 from	Soil	 in	 Taiwan	 and	
belongs	to	section	Candidi	[2,	3].		
The	strains	used	in	this	study	can	be	seen	in	Table	1.	
Table	1	The	species	with	whole	genome	sequences	used	in	this	study.	
Species Collection 
number 
JGI 
abbreviation 
Reference 
A.	campestris		 CBS	348.81	
=	IBT28561	
Aspcam1	 This	study	
A.	novofumigatus	 CBS	117520	
=	IBT16806	
Aspnov1	 This	study	
A.	ochraceoroseus	 CBS	550.77	
=	IBT	24754		
Aspoch1	 This	study	
A.	steynii		 CBS	112812	
=	IBT	23096	
Aspste1	 This	study	
A.	candidus	 CBS	102.13	
=	IBT	13984	
Aspcan1	 This	study	
A.	taichungensis	 NCBI	482145	
=IBT19404	
Asptaic1	 This	study	
A.	oryzae	 RIB40		 Aspor1	 [12,	13]	
A.	flavus	 NRRL3357	 Aspfl1	 [12]	
A.	nidulans	 FGSC	A4		 Aspnid1	 [12,	14]	
A.	niger	 ATCC	1015	 Aspni7	 [15]	
A.	fumigatus	Af293	 FGSC	A1100		
	
Aspfu1	 [16]	
A.	fumigatus	
A1163	
FGSC	A1163		
	
Aspfu_A1163
_1	
[16–19]	
N.	fischeri/A.	
fischerianus	
NRRL	181	 Neofi1	 [12,	20]	
A.	clavatus	 NRRL	1	
	
Aspcl1	 [12]	
A.	terreus	 NIH2624	 Aspte1	 [12]	
N.	crassa	 OR74A Neucr2	 [21]	
P.	chrysogenum	  Pench1	 These sequence data were produced by the US 
Department of Energy Joint Genome Institute 
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http://www.jgi.doe.gov/ in collaboration with the user 
community. 
		
	
Growth	of	strains	and	DNA	extraction	
Biomass	for	all	fungal	strains	was	obtained	from	shake	flasks	containing	200ml	of	complex	media	CYA	[22].	
Biomass	was	isolated	by	filtering	through	Miracloth	(Millipore,	475855-1R),	freeze	dried,	and	stored	at	-80C.	
Subsequently,	a	sample	of	frozen	biomass	was	used	for	RNA	purification.	First	hyphae	were	lysed	in	a	2ml	
micro	 tube,	 together	 with	 a	 5mm	 Steel	 bead	 (QIAGEN),	 placed	 in	 liquid	 nitrogen	 by	 using	 the	 QIAGEN	
TissueLyser	LT	at	45	Hz	for	50	seconds.	Then	the	QIAGEN	RNeasy	mini	Plus	Kit	was	used,	and	the	RLT	Plus	
buffer	(with	2-mercaptoethanol)	was	added	to	the	samples,	vortexed	and	spun	down.	The	lysate	was	then	
used	in	step	4	 in	the	instructions	provided	by	the	manufacturer,	and	the	protocol	was	followed	from	this	
step.	For	genomic	DNA	a	protocol	inspired	by	Fulton	et	al.	[23]	was	used.	For	details	see	Additional	file	8.		
	
Genome	sequencing	and	assembly.	A.	campestris,	A.	novofumigatus,	A.	ochraceoroseus	and	A.	steynii	were	
whole-genome	sequenced	using	PacBio	RS	and	assembled	using	Hierarchical-Based	AssembleR	(HBAR)	which	
is	 a	 developing	 version	derived	 from	Hierarchical	Genome	Assembly	 Process	 (HGAP)	 [24]	 allowing	 larger	
genomes	to	be	processed.	
	
Unamplified	libraries	were	generated	using	Pacific	Biosciences	standard	template	preparation	protocol	for	
creating	>10kb	 libraries.	5ug	of	gDNA	was	used	to	generate	each	 library	and	the	DNA	was	sheared	using	
Covaris	g-Tubes	to	generate	sheared	fragments	of	>10kb	in	length.	A	modified	version	of	the	protocol	was	
used	for	5kb	PacBio	libraries	using	a	Covaris	LE220	focused-ultrasonicator	with	their	Red	miniTUBES	for	DNA	
shearing.	 The	 sheared	 DNA	 fragments	 were	 then	 prepared	 using	 Pacific	 Biosciences	 SMRTbell	 template	
preparation	kit,	where	the	fragments	were	treated	with	DNA	damage	repair,	had	their	ends	repaired	so	that	
they	were	blunt-ended,	and	5’	phosphorylated.	Pacific	Biosciences	hairpin	adapters	were	then	ligated	to	the	
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fragments	to	create	the	SMRTbell	template	for	sequencing.	The	SMRTbell	templates	were	then	purified	using	
exonuclease	treatments	and	size-selected	using	AMPure	PB	beads.	Sequencing	primer	was	then	annealed	to	
the	SMRTbell	templates	and	Version	P4	sequencing	polymerase	was	bound	to	them.	The	prepared	SMRTbell	
template	libraries	were	then	sequenced	on	a	Pacific	Biosciences	RSII	sequencer	using	Version	C2	chemistry	
and	2	hour	sequencing	movie	run	times.	Genomes	of	A.	campestris,	A.	novofumigatus,	A.	ochraceoroseus	
and	A.	steynii	were	assembled	using	HBAR	(https://github.com/PacificBiosciences/HBAR-DTK)	and	polished	
with	quiver.	
	
A.	candidus	and	A.	taichungensis	were	whole-genome	sequenced	using	Illumina.	100ng	of	DNA	was	sheared	
to	 270bp	 using	 the	 Covaris	 LE220	 (Covaris)	 and	 size	 selected	 using	 SPRI	 beads	 (Beckman	 Coulter).	 	 The	
fragments	were	 treated	with	end-repair,	A-tailing,	 and	 ligation	of	 Illumina	 compatible	adapters	 (IDT,	 Inc)	
using	 the	 KAPA-Illumina	 library	 creation	 kit	 (KAPA	 biosystems).	 	 qPCR	 was	 used	 to	 determine	 the	
concentration	of	the	libraries.		Libraries	were	sequenced	on	the	Illumina	Hiseq	in	2x150bp	format.	
The	assemblies	were	produced	using	combination	of	Velvet	and	AllPathsLG	v.R47710	assemblers.	The	raw	
fastq	file	was	QC	filtered	to	remove	artifact/process	contamination	and	then	separated	into	two	fastq	files,	
one	with	mitochondrial	data	only	and	the	remainder	in	the	target	fastq.	The	target	fastq	was	subsequently	
assembled	using	Velvet	[25].	The	resulting	assembly	was	used	to	create	a	long	mate-pair	library	with	insert	
3000	+/-	90	bp	which	was	then	assembled	together	with	the	target	fastq	using	AllPathsLG	release	version	
R47710,		[26].		
	
Transcriptome	sequencing	and	assembly		
Stranded	cDNA	libraries	were	generated	using	the	Illumina	Truseq	Stranded	RNA	LT	kits.	mRNA	was	purified	
from	 1µg	 (100ng	 for	 WPOO)	 of	 total	 RNA	 using	 magnetic	 beads	 containing	 poly-T	 oligos.	 mRNA	 was	
fragmented	using	divalent	 cations	 and	high	 temperature.	 The	 fragmented	RNA	was	 reversed	 transcribed	
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using	random	hexamers	and	SSII	(Invitrogen)	followed	by	second	strand	synthesis.	 	The	fragmented	cDNA	
was	treated	with	end-pair,	A-tailing,	adapter	ligation,	and	10	(12	for	WPOO)	cycles	of	PCR.		qPCR	was	used	
to	determine	the	concentration	of	 the	 libraries.	Libraries	were	sequenced	on	the	 Illumina	Hiseq.	 Illumina	
reads	 of	 stranded	 RNA-seq	 data	 were	 used	 as	 input	 for	 de	 novo	 assembly	 of	 RNA	 contigs.	 Reads	 were	
assembled	 into	 consensus	 sequences	 using	 Rnnotator	 (v.	 3.3.1	 or	 later),	 which	 consists	 of	 three	 major	
components:	preprocessing	of	reads,	assembly,	and	postprocessing	of	contigs	[27].	
	
Genome	annotation.	Annotation	of	the	genomes	was	completed	using	the	JGI	annotation	pipeline	and	made	
publicly	available		via	JGI	fungal	genome	portal	Mycocosm	[28,	29].	
Also	 the	 software	 tool	 Secondary	 Metabolite	 Unknown	 Regions	 Finder	 (SMURF)	 was	 used	 to	 predict	
secondary	metabolite	gene	clusters	(SMGC)	in	the	genomes	[30].	
Sequences	were	analysed	using	InterProScan5	in	order	to	investigate	potential	protein	functions	[31].	
	
BLASTP.	Each	protein	 in	each	of	 the	genomes	has	been	compared	to	all	other	proteins	using	 the	BLASTP	
function	from	the	BLAST+suite	version	2.2.27	with	a	non-restrictive	e-value	cutoff	of	1010	[32,	33].		
	
Phylogenetic	 analysis	 –	 CVTree.	 A	 phylogenetic	 tree	 was	 constructed	 using	 the	 Composition	 Vector	
approach.	The	web	based	server	CVTree3	was	used	(	http://tlife.fudan.edu.cn/archaea/cvtree/cvtree3/)	[34,	
35].	The	proteome	for	each	of	the	species	were	uploaded	in	fasta	format	and	the	K-tuple	length	was	set	to	8	
and	 then	 the	project	as	 run	 resulting	 in	a	phylogenetic	 tree.	The	 tree	was	visualized	using	FigTree	v1.4.2	
(http://tree.bio.ed.ac.uk/software/figtree/).	
	
Identification	of	species-specific	genes	
All	predicted	sets	of	protein	sequences	for	the	4	genomes	in	this	paper	(A.	campestris,	A.	novofumigtus,	A.	
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ochraceoroseus,	A.	steynii)	and	the	nine	reference	genomes	(A.	nidulans,	A.	oryzae,	A.	 flavus,	A.	niger,	A.	
fumigatus	Af293,	A.	fumigatus	A1163,	N.	fischeri,	A.	clavatus,	A.terreus),	and	two	outgroup	species	(N.	crassa	
and	P.	chrysogenum)	were	aligned	using	the	BLASTp	function	from	the	BLAST+	suite	version	2.2.27	with	an	
e-value	<=	10^-10	[32,	33].	These	225	whole-genome	BLAST	tables	were	analyzed	to	identify	bi-directional	
hits	in	all	pairwise	comparisons.	Using	custom	Python-scripts,	paralogs	were	first	identified	within	the	same	
genome	and	grouped	into	sequence	similar	families	using	single	linkage,	meeting	the	criterion;	the	sum	of	
the	 alignment	 coverage	 between	 the	 pairwise	 sequences	 ³	 130%,	 the	 alignment	 identity	 between	 the	
pairwise	sequences	³	50%,	and	the	pairwise	hit	must	be	bi-directional	(present	in	both	BLAST	directions).	
The	orthologs	were	identified	across	genomes	and	grouped	into	sequence	similar	families	using	single	linkage	
meeting	the	same	criterions.	Singletons	were	assigned	a	family	having	only	one	gene	member.	This	allowed	
for	 identification	of	 species	unique	genes.	All	homologs	were	assigned	 functional	and	structural	domains	
using	InterPro	version	48	[36,	37]	and	checked	for	annotation	and	sequencing	errors	by	investigating	scaffold	
location	and	sequence	identity.	
	
N6-methyldeoxyadenine	analysis	
Modification	detection	was	performed	using	single-molecule	real-time	(SMRT)	sequencing	and	the	PacBio	
SMRT	Analysis	2.3.0	toolkit	[38].	Following	modification	detection,	6mA	sites	were	filtered	following	Mondo	
et	al.,	2017,	which	includes	filtering	modifications	by	both	coverage	(minimum	15x,	maximum	determined	
using	the	R-boxplot	function)	and	modification	quality	value	(mQV;	minimum	mQV	=	25).	
	
Synteny	 plots	 of	 SMGC	 –	 Easyfig.	 Synteny	 plots	 were	 made	 using	 Easyfig	 version	 2.1	
(http://easyfig.sourceforge.net)	 [39].	 All	 GenBank	 files	 describing	 the	 clusters	 to	 be	 compared	 were	
uploaded.	 The	 tBLASTx	option	was	used	with	 an	e-£	 0.001	 ,	 an	 alignment	 length	³	 50	 and	an	alignment	
identity	³	35.	Length	of	scale	was	set	to	2000	bp	under	the	figure	option.	If	necessary,	the	sequence	can	be	
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reversed	under	the	sub	region	options.	After	the	options	have	been	set	the	figure	can	be	created	choosing	
vector	format	(svg).	
	
Homology	of	A.	novofumigatus	and	A.	fumigatus	
The	number	of	proteins	from	A.	novofumigatus	with	homologs	 in	A.	fumigatus	was	determined	based	on	
BLASP	hit	with	identity	≥50%		and	the	sum	of	the	query	and	hit	coverage	≥130%.	
	
Synteny	of	A.	novofumigatus	and	A.	fumigatus	
The	 syneteny	 between A.	 novofumigatus	 and	 A.	 fumigatus	 was	 determined	 using	 MUMmer	
(http://mummer.sourceforge.net)	[40–42].	‘NUCmer’	(NUCleotide	MUMmer)	was	used	with	standard	setting	
to	 generate	 alignments	 between	 the	 two	 species,	 followed	 by	 ‘show-coords’	 to	 generate	 a	 file	with	 the	
output	from	where	the	total	coverage	of	the	genome,	maximum	block	length	and	mean	block	length	could	
be	calculated	based	on	the	A.	novofumigtus	length	of	the	alignments.		
	
Comparison	of	A.	fumigatus	and	A.	novofumigatus	secondary	metabolite	gene	clusters	
Comparison	of	the	best	hits	for	A.	fumigatus	and	A.	novofumigatus	secondary	metabolite	gene	clusters	in	
other	species,	based	on	average	percent	identity	of	the	backbone	proteins.	First,	BLASTP	comparisons	of	all	
A.	fumigatus	and	A.	novofumigatus	SMGC	backbone	proteins	against	all	SMGC	backbone	proteins	form	the	
dataset	were	created.	Subsequently,	an	average	of	backbone	proteins	 identity	was	calculated	per	cluster,	
the	best	hit	is	shown	in	the	heatmap.	Backbone	proteins	are	defined	as	proteins	with	the	annotations	PKS(-
like),	NRPS(-like),	hybrid,	DMATS	and	TC.	
	
LC-MS	analysis	of	metabolites	from	A.	novofumigatus	IBT	16806	
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Aspergillus	novofumigatus	IBT	16806	was	cultivated	on	YES	agar	plate	at	25	°C	for	7	days,	and	extracted	with	
ethyl	acetate	containing	1%	formic	acid.	The	extract	for	LC-MS	analysis	were	injected	into	a	Dionex	Ultimate	
3000	UHPLC	system	(Thermo	Scientific)	-	a	maXis	3G	QTOF	orthogonal	mass	spectrometer	(Bruker	Daltonics),	
using	Electrospray	Ionization	with	a	Kinetex	C18	column	(2.1	i.d.	x	100	mm;	Phenomenex).	Separation	was	
performed	 with	 a	 solvent	 system	 of	 water	 containing	 20	 mM	 formic	 acid	 (solvent	 A)	 and	 acetonitrile	
containing	20	mM	formic	acid	(solvent	B),	at	a	flow	rate	of	0.4	ml/min	and	a	column	temperature	of	40	°C,	
using	the	following	program:	a	linear	gradient	from	10:90	(solvent	B/solvent	A)	to	100:0	for	10	min,	100:0	for	
the	following	3	min,	and	a	linear	gradient	from	100:0	to	10:90	within	the	following	2	min.	To	illustrate	our	
approach	of	linking	metabolites	produced	by	A.	novofumigatus	to	their	respective	gene	clusters,	we	chose	
to	target	our	metabolite	analysis	towards	the	model	compounds	novofumigatonin,	ent-cycloechinulin,	epi-
aszonalenin	A	and	C,	since	they	represent	major	metabolites	produced	by	this	species	and	because	we	have	
them	as	pure	standards	in	our	 in-house	collection	of	fungal	metabolites	[43].	For	a	full	 list	of	metabolites	
known	from	A.	novofumigatus	please	consult	Frisvad	&	Larsen	[44].	
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Part 2: Protocol for preparation of Fungal DNA  
The protocol described below has successfully been employed to isolate genome-sequencing grade 
genomic DNA for more than 200 different Aspergillus species.  
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List of Materials: 
D-Sorbitol   (Sigma, S1876 – CAS 50-70-4) 
Tris-Base  (Sigma 7-9, T1378 – CAS 7786-1) 
37% HCl  (Th. Geyer, 836,1000) 
EDTA  (Merck, 324503 – CAS 6381-92-6) 
Sodium Cloride (NaCl) (AppliChem A1371,9010 – CAS 7647-14-5] 
Cetyl trimethylammonium bromide (CTAB) (Sigma 52365 – CAS 57-09-0) 
Sarkosyl NL  (Sigma, L5777 – CAS 137-16-6) 
Polyvinylpyrrolidone (PVP)  (Sigma PVP-40T – CAS 9003-39-8) 
Proteinase K  (NEB P8107S) 
Potassium acetate  (J. T. Baker 0129910025 – CAS 127-08-2) 
Phenol:Chloroform:Isoamylalcohol (25:24:1) (Sigma P3803) 
Sodium acetate  (J. T. Baker 9914011001 – CAS 6131-90-4] 
96 % Ethanol  (vwr chemicals) 
70 % Ethanol  (vwr chemicals) 
Isopropanol  (Merck, 109634 – CAS 67-63-0) 
Liquid nitrogen 
Sodium Hydroxide  (Sigma S5881 – CAS 1310-73-2) 
RNase A  (Sigma R-4875 – CAS 9001-99-4) 
 
Preparation of liquid Media  
 
Buffers: 
• 5M	Potassium	acetate	(pH	7.5):	122.5	g	potassium	acetate	and	ddH2O	up	to	250	mL.	pH	
adjusted	with	acetic	acid.		
• 3M	Sodium	acetate:	81.65	g	sodium	acetate	and	ddH2O	up	to	200	mL.	
• 1%	PVP:	2	g	PVP	in	200	mL	ddH2O	
• 5%	Sarkosyl:	10	g	Sarkosyl	in	200	mL	ddH2O.		
• 1M	Tris-HCl	(pH	9):	60.57	g	Tris-base	and	4.81	ml	37%	HCl.	Add	ddH2O	up	to	500	mL.	
• 0.5M	EDTA:	116.4	g	EDTA.	Add	ddH2O	up	to	500	mL.	Add	Sodium	Hydroxide	pellet	until	pH	
reach	8.0.		
• Buffer	A:	31.9	g	Sorbitol,	50	mL	1M	Tris-HCl	(pH	9),	5	mL	0.5M	EDTA	(pH	8)	and	ddH2O	up	
to	500	mL.	
• Buffer	B:		100	mL	1M	Tris-HCl	(pH	9),	50	mL	0.5M	EDTA,	58.44	g	NaCl,	10	g	CTAB.	Add	
ddH2O	up	to	500	mL.	
• TE	(pH	9):	1.21	g	Tris-base,	0.37	g	EDTA.	Add	ddH2O	up	to	1000	mL.	
 
All solutions above are to be autoclaved!  
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• Lysis	Buffer:	For	10	ml	pr.	sample	use:	3.75	ml	Buffer	A;	3.75	ml	Buffer	B;	1.5	ml	5	%	
Sarkosyl;	1	ml	1	%	PVP;	100	µl	Proteinase	K	
• RNase	A:	Dissolve	10	mg	dry	powder	in	1	ml	ddH2O	
 
 
Equipment: 
• Nanodrop:	NanoDrop	ND	1000	Spectrophotometer	or	NanoDrop	Lite	from	Qiagen.		
• Qubit:	Qubit	1.0	fluorometer	from	Invitrogen	and	Qubit	dsDNA	BR	Assay	Kit	(Q32853)	from	
ThermoFisher.	
• Mortar	and	pestle.	
• Centrifuge	for	50ml	Falkon	tubes	at	4oC.		
 
Protocol: 
1. Pre-heat	Buffer	B	at	65oC	
2. Prepare	Lysis	Buffer	just	before	use	and	keep	at	65oC.		
3. Transfer	freeze-dried	mycelia	into	a	mortar	and	cover	with	liquid	nitrogen.	Grind	material	
and	transfer	to	a	50	ml	Falcon	tube	as	soon	as	all	liquid	nitrogen	has	evaporated.	Powder	in	
the	tube	should	not	exceed	the	5ml	mark,	but	a	minimum	of	3	ml	is	recommended.	Note	
powder	must	not	thaw.	
4. Add	10	ml	Lysis	Buffer	and	mix	vigorously	by	vortexing.	
5. Incubate	for	30	min	at	65oC.	Mix	frequently	by	inverting	the	tube.	
6. Add	3.35	ml	5	M	Potassium	acetate.	Mix	gently	by	inverting	the	tube	5-7	times.	Incubate	
solution	30	min	on	ice.	
7. Centrifuge	for	30	min	at	5,000	g	at	4oC.	
8. Transfer	the	supernatant,	approximately	9mL,	to	a	new	50	ml	Falcon	tube	and	add	5ml	of	
Phenol:Chloroform:Isoamylalcohol	(25:24:1).	Mix	gently	5-7	times.	
9. Centrifuge	20	min	at	4,000	g	at	4	oC.	
10. Transfer	the	aqueous	phase	(~8mL)	to	a	new	50	ml	Falcon	tube.	Note	avoid	any	material	
from	the	interphase.	
11. Add	100	µl	RNase	A	(10	mg/ml)	and	mix	gently.	Incubate	at	room	temperature	for	30-60	
min.	
12. Add	1/10	volume	of	3M	Sodium	acetate	and	1	volume	ice-cold	96%	Ethanol	(Alternatively,	
Isopropanol	can	be	used,	but	it	may	adversely	influence	A260/A280	measurements).	
Incubate	solution	at	20oC	for	30	min.	
13. Centrifuge	for	30	min	at	10,000	g	and	4oC	
14. Discard	the	supernatant.	
15. Wash	the	pellet	with	2	ml	70	%	ethanol	and	pipette	as	much	away	without	disturbing	the	
pellet.	
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16. Dry	the	pellet	at	room	temperature	until	all	ethanol	has	evaporated	(approximately	15	
minutes).	
Note:	do	not	let	the	pellet	dry	out!	
17. Dissolve	the	pellet	in	500	µL	TE.	This	may	take	over-night	incubation	at	room	temperature	
with	light	shaking.	Transfer	DNA	solution	to	a	2	ml	Eppendorf	tube.	
18. Take	a	sample	for	DNA	quality	assessments	(see	below)	and	store	the	remaining	DNA	
solution	at	-20	oC	until	further	use.	
19. For	testing	DNA	quality:		
Make	a	20-fold	dilution	of	the	DNA	solution	(from	step	18)	in	a	1.5	ml	Eppendorf	tube	to	a	
total	volume	of	100	μl.	
A. Run	a	5-10	μl	diluted	sample	on	an	agarose	gel	to	estimate	the	quality	and	
concentration.	
B. Use	the	nanodrop	for	A260/A280	measurements.	Ratios	should	be	in	the	range	of	1.6-
2.2.	
C. Use	the	Qubit	to	determine	DNA	concentration	estimations.	Good	predations	fall	in	
the	range	of	20-200	ng/μl	DNA	in	stock	solution.	
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Table	S1	Overview	of	the	most	common	InterPro	domains	for	the	unique	genes	in	the	investigated	species	and	the	number	of	times	the	InterPro	
domain	is	found	in	a	unique	gene	in	the	investigated	species.	
	
Species	
Total	
predicted	
proteins	
Total	
unique	
proteins	
Unique	
genes	%	
InterPro	
annotated	
unique	
Most	common	IPR,	#	of	IPR	in	unique	genes	
IPR001138	 IPR016040	 IPR002110	 IPR016196	 IPR011009	 IPR007219	 IPR001128	
A.	campestris	 9764	 2162	 22%	 670	(31%)	 43	 34	 35	 21	 19	 10	 28	
A.	clavatus	 9121	 1053	 12%	 349	(33%)	 20	 23	 18	 20	 6	 7	 21	
A.	flavus	 12604	 1953	 15%	 659	(34%)	 52	 46	 32	 48	 25	 37	 22	
A.	fumigatus	
Af293	 9781	 188	 2%	 67	(36%)	 0	 2	 5	 3	 1	 0	 1	
A.	fumigatus	
A1163	 9916	 343	 3%	 100	(29%)	 8	 1	 8	 5	 7	 3	 3	
A.	niger	ATCC	
1015	 11910	 3168	 27%	 1232	(39%)	 135	 94	 63	 71	 37	 75	 47	
A.	nidulans	 10680	 2391	 22%	 943	(39%)	 103	 63	 37	 46	 17	 47	 36	
A.	novofumigatus	 11549	 1695	 15%	 462	(27%)	 26	 37	 30	 20	 14	 13	 36	
A.	ochraceoroseus	 8924	 1881	 21%	 519	(28%)	 57	 26	 6	 12	 27	 20	 18	
A.	oryzae	 12031	 1842	 15%	 635	(34%)	 36	 26	 46	 32	 22	 28	 16	
A.	steynii	 13211	 3520	 27%	 1270	(36%)	 163	 114	 67	 54	 27	 72	 43	
A.	terreus	 10406	 2117	 20%	 905	(43%)	 55	 66	 54	 45	 37	 52	 37	
A.	fischerianus	 10406	 704	 7%	 249	(35%)	 6	 21	 23	 14	 11	 6	 9	
N.	Crassa	 10785	 7063	 65%	 3471	(49%)	 147	 91	 53	 66	 81	 68	 28	
P.	Chrysogenum	 		 3215	 		 1101	(34%)	 126	 64	 44	 35	 57	 52	 30	
	            
IPR	ID	 Description		 		 	     
IPR001138	 Fungal	transcriptional	regulatory	protein,	N-terminal	 		 	     
IPR016040	 NAD(P)-binding	 		 Top	 IPR	with	most	counts	
IPR002110	 Ankyrin	 		 Second	 IPR	with	second	most	counts	
IPR016196	 MFS	general	substrate	transporter	 		 Third	 IPR	with	third	most	counts	
IPR011009	 Protein	kinase-like	 		 	     
IPR007219	 Fungal	specific	transcription	factor	 		 	     
IPR001128	 Cytochrome	P450	 		 	     
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Table	S2	Allergens	from	A.	novofumigatus.	A	list	of	allergens	from	A.	fumigatus	(from	www.allergome.org)	
and	the	orthologs	in	A.	novofumigatus	including	the	percent	identity	of	the	BLAST	comparison.	
Allergen	name	 A. fumigatus	AF293	accession	 A. novofumigatus	orthologue	 %	ID	
Asp_f1	 AFUA_5G02330	 jgi-Aspnov1-365359-e_gw1.2.4275.1	 98.86	
Asp_f2	 AFUA_4G09580	 jgi-Aspnov1-432190-fgenesh1_pg.5_#_493	 93.56	
Asp_f3	 AFUA_6G02280	 jgi-Aspnov1-388041-estExt_Genewise1Plus.C_3_t50474	 97.62	
Asp_f4	 AFUA_2G03830	 jgi-Aspnov1-432819-fgenesh1_pg.6_#_39	 94	
Asp_f5	 AFUA_8G07080	 jgi-Aspnov1-395206-estExt_Genewise1Plus.C_7_t30340	 95.58	
Asp_f6	 AFUA_1G14550	 jgi-Aspnov1-512129-estExt_fgenesh1_pm.C_4_t10311	 99.47	
Asp_f7	 AFUA_4G06670	 jgi-Aspnov1-443000-fgenesh1_kg.5_#_844_#_Locus964v1rpkm138.38	 92.6	
Asp_f8	 AFUA_2G10100	 jgi-Aspnov1-30553-CE30552_16949	 90	
Asp_f9	 AFUA_1G16190	 jgi-Aspnov1-430704-fgenesh1_pg.4_#_185	 94.07	
Asp_f10	 AFUA_5G13300	 jgi-Aspnov1-363785-e_gw1.2.2138.1	 95.19	
Asp_f11	 AFUA_2G03720	 jgi-Aspnov1-426603-fgenesh1_pg.1_#_378	 93.57	
Asp_f12	 AFUA_5G04170	 jgi-Aspnov1-509883-estExt_fgenesh1_pm.C_2_t10392	 99.27	
Asp_f13	 AFUA_4G11800	 jgi-Aspnov1-431992-fgenesh1_pg.5_#_295	 94.29	
Asp_f15	 AFUA_2G12630	 jgi-Aspnov1-430704-fgenesh1_pg.4_#_185	 94.07	
Asp_f17	 AFUA_4G03240	 jgi-Aspnov1-409635-estExt_Genewise1.C_5_t50054	 91.33	
Asp_f18	 AFUA_4G11800	 jgi-Aspnov1-431992-fgenesh1_pg.5_#_295	 94.3	
Asp_f22	 AFUA_6G06770	 jgi-Aspnov1-367285-e_gw1.3.3588.1	 99.09	
Asp_f23	 AFUA_2G11850	 jgi-Aspnov1-447552-estExt_Genemark1.C_1_t30040	 94.23	
Asp_f26	 AFUA_1G06830	 jgi-Aspnov1-370658-e_gw1.4.1124.1	 86.49	
Asp_f27	 AFUA_3G07430	 jgi-Aspnov1-453038-estExt_Genemark1.C_6_t10423	 90.8	
Asp_f28	 AFUA_6G10300	 jgi-Aspnov1-367561-e_gw1.3.3658.1	 96.1	
Asp_f29	 AFUA_5G11320	 jgi-Aspnov1-445073-fgenesh1_kg.8_#_93_#_Locus606v1rpkm225.43	 74.26	
Asp_AfCalAp	 AFUA_3G09690	 jgi-Aspnov1-515921-estExt_fgenesh1_pm.C_100047	 94.79	
Asp_f_chitosanase	 AFUA_4G01290	 jgi-Aspnov1-412759-estExt_Genewise1.C_8_t10196	 94.21	
Asp_f_AT	 AFUA_1G09470	 jgi-Aspnov1-512574-estExt_fgenesh1_pm.C_4_t20289	 91.19	
Asp_f_catalase	 AFUA_3G02270	 jgi-Aspnov1-440530-fgenesh1_kg.3_#_979_#_Locus6690v1rpkm8.88	 50.21	
Asp_f_DPPV	 AFUA_2G09030	 jgi-Aspnov1-453870-estExt_Genemark1.C_7_t10446	 88.57	
Asp_f_glucosidase	 AFUA_1G05770	 jgi-Aspnov1-431600-fgenesh1_pg.4_#_1081	 93.36	
Asp_f_GST	 AFUA_6G09690	 jgi-Aspnov1-458931-fgenesh1_pm.3_#_489	 96.67	
Asp_f_GT	 AFUA_6G11390	 jgi-Aspnov1-398517-estExt_Genewise1.C_1_t10227	 88.44	
Asp_f_IAO	 AFUA_6G03620	 jgi-Aspnov1-413975-estExt_Genewise1.C_9_t20169	 51.01	
Asp_f_IPMI	 AFUA_2G11260	 jgi-Aspnov1-500519-estExt_fgenesh1_pg.C_1_t20448	 96.27	
Asp_f_LPL1	 AFUA_4G08720	 jgi-Aspnov1-516331-estExt_fgenesh1_pm.C_120063	 94.96	
Asp_f_LPL3	 AFUA_3G14680	 jgi-Aspnov1-516331-estExt_fgenesh1_pm.C_120063	 90.83	
Asp_f_mannosidase	 AFUA_1G14560	 jgi-Aspnov1-460012-fgenesh1_pm.4_#_314	 94.65	
Asp_f_MDH	 AFUA_7G05740	 jgi-Aspnov1-462836-fgenesh1_pm.7_#_121	 96.19	
Asp_f_PL	 AFUA_2G00760	 jgi-Aspnov1-499715-estExt_fgenesh1_pg.C_1_t10092	 92.83	
Asp_f_PUP	 AFUA_5G03520	 jgi-Aspnov1-438430-fgenesh1_kg.2_#_311_#_Locus9805v1rpkm2.72	 95.05	
Asp_f_SXR	 AFUA_2G15430	 jgi-Aspnov1-47013-CE47012_27880	 99.57	
Asp_f_CP	 AFUA_8G01670	 jgi-Aspnov1-445108-fgenesh1_kg.8_#_128_#_Locus912v1rpkm147.61	 96.31	
Asp_f_FDH	 AFUA_6G04920	 jgi-Aspnov1-440417-fgenesh1_kg.3_#_866_#_Locus1540v1rpkm84.43	 95.16	
139 Appendix A. Supplementary section 3.1 – Paper I
	140
Table	S3	Virulence	factors	from	A.	fumigatus.	A	collection	of	virulence	factors	known	from	A.	fumigatus	and	
the	best	orthologs	in	A.	novofumigatus	along	with	the	percent	identity	of	the	BLAST	comparison.	
	
A.	fumigatus	
AF293	
accession	
Common	
name	 Gene	function	 A.	novofumigatus	orthologue	 %	ID	
AFUA_1G01550	 zrfA	
High	affinity	zinc	ion	transporter,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WKR5]	 jgi-Aspnov1-378097-e_gw1.9.842.1	 91.92	
AFUA_1G05800	 mkk2	
MAP	kinase	kinase	(Mkk2),	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WJJ0]	
jgi-Aspnov1-451544-
estExt_Genemark1.C_4_t30113	 90.68	
AFUA_1G09280	 ptcB	
Protein	phosphatase	2C,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WTH5]	
jgi-Aspnov1-460512-
fgenesh1_pm.4_#_814	 91.44	
AFUA_1G10880	 pmcA	
P-type	calcium	ATPase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WT17]	 jgi-Aspnov1-420834-gm1.5181_g	 92.44	
AFUA_1G14660	 laeA	
Regulator	of	secondary	metabolism	LaeA	
[Source:UniProtKB/TrEMBL;Acc:Q4WRY5]	 jgi-Aspnov1-370504-e_gw1.4.2095.1	 98.66	
AFUA_1G15440	 ags3	
Alpha-1,3-glucan	synthase	Ags3	
[Source:UniProtKB/TrEMBL;Acc:Q4WRQ8]	
jgi-Aspnov1-447502-
estExt_Genemark1.C_1_t20487	 54.83	
AFUA_1G16950	 pig-a	
Phosphatidylinositol:UDP-GlcNAc	transferase	subunit	
PIG-A	[Source:UniProtKB/TrEMBL;Acc:Q4WRA7]	
jgi-Aspnov1-405712-
estExt_Genewise1.C_4_t10229	 97.96	
AFUA_2G01260	 srbA	
HLH	transcription	factor,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WIN1]	
jgi-Aspnov1-455802-
fgenesh1_pm.1_#_129	 95.14	
AFUA_2G07680	 sidA	
L-ornithine	N5-oxygenase	SidA	
[Source:UniProtKB/TrEMBL;Acc:E9QYP0]	
jgi-Aspnov1-447204-
estExt_Genemark1.C_1_t20174	 96.01	
AFUA_2G07770	 rasB	
Ras	small	monomeric	GTPase	RasB	
[Source:UniProtKB/TrEMBL;Acc:Q4X241]	 jgi-Aspnov1-363087-e_gw1.1.2643.1	 99.16	
AFUA_2G08360	 pyrG	
Orotidine	5'-phosphate	decarboxylase	
[Source:UniProtKB/Swiss-Prot;Acc:O13410]	
jgi-Aspnov1-399623-
estExt_Genewise1.C_1_t30405	 97.81	
AFUA_2G11270	 ags2	
Alpha-1,3-glucan	synthase	Ags2	
[Source:UniProtKB/TrEMBL;Acc:Q4X143]	
jgi-Aspnov1-447502-
estExt_Genemark1.C_1_t20487	 96.78	
AFUA_2G12200	 pkaC1	
cAMP-dependent	protein	kinase	catalytic	subunit	PkaC1	
[Source:UniProtKB/TrEMBL;Acc:Q4X0V1]	 jgi-Aspnov1-363483-e_gw1.1.1181.1	 90.24	
AFUA_2G12640	 gprD	
Integral	membrane	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4X0Q7]	
jgi-Aspnov1-456628-
fgenesh1_pm.1_#_955	 90.43	
AFUA_2G17530	
Melanin	
cluster,	arb2	
Conidial	pigment	biosynthesis	oxidase	Arb2	
[Source:UniProtKB/TrEMBL;Acc:E9RBR0]	
jgi-Aspnov1-501077-
estExt_fgenesh1_pg.C_1_t40073	 92.15	
AFUA_2G17540	
Melanin	
cluster,	abr1	
Conidial	pigment	biosynthesis	oxidase	Abr1/brown	1	
[Source:UniProtKB/TrEMBL;Acc:Q4WZB4]	 jgi-Aspnov1-417292-gm1.1639_g	 88.61	
AFUA_2G17550	
Melanin	
cluster,	ayg1	
Conidial	pigment	biosynthesis	protein	Ayg1	
[Source:UniProtKB/TrEMBL;Acc:Q4WZB3]	
jgi-Aspnov1-438093-
fgenesh1_kg.1_#_1767_#_Locus2445v
1rpkm48.63	 94.2	
AFUA_2G17560	
Melanin	
cluster,	arp2	
Conidial	pigment	biosynthesis	1,3,6,8-
tetrahydroxynaphthalene	reductase	Arp2	
[Source:UniProtKB/TrEMBL;Acc:E9QUT3]	
jgi-Aspnov1-460884-
fgenesh1_pm.5_#_30	 49.22	
AFUA_2G17580	
Melanin	
cluster,	arp1	
Probable	scytalone	dehydratase	
[Source:UniProtKB/Swiss-Prot;Acc:O14434]	
jgi-Aspnov1-457049-
fgenesh1_pm.1_#_1376	 95.15	
AFUA_2G17600	
Melanin	
cluster,	alb1	
Conidial	pigment	polyketide	synthase	PksP/Alb1	
[Source:UniProtKB/TrEMBL;Acc:Q4WZA8]	
jgi-Aspnov1-448094-
estExt_Genemark1.C_1_t40143	 94.78	
AFUA_3G05650	 orlA	
Alpha,alpha-trehalose-phosphate	synthase	subunit	
Tps2,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WWF5]	
jgi-Aspnov1-514040-
estExt_fgenesh1_pm.C_6_t10212	 97.88	
AFUA_3G09820	 dvrA	
C2H2	transcription	factor,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WXK4]	
jgi-Aspnov1-462495-
fgenesh1_pm.6_#_581	 93.38	
AFUA_3G11250	 ace2	
C2H2	transcription	factor	(Swi5),	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WXZ7]	 jgi-Aspnov1-423283-gm1.7630_g	 87.45	
AFUA_3G11970	 pacC	
pH-response	transcription	factor	pacC/RIM101	
[Source:UniProtKB/Swiss-Prot;Acc:Q4WY67]	
jgi-Aspnov1-514555-
estExt_fgenesh1_pm.C_6_t20262	 89.44	
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AFUA_3G12690	 glfA	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WYD9]	
jgi-Aspnov1-446369-
fgenesh1_kg.13_#_42_#_Locus6047v1
rpkm11.26	 74.92	
AFUA_4G06820	 ecm33	
Protein	ecm33	[Source:UniProtKB/Swiss-
Prot;Acc:Q4WNS8]	
jgi-Aspnov1-442983-
fgenesh1_kg.5_#_827_#_Locus141v1r
pkm963.23	 87	
AFUA_4G11800	 Alp1	
Alkaline	protease	1	[Source:UniProtKB/Swiss-
Prot;Acc:P28296]	
jgi-Aspnov1-431992-
fgenesh1_pg.5_#_295	 94.29	
AFUA_4G12470	 cpcA	
BZIP	transcription	factor	CpcA	
[Source:UniProtKB/TrEMBL;Acc:E9QUZ5]	
jgi-Aspnov1-461084-
fgenesh1_pm.5_#_230	 90.87	
Afua_4g14770	
Helvolic	acid	
cluster	
Protostadienol	synthase	A	[Source:UniProtKB/Swiss-
Prot;Acc:Q4WR16]	
jgi-Aspnov1-501426-
estExt_fgenesh1_pg.C_2_t10392	 42.86	
Afua_4g14780	
Helvolic	acid	
cluster	
Cytochrome	P450	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR17]	
jgi-Aspnov1-458437-
fgenesh1_pm.2_#_1359	 47.7	
Afua_4g14790	
Helvolic	acid	
cluster	
Cytochrome	P450	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR18]	
jgi-Aspnov1-458437-
fgenesh1_pm.2_#_1359	 92.5	
Afua_4g14800	
Helvolic	acid	
cluster	
Short	chain	dehydrogenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR19]	
jgi-Aspnov1-439546-
fgenesh1_kg.2_#_1427_#_Locus1689v
1rpkm76.29	 94	
Afua_4g14810	
Helvolic	acid	
cluster	
Cytochrome	P450	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR20]	
jgi-Aspnov1-458435-
fgenesh1_pm.2_#_1357	 85.6	
Afua_4g14820	
Helvolic	acid	
cluster	
Transferase	family	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WR21]	
jgi-Aspnov1-439545-
fgenesh1_kg.2_#_1426_#_Locus3005v
1rpkm38.16	 91	
Afua_4g14830	
Helvolic	acid	
cluster	
Cytochrome	P450	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR22]	
jgi-Aspnov1-458437-
fgenesh1_pm.2_#_1359	 47.59	
Afua_4g14840	
Helvolic	acid	
cluster	
Transferase	family	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WR23]	
jgi-Aspnov1-439543-
fgenesh1_kg.2_#_1424_#_Locus3740v
1rpkm28.06	 90	
Afua_4g14850	
Helvolic	acid	
cluster	
Extracellular	3-ketosteroid	1-dehydrogenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WR24]	 jgi-Aspnov1-118200-CE118199_1683	 91.79	
AFUA_5G04170	 hsp90	
Heat	shock	protein	90	[Source:UniProtKB/Swiss-
Prot;Acc:P40292]	
jgi-Aspnov1-509883-
estExt_fgenesh1_pm.C_2_t10392	 99.27	
AFUA_5G08570	 pkaC2	
cAMP-dependent	protein	kinase	catalytic	subunit,	
putative	[Source:UniProtKB/TrEMBL;Acc:E9QXD5]	 jgi-Aspnov1-100079-CE100078_981	 95.71	
AFUA_5G09240	 cu/zn	sod	 Superoxide	dismutase	[Source:UniProtKB/Swiss-Prot;]	
jgi-Aspnov1-501817-
estExt_fgenesh1_pg.C_2_t20321	 97.33	
AFUA_5G09360	 calA	
Serine/threonine-protein	phosphatase	2B	catalytic	
subunit	[Source:UniProtKB/Swiss-Prot;Acc:Q4WUR1]	
jgi-Aspnov1-457892-
fgenesh1_pm.2_#_814	 97.59	
AFUA_5G09580	 rodA	 Hydrophobin	[Source:UniProtKB/Swiss-Prot;Acc:P41746]	
jgi-Aspnov1-402332-
estExt_Genewise1.C_2_t40215	 96.43	
AFUA_5G10760	 mnt1	
Alpha-1,2-mannosyltransferase	(Kre2),	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WV44]	 jgi-Aspnov1-108431-CE108430_6570	 94	
AFUA_5G11230	 rasA	
RAS	small	monomeric	GTPase	RasA	
[Source:UniProtKB/TrEMBL;Acc:E9QX28]	 jgi-Aspnov1-109419-CE109418_6451	 99.53	
AFUA_5G13300	 pep1	
Aspartic	protease	pep1	[Source:UniProtKB/Swiss-
Prot;Acc:P41748]	 jgi-Aspnov1-363785-e_gw1.2.2138.1	 95.19	
AFUA_6G04820	 pabaA	
Para-aminobenzoate	synthase	PabaA	
[Source:UniProtKB/TrEMBL;Acc:Q4WDI0]	
jgi-Aspnov1-450180-
estExt_Genemark1.C_3_t20429	 88.47	
AFUA_6G09570	
Gliotoxin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK6]	
jgi-Aspnov1-508952-
estExt_fgenesh1_pm.C_1_t20245	 30.19	
AFUA_6G09580	
Gliotoxin	
cluster	
C6	finger	domain	protein,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK5]	
jgi-Aspnov1-511168-
estExt_fgenesh1_pm.C_3_t20002	 82.02	
AFUA_6G09590	
Gliotoxin	
cluster	
Zinc	alcohol	dehydrogenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK4]	
jgi-Aspnov1-511167-
estExt_fgenesh1_pm.C_3_t20001	 84.89	
AFUA_6G09600	
Gliotoxin	
cluster	
Zinc	metallopeptidase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK3]	
jgi-Aspnov1-502750-
estExt_fgenesh1_pg.C_3_t20015	 90.57	
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AFUA_6G09610	
Gliotoxin	
cluster	
Nonribosomal	peptide	syntethase	9	
[Source:UniProtKB/Swiss-Prot;Acc:Q4WMK2]	
jgi-Aspnov1-404104-
estExt_Genewise1.C_3_t30145	 77.01	
AFUA_6G09620	
Gliotoxin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK1]	
jgi-Aspnov1-386801-
estExt_Genewise1Plus.C_3_t30133	 84.72	
AFUA_6G09630	
Gliotoxin	
cluster	
C6	finger	domain	protein	GliZ	
[Source:UniProtKB/TrEMBL;Acc:Q4WMK0]	 jgi-Aspnov1-366288-e_gw1.3.282.1	 83.75	
AFUA_6G09640	
Gliotoxin	
cluster	
Aminotransferase	GliI	
[Source:UniProtKB/TrEMBL;Acc:Q4WMJ9]	
jgi-Aspnov1-458936-
fgenesh1_pm.3_#_494	 87.07	
AFUA_6G09650	
Gliotoxin	
cluster	
Membrane	dipeptidase	GliJ	
[Source:UniProtKB/TrEMBL;Acc:Q4WMJ8]	 jgi-Aspnov1-367031-e_gw1.3.965.1	 91.24	
AFUA_6G09660	
Gliotoxin	
cluster	
Nonribosomal	peptide	synthetase	10	
[Source:UniProtKB/Swiss-Prot;Acc:Q4WMJ7]	
jgi-Aspnov1-511160-
estExt_fgenesh1_pm.C_3_t10488	 92.06	
AFUA_6G09670	
Gliotoxin	
cluster	
Cytochrome	P450	oxidoreductase	GliC	
[Source:UniProtKB/TrEMBL;Acc:E9RCR4]	 jgi-Aspnov1-481241-MIX15903_10_44	 92.59	
AFUA_6G09680	
Gliotoxin	
cluster	
O-methyltransferase	GliM	
[Source:UniProtKB/TrEMBL;Acc:Q4WMJ5]	 jgi-Aspnov1-368520-e_gw1.3.829.1	 93.5	
AFUA_6G09690	
Gliotoxin	
cluster	
Glutathione	S-transferase	GliG	
[Source:UniProtKB/TrEMBL;Acc:A4GYZ0]	
jgi-Aspnov1-458931-
fgenesh1_pm.3_#_489	 96.25	
AFUA_6G09700	
Gliotoxin	
cluster	
Gliotoxin	biosynthesis	protein	GliK	
[Source:UniProtKB/TrEMBL;Acc:E9R9Y3]	
jgi-Aspnov1-429762-
fgenesh1_pg.3_#_503	 90.33	
AFUA_6G09710	
Gliotoxin	
cluster	
MFS	gliotoxin	efflux	transporter	GliA	
[Source:UniProtKB/TrEMBL;Acc:E9R876]	 jgi-Aspnov1-367489-e_gw1.3.2721.1	 94.1	
AFUA_6G09720	
Gliotoxin	
cluster	
Methyltransferase	GliN	
[Source:UniProtKB/TrEMBL;Acc:Q4WMJ1]	
jgi-Aspnov1-502743-
estExt_fgenesh1_pg.C_3_t20001	 84.04	
AFUA_6G09730	
Gliotoxin	
cluster	
Cytochrome	P450	oxidoreductase	GliF	
[Source:UniProtKB/TrEMBL;Acc:Q4WMJ0]	
jgi-Aspnov1-458927-
fgenesh1_pm.3_#_485	 95.44	
AFUA_6G09740	
Gliotoxin	
cluster	
Thioredoxin	reductase	GliT	
[Source:UniProtKB/TrEMBL;Acc:E9RAH5]	
jgi-Aspnov1-511158-
estExt_fgenesh1_pm.C_3_t10480	 91.92	
AFUA_6G09745	
Gliotoxin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WMI8]	
jgi-Aspnov1-386790-
estExt_Genewise1Plus.C_3_t30100	 89.84	
AFUA_6G10240	 fos-1	(tcsA)	
Sensor	histidine	kinase/response	regulator	Fos-1/TcsA	
[Source:UniProtKB/TrEMBL;Acc:Q4WMD9]	
jgi-Aspnov1-429720-
fgenesh1_pg.3_#_461	 93.36	
AFUA_6G11390	 gel2	
1,3-beta-glucanosyltransferase	gel2	
[Source:UniProtKB/Swiss-Prot;Acc:P0C954]	
jgi-Aspnov1-398517-
estExt_Genewise1.C_1_t10227	 48.38	
AFUA_7G04800	 gprC	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WGE9]	
jgi-Aspnov1-462935-
fgenesh1_pm.7_#_220	 94.32	
AFUA_8G00170	
Fumitremor
gin	cluster	
Nonribosomal	peptide	synthetase	13	
[Source:UniProtKB/Swiss-Prot;Acc:Q4WAW3]	
jgi-Aspnov1-507323-
estExt_fgenesh1_pg.C_90140	 34.91	
AFUA_8G00190	
Fumitremor
gin	cluster	
Cytochrome	P450,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAW5]	
jgi-Aspnov1-510751-
estExt_fgenesh1_pm.C_3_t10008	 64.49	
AFUA_8G00200	
Fumitremor
gin	cluster	
O-methyltransferase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAW6]	
jgi-Aspnov1-449391-
estExt_Genemark1.C_3_t10007	 71.39	
AFUA_8G00210	
Fumitremor
gin	cluster	
Dimethylallyl	tryptophan	synthase	FtmPT1	
[Source:UniProtKB/TrEMBL;Acc:Q4WAW7]	
jgi-Aspnov1-396938-
estExt_Genewise1Plus.C_10_t10291	 35.94	
AFUA_8G00220	
Fumitremor
gin	cluster	
Cytochrome	P450,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAW8]	 jgi-Aspnov1-479619-MIX14281_2_12	 44.02	
AFUA_8G00230	
Fumitremor
gin	cluster	
Phytanoyl-CoA	dioxygenase	family	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAW9]	
jgi-Aspnov1-404130-
estExt_Genewise1.C_3_t30177	 33.3	
AFUA_8G00240	
Fumitremor
gin	cluster	
Cytochrome	P450	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAX0]	 jgi-Aspnov1-419348-gm1.3695_g	 42.5	
AFUA_8G00250	
Fumitremor
gin	cluster	
Dimethylallyl	tryptophan	synthase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAX1]	
jgi-Aspnov1-463437-
fgenesh1_pm.8_#_19	 57.76	
AFUA_8G00260	
Fumitremor
gin	cluster	
F-box	domain	and	ankyrin	repeat	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAX2]	
jgi-Aspnov1-516072-
estExt_fgenesh1_pm.C_100234	 27.92	
AFUA_8G00370	
Fumagillin	
cluster	
Polyketide	synthase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY3]	 jgi-Aspnov1-424178-gm1.8525_g	 84.34	
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AFUA_8G00380	
Fumagillin	
cluster	
DltD	N-terminal	domain	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY4]	
jgi-Aspnov1-412667-
estExt_Genewise1.C_8_t10092	 96.92	
AFUA_8G00390	
Fumagillin	
cluster	
O-methyltransferase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY5]	
jgi-Aspnov1-463456-
fgenesh1_pm.8_#_38	 96.77	
AFUA_8G00400	
Fumagillin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY6]	
jgi-Aspnov1-463456-
fgenesh1_pm.8_#_38	 85.06	
AFUA_8G00410	
Fumagillin	
cluster	
Methionine	aminopeptidase	2-1	
[Source:UniProtKB/Swiss-Prot;Acc:Q4WAY7]	
jgi-Aspnov1-463457-
fgenesh1_pm.8_#_39	 91.48	
AFUA_8G00420	
Fumagillin	
cluster	
C6	finger	transcription	factor,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY8]	
jgi-Aspnov1-434405-
fgenesh1_pg.8_#_51	 86.95	
AFUA_8G00430	
Fumagillin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAY9]	
jgi-Aspnov1-412676-
estExt_Genewise1.C_8_t10101	 95.54	
AFUA_8G00440	
Fumagillin	
cluster	
Steroid	monooxygenase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ0]	
jgi-Aspnov1-434407-
fgenesh1_pg.8_#_53	 87.4	
AFUA_8G00460	
Fumagillin	
cluster	
Methionine	aminopeptidase	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ1]	
jgi-Aspnov1-463462-
fgenesh1_pm.8_#_44	 96.22	
AFUA_8G00470	
Fumagillin	
cluster	
Putative	uncharacterized	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ2]	
jgi-Aspnov1-395381-
estExt_Genewise1Plus.C_8_t10105	 85.82	
AFUA_8G00480	
Fumagillin	
cluster	
Phytanoyl-CoA	dioxygenase	family	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ3]	
jgi-Aspnov1-445026-
fgenesh1_kg.8_#_46_#_Locus3448v1r
pkm31.50	 94.01	
AFUA_8G00490	
Fumagillin	
cluster	
PKS-like	enzyme,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ4]	
jgi-Aspnov1-445027-
fgenesh1_kg.8_#_47_#_Locus11024v1
rpkm1.79	 72.1	
AFUA_8G00500	
Fumagillin	
cluster	
Acetate-CoA	ligase,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ5]	
jgi-Aspnov1-412687-
estExt_Genewise1.C_8_t10112	 92.09	
AFUA_8G00510	
Fumagillin	
cluster	
Cytochrome	P450	oxidoreductase	OrdA-like,	putative	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ6]	
jgi-Aspnov1-412689-
estExt_Genewise1.C_8_t10114	 94.03	
AFUA_8G00520	
Fumagillin	
cluster	
Integral	membrane	protein	
[Source:UniProtKB/TrEMBL;Acc:Q4WAZ7]	 jgi-Aspnov1-377876-e_gw1.8.1481.1	 91.23	
AFUA_8G02750	 cgrA	
rRNA-processing	protein	cgrA	[Source:UniProtKB/Swiss-
Prot;Acc:Q9HEQ8]	
jgi-Aspnov1-454324-
estExt_Genemark1.C_8_t10302		 95	
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Table	S4	Table	of	the	terrequinone	proteins	from	A.	nidulans	and	the	BLASTP	hits	found	in	A.	steynii.	
A. Nidulans 
terrequinone proteins 
Hit protein ID in  
A. steynii 
% Identity % Coverage 
TdiA - ABU51602.1 365047 71.7 101 
tdiB - ABU51603.1 415228 56.2 92 
tdiC - ABU51604.1 429405 52.7 88.6 
tdiD - ABU51605.1 479193 69.5 96.1 
tdiE - ABU51606.1 365428 56.1 97.7 
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Table	S5	
Part	1	Overview	of	chlorinating	enzymes	identified	from	literature.	The	sequence	of	each	of	these	proteins	were	used	to	search	
for	similar	proteins	in	A.	campestris,	A.	candidus	and	A.	taichungensis	using	BLASTP	comparison,	but	no	hits	were	found.		
Protein Description Reference GenBank 
A. 
campestris 
A. 
candidus 
A. 
taichungensis 
CmaB a chlorinating non-
haem iron enzyme from 
Pseudomonas syringae 
[1] AAC46036.1	
 
No hits No hits No hits 
PrnA a flavin dependent 
tryptophan halogenase 
from Pseudomonas 
fluorescens 
[2] 
 
AAB97504.1	
 
No hits No hits No hits 
PtaM a flavin dependent 
halogenase from 
Pestalotiopsis fici 
[3] AGO59046.1	
 
No hits No hits No hits 
Thr3 an iron non heme alpha 
ketoglutarate dependent 
halogenase from 
Streptomyces sp. OH-
5093 
[4] CCF23457.1 
 
No hits No hits No hits 
 
 
Part	2	Relevant	InterPro	domains	identified	by	comparing	the	proteins	listed	in	Suppl.	Table	6	to	the	InterPro	database	using	
InterProScan	5	[5]	and	an	additional	word	search	of	the	database	[6].	The	identified	InterPro	domains	were	searched	for	in	the	
annotated	A.	campestris,	A.	candidus	and	A.	taichungensis	genomes	including	the	number	of	hits.		
IPR ID Description 
Hits 
A. campestris 
Hits 
A. candidus 
Hits 
A. taichungensis 
IPR000028 Chloroperoxidase Heme dependent 4 4 4 
IPR001568 Ribonuclease T2 3 2 2 
IPR008775 Phytanoyl-CoA dioxygenase 5 5 4 
IPR010092 chlorinating enzyme FE(II)nonheme halogenase 0 0 0 
IPR006905 tryptophan halogenase 0 0 0 
IPR002747 SAM depdent chlorinase/fluorinase 0 0 0 
IPR016119 bromoperoxidase/chloroperoxidase C-terminal 0 0 0 
 
 
Part 3 Overview of the potential chlorinating proteins in the chlorflavonin candidate cluster in A. campestris including the best 
BLASTP hit in NCBI nr database and the identified InterPro IDs found using InterPro Scan 5 [5] on the protein sequences. 
Protein ID BLAST hit InterPro Scan hit 
286063 Hypothetical protein [Solirubrobacterales bacterium 
URHD0059] 93% coverage and 36% identity 
IPR029039 – flavoprotein-like 
IPR005025 – NADPH-dependent 
FMN reductase-like 
277538 Related to scytalone dehydratase [Fusarium fujikuroi 
IMI 58289], 100% coverage and 53% identity 
IPR004235 – Scytalone dehydratase 
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331187 Peptidase S15/CocE/NonD, C-terminal [Penicillium 
expansum] 97% coverage and 41% Identity 
IPR011008 Dimeric alpha-beta 
barrel 
3988 Hypothetical protein HIM_08269 [Hirsutella 
minnesotensis 3608] 
98% coverage and 53% Identity 
3-hydroxybenzoate 6-hydroxylase 1 [Tolypocladium 
ophioglossoides CBS 100239]  
98% coverage and 53% Identity 
IPR006076 –FAD dependent 
oxidoreductase 
IPR003042 – Aromatic-ring 
hydroxylase 
IPR023753 – FAD/NAD(P) binding 
domain 
IPR002938 – FAD-binding domain 
 
 
1. Vaillancourt FH, Yeh E, Vosburg D a, O’Connor SE, Walsh CT. Cryptic chlorination by a non-
haem iron enzyme during cyclopropyl amino acid biosyn. Nature. 2005;436:1191–4. 
http://www.nature.com/nature/journal/v436/n7054/pdf/nature03797.pdf. Accessed 3 Nov 2015. 
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http://jb.asm.org.proxy.findit.dtu.dk/content/180/7/1939. Accessed 3 Nov 2015. 
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protein function classification. Bioinformatics. 2014;30:1236–40. 
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B Supplementary material section 3.2 –
Manuscript II
Following is the supplementary material for the article presented in Chapter 3
section 3.2 ’Friends and foes – A comparative genomics study of 23 Aspergillus
species from section Flavi’.
Table B.1 Growth section Flavi quantitatively. Growth analysis of 23 Flavi
species plus 8 additional species on 35 different growth media, quantitated by
growth from 0-10, normalized based on growth on 1% glucose
Supplementary Table B.1 can be found using the following link:
https://files.dtu.dk/u/qpZ1Lj8WdSS4lnUs/TableB1 GrowthQuatitatively.xlsx?l
Table B.2 CAZy content in section Flavi. Overview of the CAZy content and
plant degradation related CAZy content per species and per CAZy families.
Supplementary Table B.2 can be found using the following link:
https://files.dtu.dk/u/4b84FHQ OB zvzgW/TableB2 CAZy analysis.xlsx?l
Table B.3 Secondary metabolite gene clusters section Flavi. Long format table
with all the predicted clusters in the species and the cluster family they belong to.
Column 1 - Species, column 2 - JGI protein id of the predicted backbone, column
3 - cluster family number.
Supplementary Table B.3 can be found using the following link:
https://files.dtu.dk/u/mS3dxwyt3c-LLd3F/TableB3 SecMetFamilies.csv?l
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Table B.4 Chemical analysis of known compounds produced by Flavi species
after growth on CYA for 7 days at 30◦C.
Supplementary Table B.4 can be found using the following link:
https://files.dtu.dk/u/5YhxWHAIcVH3iHFa/TableB4 ChemicalDataFlavi.xlsx?l
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A. pseudocaelatus - Flavi
A. leporis - Flavi
A. parvisclerotigenus - Flavi
A. alliaceus - Flavi
A. coremiiformis - Flavi
A. caelatus - Flavi
A. steynii - Circumdati
A. albertensis - Flavi
A. arachidicola - Flavi
A. campestris - Candidi
A. fumigatus - Fumigati
A. flavus - Flavi
A. terreus - Terrei
A. oryzae - Flavi
A. nomius - Flavi
A. bombycis - Flavi
A. minisclerotigenes - Flavi
A. novoparasiticus - Flavi
A. sergii - Flavi
A. parasiticus - Flavi
A. pseudotamarii - Flavi
A. niger ATCC 1015 - Nigri
P. digitatum - Penicillium
A. tamarii - Flavi
A. avenaceus - Flavi
N. crassa - Neurospora
A. nidulans - Nidulantes
A. transmontanensis - Flavi
A. bertholletius - Flavi
A. sojae - Flavi
A. pseudonomius - Flavi
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Phylogeny based on 300 genes
Figure B.1 Phylogenetic tree based on 300 monocore genes. Phylogenetic tree
constructed using RAxML [119], MUSCLE [120], and Gblock [121] based on 300
monocore genes.
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Phylogeny based on 500 genes
Figure B.2 Phylogenetic tree based on 500 monocore genes. Phylogenetic tree
constructed using RAxML [119], MUSCLE [120], and Gblock [121] based on 200
monocore genes.
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Supplementary Figures B.3 can be found using the following link:
https://files.dtu.dk/u/xixzBFOscwjULHMG/FigureB3?l
Figure B.3 Phylogenetic trees constructed using RAxML [119] and MUS-
CLE [120] of 18 single gene tress from monocore families.
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Figure B.4 Most common InterPro domains in species unique proteins. Bar
plot showing the number of species unique proteins with an InterPro domain per
species, shown for the most common InterPro annotations [102]. Light grey star
indicates p-values below 0.005 and dark grey star indicates p-value below 0.00001
of enrichment in the species unique genes for the specific functional domain.
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Figure B.5 Most common GO domains in species unique proteins. Bar plot
showing the number of species unique proteins with a GO domain per species,
shown for the most common GO annotations [99]. Dark grey star indicates p-
value below 0.00001 of enrichment in the species unique genes for the specific
functional domain.
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p-value < 0.005
p-value < 0.00001
p-value < 0.05
Figure B.6 Most common KOG domains in species unique proteins. Bar plot
showing the number of species unique proteins with an KOG domain per species,
shown for the most common KOG annotations [100]. P-values indicates enrich-
ment of a certain KOG term in the species unique genes for the specific functional
domain. The p-values are indicated by stars of light to dark grey the lightest star
indicates p-values below 0.05, followed by p-values below 0.005 and the darkest
stars indicates p-value below 0.00001.
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Figure B.7 Growth section Flavi. Growth analysis of 23 Flavi species plus 8
additional species on 35 different growth media.
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Figure B.8 Phylogenetic tree of GH28. Phylogenetic tree of all proteins assigned
to the GH28 CAZy catagory. The GH28 family consits of polygalacturonase.
Alignment of the members of GH28 CAZy family found in all section Flavi species
was created using clustalo. The ML phylogenetic tree was created using the ape
package in R.
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Figure B.9 Heatmap cluster families. Cluster families with members in at least
5 species are illustrated by a heatmap. The top rows indicate the backbone en-
zymes found within the cluster family. Compounds with similar clusters are added
from the dereplication using MIBiG (marked by orange boxes and black text) in
addition to manually curated compounds (marked by black boxes and blue text).
Aspergillic acid [122], aflatrem [123], chrysogine [124], tenuazonic acid [125], dit-
ryptophenaline [126].
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A. novoparasiticus
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A. sergii
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Figure B.10 Miyakamide and putative clusters. A) Miyakamide B1 showing the
three amino acid parts (organge line), the acetylation (purple circle), the decar-
boxylation (green circle) and the N-methylation (blue circle). B) Syntenic plot of
the putative miyakamide cluster family plus surrounding genes. The syntney plot
was generated using EasyFig [127] with the minimum length 50 bp and the min-
imum identity to 50%. The genes potentially involved in miyakamide production
are marked by orange.
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Figure B.11 Synteny of aflatoxin cluster family. Syntenic plot of the predicted
clusters belonging to the ’sterigmatocystin - aflatoxin - cyclopiazonic-acid’ cluster
family. The syntney plot was generated using EasyFig [127] with the minimum
length 50 bp and the minimum identity to 50%. The genes are color coded based on
known pathways; aflatoxin (orange), cyclopiazonic-acid (turquoise) and unknown
(blue).
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Figure B.12 Investigation of aflP and aflQ. The aflP gene is important for the
last steps in the biosynthesis of aflatoxin, but it is missing in most of the predicted
aflatoxin clusters. Here is an alignment of the aflP protein against the best hits
in the other Flavi species.
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Figure B.13 Gene prediction of aflP. An overview of the gene prediction in the
aflP gene in A. paraciticus and the RNA coverage from JGI at Mycocosm.
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Additional files for the manuscript: ’Resistance Gene Directed Genome Mining of
50 Aspergillus species’ presented in section
1021530200400IPR000873IPR001031IPR001077IPR001128IPR001138IPR001242IPR002198IPR002347IPR002401IPR002403IPR002938IPR003042IPR003439IPR003593IPR003663IPR005828IPR005829IPR006094IPR006162IPR006163IPR007114IPR007219IPR009081IPR010071IPR010080IPR011032IPR011701IPR013120IPR013149IPR013154IPR013217IPR013968IPR014030IPR014031IPR014043IPR015424IPR016035IPR016036IPR016039IPR016040IPR016166IPR016196IPR016461IPR017795IPR017972IPR018201IPR020801IPR020806IPR020807IPR020841IPR020843IPR020845IPR020846IPR020904IPR025110IPR027417IPR029058IPR029063InterPro IDSize of hfamSize of hfam by IPR
Figure C.1 Common InterPro domains in secondary metabolism. Visualization
of the most common InterPro annotations of secondary metabolite genes (found in
more than 1000 secondary metabolite proteins) and the size of the protein families.
Two horizontal lines indicate the recommended protein family size cut-offs where
XInput is 2 (102) and 3 (153).
Table C.1 Species used in this study, showing species name, section, and link to
the JGI pages with the genomes.
Supplementary Table C.1 can be found using the following link:
https://files.dtu.dk/u/86 pamYv6WThr-lo/TableC1 SpeciesOverview.xlsx?l
Table C.2 Overview of the 72 identified putative resistance genes families and
the parameters where they were identified.
Supplementary Table C.2 can be found using the following link:
https://files.dtu.dk/u/46k5NnYpOTvxqTk0/TableC2 SelectedHfam.csv?l
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PCA- protein family 597268
Figure C.2 Principal component analysis of the protein family 597268 containing
two potential resistance genes (protein id 11595 and 32200) found in A. oryzae and
A. flavus. The panels to the left are colored based on the sections the proteins
belong to while the panels to the right are colored based on if the protein if found in
a a selected cluster (StrictClust- green), not in a cluster (0-blue), and the homolg
to the ones found in selected clusters (outsideSC-yellow).
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A.luchuensis CBS 106.47 Nigri 140854 c1 0
A.aculeatinus Nigri 311356 c1 0
A.brasiliensis Nigri 123050 c1 0
A.brunneoviolaceus Nigri 375852 c1 0
A.campestris Candidi 112377 c2 0
A.campestris Candidi 238739 c2 0
A.carbonarius Nigri 207389 c1 0
A.clavatus Clavati 3879 c1 0
A.ellipticus Nigri 357291 c1 0
A.flavus Flavi 27673 c2 outsideSC
A.flavus Flavi 32200 c2 StrictClust
A.fumigatus A1163 Fumigati 101173 c1 0
A.glaucus Aspergillus 1110446 c1 0
A.heteromorphus Nigri 358586 c1 0
A.homomorphus Nigri 415175 c1 0
A.niger (lacticoffeatus) Nigri 345282 c1 0
A.nidulans Nidulantes 701 c1 0
A.niger ATCC 1015 Nigri 1151530 c1 0
A.niger CBS 513.88 Nigri 161030 c1 0
A.novofumigatus Fumigati 499968 c2 0
A.novofumigatus Fumigati 513964 c2 0
A.ochraceoroseus Ochraceorosei 426476 c1 0
A.oryzae Flavi 8276 c2 outsideSC
A.oryzae Flavi 11595 c2 StrictClust
A.niger (phoenicis) Nigri 210485 c1 0
A.piperis Nigri 448296 c2 0
A.saccharolyticus Nigri 362812 c1 0
A.sclerotiicarbonarius Nigri 326314 c1 0
A.sclerotioniger Nigri 524617 c1 0
A.steynii Circumdati 478553 c1 0
A.sydowii Nidulantes 162985 c1 0
A.terreus Terrei 3672 c1 0
A.uvarum Nigri 403235 c1 0
A.versicolor Nidulantes 133601 c1 0
A.wentii Cremei 40694 c2 0
A.wentii Cremei 184594 c2 0
A.ibericus Nigri 407546 c1 0
N.fischeri Fumigati 1508 c1 0
E.ruber Aspergillus 449832 c1 0
P.brevicompactum AgRF18 Penicillium 366032 c2 0
P.brevicompactum AgRF18 Penicillium 390766 c2 0
A.taichungensis Candidi 92369 c2 0
A.taichungensis Candidi 163923 c2 0
A.welwitschiae Nigri 2602 c1 0
A.candidus CBS 102.13 Candidi 78578 c2 0
A.candidus CBS 102.13 Candidi 115538 c2 0
A.eucalypticola Nigri 306460 c1 0
A.fumigatus Fumigati 1984 c1 0
A.neoniger Nigri 310528 c1 0
A.piperis Nigri 199578 c2 0
A.tubingensis Nigri 125801 c1 0
A.vadensis Nigri 346605 c1 0
A.violaceofuscus Nigri 438171 c1 0
A.luchuensis IFO 4308 Nigri 15031 c1 0
A.fijiensis Nigri 456037 c1 0
A.japonicus Nigri 404113 c1 0
A.costaricaensis Nigri 214482 c1 0
A.elegans Circumdati 392400 c1 0
A.indologenus Nigri 446717 c1 0
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Figure C.3 Phylogenetic tree of protein family 597268 containing two potential
resistance genes (protein id 11595 and 32200) found in A. oryzae and A. flavus.
The node labels shows bootstraps values based on 500. The tip labels have the
species name, the section, protein id, number of homologs in the species and an
indication if it is found in a selected cluster (StrictClust), a predicted cluster
(Clust), not in a cluster (0) and the homolg to the ones found in selected clusters
(outsideSC)
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Table D.1 Overview of used and created strains.
Table D.2 Overview of primers used in this study. U=2-deoxyuridine. The primer
sequence is shown 5’-3’)
Supplementary Table D.2 can be found using the following link:
https://files.dtu.dk/u/1vzZDUN82QLE NkP/Atable D2 primers.xlsx?l
170
Table D.3 Overview of used and created plasmids.
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Figure D.1 Compound withm/z for [M+H]+ 189.0869 and N-acetyl-glutamine
standard. A) Top row: base peak chromatogram of the crude extract A. aculat-
inus ∆pyrG :11594-11596 mutant 1 on MM in positive ionization mode. Middle
row: extracted ion chromatogram of m/z 189.0869 of A. aculatinus ∆pyrG :11594-
11596 mutant 1 on MM in positive ionization mode. Bottom row: base peak
chromatogram of the N-acetyl-glutamine standrad in positive ionization mode.
Identity was confirmed by correct retention time. B) Tandem mass spectrometry
(MS/HRMAS) spectra at 12, 20 and 40 eV of peak identified as N-acetyl-glutamine
(m/z 189.0869) of A. aculeatinus ∆pyrG :11594-11596 (left) compared to the N-
acetyl-glutamine standard (right).
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Figure D.2 A) Possible fragmentation of N-acetyl-valine methylamide corre-
sponding to observed fragmentation ions in the MS/HRMS spectra at 10 eV B)
MS/HRMS spectrum at 10 eV of compound from A. aculatinus ∆pyrG :11594-
11596 with m/z 173.1285
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Figure D.3 Base peak chromatograms in positive ionization mode of the crude
extracts of wild type A. aculatinus (row1-3), and four different mutants with the
NRPS-like (protein ID 11594) and N-acetyltransferase (protein ID 11596) ran-
domly inserted. Display the identification of the peak with m/z for [M+H]+
173.1285 only present in the four mutants.
